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Introduction and objective and outline of the thesis
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Discovery of Staphylococcus aureus
“My delight may be conceived when there were revealed to me beautiful tangles, tufts and chains 
of round organisms in great numbers, which stood out clear and distinct among the pus cells and 
debris...” is a quote by Alexander Ogston (1844-1929), a Scottish surgeon who discovered the bacteria 
Staphylococci in 1880 in the abscess of one of his patients [1]. Ogston, an early adapter of the antisepsis 
theory advocated by Joseph Lister (1827-1912), was convinced that the source of suppuration was 
not air or ‘miasma’, as postulated by Lister and others, but was caused by some special germ [2]. 
Ogston hypothesized that the micrococci, found in the abscesses of his patients, were the cause of 
infection. By injecting the pus from abscesses of his patients into mice and guinea pigs, he showed that 
new abscesses were formed, followed by signs of sepsis [3]. Examination of the blood of those septic 
animals once again revealed micrococci. However, pus and abscess formation was absent when Ogston 
threated the pus sample with heat or carbolic acid before injecting it [3].
Ogston was not the first to describe micrococci and Theodor Billroth (1829-1894) already designated 
those in chains as Streptococci in 1874 [4]. In 1882, Ogston named the micrococci that clustered, 
Staphylococci, from the Greek staphyle, meaning bunch of grapes [5].
Two years later in 1884, a German surgeon, Anton Rosenbach (1842-1924) was able to isolate two 
strains of staphylococci from solid medium and named them after the pigmented appearance of their 
colonies; Staphylococcus aureus, originating from aurum, the Latin word for gold and Staphylococcus 
albus (nowadays epidermidis), from albus, the Latin word for white [6].
            
Treatment of Staphylococcal infections 
In the pre-antibiotic era staphylococcal infections were often life-threatening [7]. The treatment of 
such infections mainly relied on the use of antiseptics such as carbolic acid [8]. During World War I, 
studies on antiseptics intensified because of the countless number of septic war wounds and treatment 
with hypochlorite became a common therapy [9]. After the Great War, it became clear that the use 
of antiseptics not only affected the growth of bacteria, but also harmed tissue cells and leukocytes 
resulting in a negative overall impact on healing [10]. In 1928, a British microbiologist named Alexander 
Fleming (1881-1955) noticed that staphylococcal growth was inhibited around a mold that had 
contaminated his plates. This historic observation eventually led to the discovery of penicillin [11]. The 
first clinical trial with this new drug was reported in 1941, where 10 cases showed a favorable outcome 
after treatment with penicillin [12]. Thereafter, penicillin was widely used in World War II (Figure 1) and 
its success led to the assumption that all staphylococcal infections could now be successfully treated.
Development of antibiotic resistance of S. aureus 
In 1944, shortly after the widespread introduction of penicillin, an increasing proportion of S. 
aureus cultured in hospitals developed resistance against the drug by producing an enzyme named 
penicillinase [13, 14]. In the 1950s, many of the hospital-acquired S. aureus infections were caused by 
these penicillin-resistant strains [15-17], but newly available antimicrobial agents, such as tetracycline 
and erythromycin, made staphylococcal infections still treatable. However, an assessment of the 
epidemiology of drug resistant S. aureus strains between 1957 and 1966 showed that replacement of 
penicillin and streptomycin by newer antibiotics resulted in mutually related S. aureus types, in which 
resistance to several antibiotics was acquired [18].
 A revival in the battle against resistant S. aureus was seen in the 1960s when a new semi-synthetic 
penicillin was introduced [19, 20]. This new penicillin was designated celbenin, nowadays methicillin, 
and proved effective against penicillin-resistant staphylococci [21]. Besides methicillin, other 
semisynthetic penicillins, such as oxacillin and flucloxacillin, appeared on the market, which led to 
a major reduction of the morbidity and mortality caused by staphylococcal infections. However, this 
reduction was only temporary as new celbenin (methicillin) resistant S. aureus strains quickly emerged 
[22]. This resistance was caused by penicillin-binding-protein 2a, encoded by the mecA gene that is 
carried on a chromosomal genetic element designated staphylococcal chromosome cassette mec 









Figure 1: Penicillin use in World War II. In 1944, laboratories across the country were stepping up their production 
of penicillin, including Schenley in Indiana, whose advertisement stated, "When the thunderous battles of this 
war have subsided to pages of silent print in a history book, the greatest news event of World War II may well be 
the discovery and development of penicillin." Credit: Research and Development Division, Schenley Laboratories, 
Inc., Lawrenceburg, Indiana
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Methicillin resistant S. aureus (MRSA) 1961-1990, a hospital-acquired pathogen 
After its first emergence in 1961, the number of staphylococcal infections caused by MRSA was limited 
although small outbreaks in Great Britain in the early 1960s have been described [24, 25]. After that, 
a period without major MRSA epidemics was observed until a new series of hospital outbreaks with 
MRSA occurred in the late 1960s [26]. This time, the MRSA outbreaks were not restricted to Great 
Britain, but also occurred in the United States and Australia [27, 28]. These early MRSA outbreaks 
could be controlled by new antimicrobial agents, mainly aminoglycosides such as gentamicin, but in 
1976 a MRSA strain that acquired gentamicin resistance caused a hospital outbreak [29]. Subsequently, 
this MRSA variant and others spread globally, replacing methicillin-sensitive S. aureus (MSSA) isolates 
in many hospitals [30, 31]. In the 1980s, the magnitude of the MRSA problem became apparent 
when it was clear that MRSA was as virulent as MSSA and the prevalence of MRSA in many hospitals 
had rapidly risen [30, 32, 33]. The high prevalence of MRSA eventually led to the development of 
surveillance systems, infection control policies and restricted use of antibiotics. Among the first 
countries to implement these measurements was Denmark, rapidly leading to a decline of MRSA in 
Danish hospitals [34, 35]. In the Netherlands, following some MRSA outbreaks in the mid-1980s [36], 
a National surveillance of MRSA was introduced in 1989 [37]. Hospitals could send their MRSA isolates 
to the national institute for public health and the environment (RIVM) for further characterization to 
study the routes and rates of transmission of this pathogen. Initially, MRSA isolates were characterized 
using bacteriophage typing, but this was replaced by pulsed-field gel electrophoresis (PFGE) in 2002 
[38, 39]. 
MRSA 1990-2003, emergence in the community
A Dutch MRSA surveillance study between 1989 and 1992 showed a MRSA prevalence of 0.54%, and 
nearly 70% of those MRSA isolates could be related to importation from foreign hospitals [37]. In 
those foreign hospitals, only limited differentiation was found among the circulation MRSA clones [40]. 
However, in the early 1980s reports appeared that described MRSA carriers without known risk factors 
and who were not previously hospitalized. Many of those patients turned out to be intravenous drug 
users [41, 42]. In 1995, Moreno et al. published a report showing that many patients already were 
MRSA positive upon hospital admission and had no identifiable risk factors [43].After that, other studies 
revealed the presence of this new variant of MRSA, now designated as community-acquired MRSA (CA-
MRSA), in hospitals [44]. In the following years, it became clear that outbreaks and transmissions of CA-
MRSA were not restricted to hospitals in the US, but also occurred in other countries and communities, 
such as prisons and football teams revealing additional reservoirs for this pathogen  [45, 46].      
Differences between hospital- and community-acquired MRSA; fading boundaries
With the appearance of the first reports on CA-MRSA, it became clear that CA-MRSA differed not 
only in epidemiology, but also in molecular characteristics. First, the SCCmec, a chromosomal mobile 
genetic element carrying the mecA gene, differs from HA-MRSA in both size and composition. The 
differences in SCCmec have been used for characterization [47]. HA-MRSA isolates typically carry 
SCCmec types I, II or III, whereas CA-MRSA isolates usually yield SCCmec types IV or V  [48]. Second, 
CA-MRSA strains often carry a virulence factor designated Panton-Valentine leucocidin (PVL) that is 
capable of destroying leucocytes and other human immune response cells such as macrophages  [48, 
49]. However, shortly after the emergence of MRSA in the community, reports appeared describing the 
presence and transmission of CA-MRSA in healthcare settings [50]. David et al. showed that HA-MRSA 
infections were decreasing in an academic hospital, but this decrease was neutralized by an increase 
in the proportion of CA-MRSA infections [51]. In fact, USA300, one the main clades of CA-MRSA, was 
the most frequently found MRSA variant causing bacteremia in U.S. hospitals between 2009 and 2010 
[52]. In addition, molecular characteristics, previously attributed to be specific for CA-MRSA, were also 
identified in MRSA strains with a clear hospital association, suggesting that the previously deposited 









MRSA 2003-present, introduction of MRSA from the animal reservoir
MRSA in animals was first described in 1972 when MRSA was detected in the milk of mastitic cows [54]. 
After that, MRSA has been detected in many different animal species, but generally, a distinction is 
made between food production and companion animals, since MRSA acquisition in companion animals 
is considered to be as result of human-to-animal transmission [55, 56]. 
The first report of MRSA in pigs appeared in France in 2005, where indistinguishable MRSA isolates 
were found in pigs and pig farmers [57]. Within the same year, MRSA was found in pig farms in the 
Netherlands [58]. Surprisingly, the molecular characteristics of the Dutch MRSA isolates, based on 
multi-locus sequence typing (MLST), were identical to the French isolates and all belonged to clonal 
complex (CC) 398 [59]. Another study among Dutch slaughterhouses found a MRSA prevalence among 
pigs of 39% and all isolates belonged to MRSA CC398 [60]. After the initial publications, MRSA CC398 
was also identified in other European countries [61, 62], North America [63, 64] and Asia [65], revealing 
a worldwide dissemination.  Besides pigs, MRSA CC398 was also found in other livestock animals such 
as poultry, veal calves and horses leading to the designation livestock-associated MRSA (LA-MRSA) [66-
68]. 
LA-MRSA in the Netherlands, rapid increase in the number of submitted isolates for surveillance
Although LA-MRSA was originally reported from France, most of the subsequent LA-MRSA studies were 
performed in the Netherlands. One of the main findings was that contact of humans with livestock is 
an important risk factor for human LA-MRSA carriage [69]. Therefore, contact with livestock was added 
as a MRSA risk factor to the guidelines for the Dutch MRSA ‘search & destroy’ policy in 2006 and 2007. 
As a result, the number of submitted LA-MRSA isolates from humans to the Dutch MRSA surveillance 
rapidly increased. At its peak in 2009, 42% of the MRSA isolates send to the RIVM were classified as LA-
MRSA. After that, a slow but steady decrease in the number of submitted LA-MRSA was observed and 
in 2014, the proportion of LA-MRSA was 30% (Figure 2).
Figure 2: Number of isolates submitted for typing to the Dutch MRSA surveillance from 2008 to 2014. The blue 
bars represent the number of non-LA-MRSA isolates and the light yellow bars denote the number of LA-MRSA 
isolates.
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Molecular characterization of LA-MRSA isolates
Molecular characterization of LA-MRSA turned out to be a challenge. PFGE using SmaI, the gold 
standard technique for typing S. aureus in the Dutch MRSA surveillance until 2007, did not work 
for LA-MRSA due to a methylation of the SmaI recognition site [70]. MLST of LA-MRSA, comprising 
the sequencing of seven housekeeping genes of S. aureus, resulted in very limited differentiation 
since most isolates either yielded ST398 (CC398) or ST9 (CC9) [71]. Due to the rapid increase in the 
number of PFGE non-type-able LA-MRSA isolates and the fact that both PFGE and MLST are laborious 
techniques, staphylococcal protein A (spa-typing) was introduced at the RIVM for the national MRSA 
surveillance in 2007. Spa-typing consists of sequence typing the X region of the spa-gene. The X region 
contains a varying number of 24-bp repeats and is highly polymorphic [72, 73]. Spa-types are assigned 
based on both the number and the composition of the repeats [74]. Virtually all LA-MRSA isolates 
could be typed with spa-typing and more LA-MRSA types could be identified than based on MLST [75]. 
However, LA-MRSA still represented a homogenous MRSA clade since most of the isolates belong to 
three predominant spa -types, t011, t108 or t034. In 2009, over 85% of the Dutch LA-MRSA isolates 
belonged to either t011 or t108 [76]. In 2008, a year after the introduction of spa-typing as the standard 
molecular typing technique in the Dutch MRSA surveillance, multiple-locus variable number of tandem 
repeat analysis (MLVA) was added as a second typing technique for the Dutch MRSA surveillance. MLVA 
of S. aureus involves the amplification of eight tandem repeat loci in two multiplex PCRs. The resulting 
fluorescently labeled PCR products are sized on an automated DNA sequencer and the number of 
repeats of each loci is used to create MLVA profiles. The main advantage of MLVA over spa-typing is 
that the MLVA profiles can be used for categorical clustering making it useful for epidemiological and 
evolutionary studies [77]. Yet, similar to spa-typing and MLST, the discriminatory power of MLVA for LA-
MRSA turned out to be limited. Most LA-MRSA isolates belonged to a single MLVA complex (MC) 398 
and the vast majority of isolates yielded either MT398 (mostly comprised of spa-type t011 isolates) or 
MT572 (mostly comprised of spa-type t108 isolates) [77]. This limited discrimination of LA-MRSA has 
hampered studies on the origin and transmission routes of this MRSA clade.
Human-to-human transmission of LA-MRSA
Although the reservoir for LA-MRSA seems extensive in both livestock and in people who work in animal 
husbandry, human-to-human transmission of LA-MRSA seems to occur infrequently and if transmission 
takes place it appears to be limited to familial communities [59, 78]. Four studies conducted in the 
Netherlands compared the transmissibility of LA-MRSA with other MRSA lineages in healthcare settings. 
In the first study, none of the 408 exposed patients and healthcare workers were colonized while in 
contact with LA-MRSA carriers without transmission-based precautions, while for non-LA-MRSA 23 
secondary events were identified [79]. In 2011, Bootsma et al. found that LA-MRSA was 5.9 times 
less transmissible compared to other MRSA variants and Wassenberg et al. reported that nosocomial 
transmission of LA-MRSA was 72% less likely to occur than that of non-LA-MRSA isolates [80, 81]. Finally, 
transmissibility of LA-MRSA was shown to be 4.4 times lower than other MRSA and only three of the 47 
secondary cases in this study were attributed to LA-MRSA [82]. Despite the low apparent transmissibility 
of LA-MRSA, nosocomial outbreaks have occurred. The first reported LA-MRSA outbreak took place in 
2007 and comprised five patients and five healthcare workers. All persons were colonized with LA-
MRSA, yielding the relatively rare spa-type t567, and none of the patients reported having contact 
with livestock [83]. A second outbreak took place in a Dutch residential care facility and consisted of six 
individuals. In this putative outbreak, two different spa-types (t011 and t2383) were identified, but PFGE 
using Cfr9I, a neoschizomer of SmaI, showed indistinguishable banding patterns for all isolates [84]. 
More recently, several reports have appeared that suggested to have identified an animal-independent 
S. aureus lineage capable of causing human-to-human transmission [85, 86]. This clade of livestock S. 
aureus is distinct from other LA-MRSA by lacking the resistance genes for tetracycline and the presence 
of the bacteriophage φ3 [86, 87]. The presence of tetracycline resistance determinants (tetM and tetK) 
was thought to be the reflection of the selective pressure exerted by tetracycline antibiotic use in 









play a major role human niche adaptation [89]. For LA-MRSA it is suggested that after the jump from 
humans to livestock they acquired the resistance genes for tetracycline and the lost some human-
niche specific genes, carried by φ3, while the animal-independent clade did not underwent these 
evolutionary alterations [87]. However, most studies that identified the animal-independent CC398 
lineage were dominated by isolates obtained from animals and the human-associated isolates were 
mostly comprised of methicillin sensitive S. aureus (MSSA). In contrast, two recent reports suggest 
the spread of LA-MRSA into the general population. First, Wulf et al. found that 7% of the LA-MRSA 
in newly identified carriers from 2002 to 2008 in their laboratory was due to unexpected cases [90]. 
A broader study, including all Dutch MRSA surveillance data from 2008 and 2009, found that nearly a 
quarter of the MRSA isolates did not have a link with known defined risk groups and these MRSAs were 
designated as MRSA of unknown origin (MUO). Of the MUOs, 26% belonged to LA-MRSA suggesting 
spread through the community independent of contact with livestock [91].
Persistent carriage of LA-MRSA in humans
Despite the high prevalence of LA-MRSA in the Netherlands, very little is known about the dynamics of 
LA-MRSA carriage in humans, especially in healthcare settings. Carriage studies performed in livestock 
settings revealed contradictory results. Van Cleef et al. suggested that LA-MRSA is not a good human 
colonizer, since 94% of the persons who acquired LA-MRSA during visits to livestock farms was tested 
negative after 24 hours [92]. Furthermore, LA-MRSA prevalence among veal calf farmers rapidly declined 
during absence of contact with animals. During holiday periods the prevalence was 11% compared to 
26% in exposed periods, a decrease of 58% [93]. On the other hand, nasal colonization of LA-MRSA was 
found in 45% of the investigated livestock veterinarians [78]. In addition, 59% of the pig farmers in a 
German study were still carrying LA-MRSA after the holidays, suggesting persistent LA-MRSA carriage 
[94]. Recently, two longitudinal studies about the dynamics of LA-MRSA carriage among pig farmers 
and livestock veterinarians found a high prevalence of persistent LA-MRSA carriage [95, 96]. During 
the one-year sample period among pig farmers, 38% of the persons carried LA-MRSA on each of the 
six sampling moments [95]. Within the livestock veterinarians, 23% was LA-MRSA positive on all five 
sampling moments in this two-year prospective cohort study and 56% of those veterinarians carried 
LA-MRSA isolates with identical MLVA-types during the study period [96]. However, based on the 
limited differentiation with the typing techniques used these studies, it is hard to adjudicate whether 
these persons could be considered as truly persistent LA-MRSA carriers.      
Infections in humans caused by LA-MRSA    
Similar to persistence and human-to-human transmission, infections caused by LA-MRSA seem to be 
scarce. In an European survey among 26 countries of invasive S. aureus infections cultured from blood, 
only 0.4% were CC398 and all isolates were MSSA [97]. A surveillance among 17 European countries 
found that the proportion of LA-MRSA cultured from blood was significantly lower compared to other 
MRSA variants, suggesting that LA-MRSA is less invasive [98]. Furthermore, several studies have shown 
that the presence of toxin genes in LA-MRSA is very limited [99, 100]. The virulence factor PVL seems 
also nearly absent in LA-MRSA. For instance, of the 793 LA-MRSA isolates, submitted to the Dutch 
MRSA surveillance in 2007, only a single LA-MRSA isolate harbored the PVL-genes [75]. In contrast, a 
recent review on human infections of S. aureus CC398 identified 74 publications were human infections 
of any type were described [101]. Most of these reports originated from Europe [98], but infections 
have also been found in other parts of the world such as USA [102] and Hong Kong [103]. The most 
common type of infections caused by LA-MRSA varies from mild or localized infections such as skin and 
soft tissue infections and wounds [79, 104]. However, serious invasive infections, such as endocarditis 
have also been described [105]. In addition, Kock et al. found that 8% of the isolates originating from 
blood cultures collected between 2008 and 2012 were classified as LA-MRSA [106].
Although LA-MRSA is considered as a MRSA variant that only sporadically causes infections, a number 
of deaths have been attributed to LA-MRSA. In Spain, a fatal infection with LA-MRSA occurred in a 
79-year-old patient. The patient lived on a pig farm and samples from the patient, pigs and a family 
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member were indistinguishable, based on spa-typing and PFGE, suggesting transmission from the 
pig or by the household member [107]. Recently, the Danish Statens Serum Institute reported four 
case histories of individuals that died from sepsis caused by LA-MRSA (SSI, Epi-News No. 24a -2014). 
Remarkably, none of these patients had any contact to pig farming.
Objective and outline of the thesis
The emergence of livestock-associated methicillin resistant Staphylococcus aureus (LA-MRSA) has had 
a major impact in the Netherlands. One of the main concerns of LA-MRSA is its clinical importance 
in regards to its ability to transmit, persist and cause disease in humans. The study presented in this 
thesis was aimed at studying these aspects utilizing isolates and data obtained during the Dutch 
national MRSA surveillance. This surveillance system can be used to study the routes of transmission, 
identify trends and shifts in the MRSA population in the Netherlands and supports infection control 
in healthcare settings. This requires molecular typing techniques with sufficient discriminatory power 
and for most MRSA variants the currently used techniques are very successful.  However, molecular 
characterization of LA-MRSA turned out to be a challenge, since the typing techniques utilized by the 
RIVM provided very limited discrimination for LA-MRSA. This limited differentiation has hampered 
studies on the origin and the transmission routes of LA-MRSA and adjudications on the potential of 
this pathogen to cause public health problems are difficult to make. The objective of the research this 
thesis was to develop and use molecular typing tools to assess the capability of LA-MRSA to transmit, 
persist and cause disease in humans and to study the possible temporal changes in the characteristics 
of the most predominant MRSA clade in the Netherlands.
 
For surveillance purposes, molecular tools with sufficient discriminatory power and a high throughput 
are needed. Starting in 2008, the Dutch MRSA surveillance is based on two typing techniques, 
Staphylococcal protein A (spa)-typing and multiple locus variable number of tandem repeat analysis 
(MLVA), for typing. In chapter 2 we assessed whether both spa-typing and MLVA are required for the 
MRSA surveillance. For this, we compared and evaluated the typing results of spa-typing and MLVA of 
all LA-MRSA and non-LA-MRSA isolates we received for our national MRSA surveillance during 2008–
2013.
Pulsed-field gel electrophoreses (PFGE) of S. aureus, the gold-standard typing technique at the time of 
emergence of LA-MRSA, provides a banding pattern, which can be used for comparison with the profiles 
of other S. aureus isolates. PFGE is highly discriminative and is widely used in many laboratories making 
it a good tool to study possible transmission and outbreaks of MRSA isolates. However, PFGE of LA-
MRSA did not result in banding patterns due to a methylation in the recognition site of the restriction 
enzyme SmaI, used in conventional PFGE approaches. In chapter 3, we optimized PFGE with restriction 
enzyme Cfr9I, a neoschizomer of SmaI, and evaluated its use to characterize a limited number of LA-
MRSA isolates. In chapter 4, we applied PFGE using Cfr9I during a presumed outbreak of LA-MRSA in 
a Dutch nursing home. PFGE using Cfr9I was able to confirm the outbreak, but found that the isolates 
of a single healthcare worker did not belong to the outbreak despite the fact that other techniques 
suggested otherwise.
Although PFGE with Cfr9I yields a relatively high discriminatory power for LA-MRSA isolates, PFGE 
remains a time-consuming, laborious and non-portable method. In chapter 5, we assessed and 
validated the capability of whole genome mapping (WGM) to differentiate LA-MRSA isolates. A whole 
genome map is a high-resolution, ordered, whole genome restriction map and for S. aureus isolates 
these maps consists of 200–300 restriction fragments. In contrast, in PFGE of S. aureus only 10–15 non-
ordered restriction fragments are used for the analysis. We used WGM in chapter 6 to identify possible 
persistence in and transmission of LA-MRSA between humans. For this, we used LA-MRSA isolates 
originating from a 2-year prospective longitudinal cohort study in which livestock veterinarians and 








onNext generation sequencing (NGS) is the ultimate typing tool for studying the origin and transmission 
routes of all virtually all microorganisms. In contrast to PFGE and WGM, NGS for LA-MRSA also allows 
for the study of genes involved in pathogenesis, antibiotic resistance and virulence. Chapter 7 describes 
the molecular characterization, including NGS of a subset of isolates, and epidemiological data of more 
than 9,000 LA-MRSA isolates submitted for the national MRSA surveillance from 2003-2014 to assess 
the characteristics of LA-MRSA in the Netherlands. Next generation sequencing was further applied in 
chapter 8, where we describe human-to-human transmission of LA-MRSA in Dutch healthcare settings 
based on the NGS data of more than 200 LA-MRSA isolates.
To further explore the capability of LA-MRSA to transmit between humans in a healthcare setting we 
performed a study, described in chapter 9, to assess the proportion of LA-MRSA in MRSA positive 
individuals without contact with pigs/veal calves or other known risk factors (MRSA of unknown origin; 
MUO) in 17 different hospitals.
 
Finally, in chapter 10 the major findings of the thesis are summarized and discussed and future 
perspectives are presented.                 
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Multiple-locus variable number tandem repeat 
analysis is superior to spa-typing and sufficient to 

















































Aim: Assess the best approach to type methicillin resistant Staphylococcus aureus (MRSA), Staphylococcal 
protein A (spa)-typing, multiple-locus variable number tandem repeat analysis (MLVA) or both.
Material & Methods: Discriminatory power of spa-typing and MLVA was determined using 20,771 
MRSA isolates.
Results: There were twice as many MLVA-types (MTs) as spa-types present in the collection. Among 
the top 70% of the isolates, 37 spa-types and 139 MTs were found. MLVA diversity among the top-10 
spa-types was high (diversity index 0.96), while spa-diversity among the top-10 MTs was much lower 
(diversity index 0.83). The probability that two MRSA isolates with the same spa-type also had the 
same MT was low (Wallace’s coefficient 0.27). In contrast, most MRSA isolates yielding the same MT 
also had the same spa-type (Wallace’s coefficient 0.90).
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Introduction
Methicillin resistant Staphylococcus aureus (MRSA) is a bacterial pathogen that is associated with 
serious hospital- and community-acquired infections [1, 2]. Adequate molecular characterization of 
MRSA strains and surveillance of MRSA has shown to be an effective control measure to prevent the 
spread of MRSA in healthcare settings [3]. In the Netherlands, a low MRSA prevalence country [4], 
MRSA surveillance started in 1989 by the National Institute for Public Health and the Environment 
(RIVM). Typing of the MRSA isolates was originally performed using phage typing, but replaced in 2002 
by pulsed-field gel electrophoresis, the traditional gold standard for molecular typing of MRSA [5, 6]. 
However, due to its laborious character and difficulties in exchanging data between laboratories, this 
method was replaced by Staphylococcal protein A (spa)-typing in 2007 [7]. This method, based on the 
sequence analysis of the variable repeat X region of the spa-gene, has become a useful typing tool 
because of its ease of performance and standardized nomenclature [8-10]. Although spa-typing has 
been successfully used for approximately 30,000 MRSA isolates in the Dutch national MRSA surveillance 
since 2007, the utility of this typing technique has recently become a subject of debate. The main 
reason is its inability to provide solid supporting information on epidemiological questions, such as 
transmission events [11-13]. To overcome this problem additional typing techniques are required. For 
the Dutch MRSA surveillance, multiple-locus variable number of tandem repeat analysis (MLVA) was 
introduced for S. aureus in 2008 and since then all isolates have been characterized by both methods.
To assess whether both spa-typing and MLVA are required for the MRSA surveillance, we compared 
and evaluated the typing results of spa-typing and MLVA of all MRSA isolates we received for our 
national MRSA surveillance during 2008-2013. 
Material and methods
Strain selection
In the Netherlands, the National Institute of Public Health and the Environment (RIVM) serves as 
the reference center for national surveillance of MRSA. All medical microbiology laboratories in the 
Netherlands are requested to send the first MRSA isolate of a patient or healthcare worker to the 
RIVM. The MRSA isolates originate from humans who were MRSA-positive during MRSA-screening or 
routine clinical diagnostics. As a result, virtually all MRSA isolated from humans admitted to health 
care centers are sent to the RIVM for molecular typing. From the resulting database, all surveillance 
MRSA isolates received from 2008 until 2013 with complete spa- and MLVA-profiles (n = 20,771) were 
selected for comparative analyses. Isolates were grouped as MRSA and LA-MRSA, where LA-MRSA is 
defined as isolates belonging to MLVA complex 398 (MC398). 
Molecular typing
Spa-typing and MLVA were performed as described previously [7, 14], but in 2013 the separate 
components for the PCR mixes of spa and MLVA were replaced by ready-made PCR mixes (Eurogentec, 
Seraing, Belgium, art.no. CS-ALIQ-PROD-SPA and CS-ALIQ-PROD-MLVA) (Table 1). For spa-typing, 1 µl 
of lysate was added to 24 µl of the ready-made mix and for MLVA 2 µl of lysate was added to 23 µl of 
the ready-made mix. Lysates were made by resuspending a 1 µl inoculation loop of MRSA culture from 
blood agar plates, into 30 µl of lysis mix (100 µg/ml Lysostaphine (Sigma, catnr: L 7386) in TE (10 mM 
Tris.HCl, 1 mM  EDTA, pH 8). After 30 min incubation at 37°C and 5 min at 95°C, 120 µl of TE was added 
to the lysates.    
The MLVA-mixes also contain specific primers for the detection of the mecA gene, the mecA gene 
variant LGA251 (mecC) and Panton Valentine leukocidin (PVL) (lukF). The primers for mecA and mecC 
were added to MLVA mix1 and the primers for the detection of PVL were included in MLVA mix 2. The 
presence of the mecA gene or mecC resulted either in a peak with a fixed size of 147 bp (mecA) or 165 
bp (mecC), while a peak with fixed size of 165 bp appeared when an isolate carried the lukF gene (PVL).
Isolates were considered as non-typeable (NT) for spa-typing if the spa-gene could not be amplified 
by PCR. Isolates lacking more than two variable number of tandem repeats (VNTRs) in MLVA were 




































Discriminatory power of and congruence between typing methods
Simpson’s index of diversity [15] was used to assess the discriminatory power of the typing methods 
used in this study. The determination of the confidence intervals (CI) of the Simpson’s indices was 
calculated as described by Grundmann et al. [16]. To assess congruence between spa-typing and MLVA, 
the Wallace’s coefficient was calculated [17]. Simpson’s indices and Wallace coefficients were either 
calculated in Excel or by using an online tool (www.comparingpartitions.info) [18].
   
Results
Discriminatory power of spa-typing
In this study, 788 different spa-types were found among the 12,728 MRSA isolates and the diversity 
index (DI) of spa-typing was 0.96. The predominant spa-types were t008 (n = 1,710), t002 (n = 1,224) 
and t1081 (n = 527) and together they represented 27% of all MRSA isolates (Table 2). 
LA-MRSA isolates (n = 8,043) yielded 110 different spa-types. The most frequently found spa-types 
were t011 (n = 4,846), t108 (n = 1,504) and t034 (n = 612). Together they represent 87% of all LA-MRSA 
isolates. The DI of LA-MRSA was 0.60 and notably lower than the DI of MRSA isolates.
Discriminatory power of MLVA
The number of MLVA-types (MTs) present in the collection of MRSA isolates (n = 12,728) was 1,592 and 
the top 3 MTs (MT314, MT240 and MT1352) covered 13% of all MRSA isolates.
When all MRSA isolates were taken into account, MLVA had a DI of 0.99. However, a subdivision of 
MRSA isolates into different MCs revealed that the DIs of the individual MCs differed considerably. Of 
the top 10 MCs, the DI for nine of the MCs was above 0.82 (Table 2). In MC80 the DI was only 0.72.
In LA-MRSA, which is composed of a single MLVA-complex (MC398), 136 different MTs were present 
among 8,043 isolates. The DI for MLVA of LA-MRSA was 0.63 and was lower compared to other MCs. 
MT398, the most prevalent MT among MC398, accounted for 57% (n = 4,585) of the isolates. Like spa-
typing, MLVA could not sufficiently discriminate LA-MRSA, which is illustrated by the fact that the top 3 
MTs yielded 82% of all LA-MRSA isolates (Table 2).
Table 1: Composition of the MLVA and spa-typing PCR-mixes
PCR mix Target Conc. Primer 
(pmol/µl)
Forward primer sequence* Reverse primer sequence
MLVA-mix 1 VNTR09_01 10 FAM-ATAAGCATTGAAACCATTATGATG GCAACTTCTTAAAACAAAATATTG
VNTR61_01 10 DFO-AATGCACATGAAACACTAATT GGTCAAGAATATTTAAAATCAATT
VNTR61_02 10 HEX-CTGTGAAGTTAGATAGATGAGTTT GCAATTAACGATTTCTTCAC
VNTR67_01 10 ROX-CGTGAATCTCTTTTATAAGAGTGT CCCTCCTATTAATATATATACCGT
mecA gene 10 FAM-AACGGTTTTAAGTGGAACG GCATATGAGATAGGCATCGT
mecC gene 10 FAM-CTTTAGACACATTATTGGAGAAA CGATGGGGTACTTACCA
MLVA-mix 2 VNTR21_01 10 HEX-GTCGATAAAGCATAAAGCTTT AGCAATGAATCAATAATTTTCA
VNTR24_01 10 ROX-CAGCAGTAGTGCCGTT GTAACGGCTTCATCCA
VNTR63_01 10 FAM-TGAAGATGTAGTAGGAATGTTAGT AGAAAAAGCTAAAGAAGTTGAA
VNTR81_01 5 DFO-TTTGGATATGAAGCGAGA CATATGTCGCAGTACCATC
lukF gene (PVL) 10 FAM-GGTGCATAATCTACAACGTTTAC AATACTCAAAGCTGCTGGAA
Spa-mix spa gene 10 TAAAGACGATCCTTCAGTGAGC CAGCAGTAGTGCCGTTTGCTT
*The designations at the 5' end of the primers represent the fluorescent labels
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Comparing spa-typing and MLVA  
The number of MTs in the collection was nearly twice as high as the number of spa-types, yet little 
difference was observed between the DIs of spa-typing and MLVA. However, a difference between 
spa-typing and MLVA was seen when the number of types, sorted in frequency, was plotted against the 
cumulative proportion of the MRSA isolates. This revealed that the top 37 spa-types represent 70% of 
the MRSA isolates, while nearly four times as many MTs (139 MTs) represent a similar fraction of the 
isolates (Figure 1).
No significant difference was seen among LA-MRSA types, where 70% of the isolates only represented 
two MTs and a single spa-type. 
All non-LA-MRSA isolates (n = 12,728) were ordered according to frequency of spa-types and subsequent 
subdivided into MTs and vice versa. Simpson’s diversity index was calculated for each of the top 10 
*Percentage of either the MRSA or the LA-MRSA group     
Figure 1: Discriminatory power of spa-typing and MLVA for MRSA isolates. The number of types, sorted in 
frequency, was plotted against the cumulative proportion of the MRSA isolates in the study. To prevent too 
much compression of the bars in the Y-axis direction only the results of 0-90% of the isolates are shown.
Table 2: Discriminatory power of spa-typing and MLVA
Group Typing method n No. of types Top 3 types % isolates in Top 3 types* DI (95% CI) 
MRSA Spa-typing 12728 788 t008, t002, t1081 27 0.96 (0.96-0.96) 
LA-MRSA Spa-typing 8043 110 t011, t108, t034 87 0.60 (0.58-0.61) 
MRSA MLVA all MCs 12728 1592 MT314, MT240, MT1352 13 0.99 (0.99-0.99) 
 
MLVA-MC1 343 78 MT149, MT152, MT222 48 0.90 (0.87-0.92) 
 
MLVA-MC5 3146 346 MT5, MT130, MT67 19 0.97 (0.97-0.98) 
 
MLVA-MC8 2980 183 MT314, MT240, MT195 50 0.90 (0.89-0.91) 
 
MLVA-MC22 1282 131 MT22, MT491, MT489 46 0.91 (0.90-0.92) 
 
MLVA-MC30 848 106 MT212, MT396, MT402 52 0.82 (0.80-0.85) 
 
MLVA-MC45 1495 127 MT1352, MT527, MT528 47 0.89 (0.88-0.91) 
 
MLVA-MC80 401 46 MT80, MT166, MT158 70 0.72 (0.67-0.76) 
 
MLVA-MC482 229 37 MT482, MT631, MT1205 59 0.83 (0.78-0.87) 
 
MLVA-MC621 475 75 MT621, MT710, MT625 48 0.85 (0.82-0.88) 
 
MLVA-MCnone 624 260 MT3095, MT1574, MT840 17 0.98 (0.98-0.99) 





















































types and this revealed that the MLVA-diversity among the top 10 spa-types was high, ranging from DI 
0.94 for spa-type t002 to DI 0.36 for spa-type t1081. The DI for MLVA-diversity of the top-10 spa-types 
was 0.96. In contrast, spa-diversity among the top 10 MLVA-types was much lower, ranging from DI 
0.53 for MT5 to DI 0.00 for MT1352, with a DI of 0.83 for the spa-diversity within the top 10 MTs (Figure 
2). The top 10 spa-types (n = 5,892) yielded 394 different MTs while the top 10 MTs (n = 3,362) only 
comprised 45 different spa-types. 
In total, 87 of the 20,771 (0.4%) isolates could not be typed with spa-typing. The number of spa non-
typeable (NT) isolates increased during our study period from two isolates in 2008, to 47 isolates in 
2013. With MLVA, only three (0.01%) isolates were NT and these isolates were found in 2010, 2012 and 
2013.
The likelihood that two isolates with the same spa-type also had the same MLVA-type and vice versa, 
was considered as the congruence between methods. In this study, congruence was expressed using 
the Wallace’s coefficient (Table 3). The probability that two MRSA isolates with the same spa-type also 
have the same MT was only 0.27. In contrast, two MRSA isolates yielding the same MT will also yield 
the same spa-type in the majority of cases (Wallace’s coefficient 0.90). 
Comparison of spa-typing and MLVA for LA-MRSA isolates yielded high Wallace coefficients (0.87 and 
0.96), indicating virtually complete congruence (Table 3).
 Table 3: Congruence between spa-typing and MLVA expressed as the Wallace coefficient  
Discussion
Since 2008, a combination of spa-typing and MLVA have been the methods of choice for typing MRSA 
isolates collected for the Dutch MRSA surveillance. Here, we compared and evaluated the typing results 
of spa-typing and MLVA of over 20,000 MRSA isolates collected during 2008-2013. This revealed that 
MLVA has a considerably higher discriminatory power than spa-typing and performing both methods 
will not increase typing resolution. 
In this study, MLVA yielded nearly twice as many types than spa-typing, but this was not reflected by 
the calculated index of diversity. However, the difference in discriminatory power became obvious 
when the number of types were plotted against the percentage of isolates, showing MLVA was superior 
to spa-typing. This difference was even more pronounced when the diversity of MLVA within spa-types 
was compared to the diversity of spa-types within MLVA-types. 
The discriminatory power of spa-typing and MLVA for isolates belonging to the LA-MRSA clade, was 
comparably low. This is not surprising since LA-MRSA is a genetically homogeneous MRSA variant 
and higher resolution typing techniques, such as whole genome mapping or typing based on next-
generation sequencing are needed to differentiate isolates belonging to this clade [14, 19, 20]. 
Spa-typing and MLVA are well validated and meet the criteria of a typing method as described by van 
Belkum et al [21]. However, for spa-typing, typeability is becoming an issue since non-typeable isolates 
are increasingly found in the Dutch MRSA surveillance. MLVA seems, at least at the moment, impervious 
for non-typeability. This study is not the first to describe the limitations of spa-typing. Khandavilli et 
al. used spa-typing to discriminate between two prevalent MRSA variants, E-MRSA 15 and 16, in the 
United Kingdom [12]. In their study, only two spa-types made up 73% of the isolates, showing that spa-
typing alone is not sufficient and that additional typing methods are required to correctly discriminate 
the UK MRSA isolates.
 Wallace coefficient
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Figure 2: Spa- and MLVA-diversity among the top 10 spa-types and the top 10 MLVA-types. Diversity indices for 
MLVA were calculated for each of the top 10 spa-types and vice versa and are displayed at the tops of the bars in 
the graph. The numbers in parentheses, below the spa-types and MLVA-types display the number of isolates for 



































The introduction of spa-typing has been successful and the technique is widely used. The method is 
cost-effective, the results are unambiguous and portable and an Internet accessible database with type 
information is available. However, there are a number of drawbacks. First, it is very difficult to interpret 
the meaning of differences in a single chromosomal locus such as the spa-gene in an epidemiological 
context. So, if two isolates obtained from two patients carry different spa-genes, does this then mean 
they represent different MRSA strains? Is a single nucleotide as important as the loss or gain of complete 
repeats? In contrast, MLVA utilizes the composition of eight different loci in the MRSA chromosome, 
providing a more solid ground for strain identification. If two MRSA isolates differ in a single MLVA 
locus, we consider these likely to represent the same strain. If isolates differ in two MLVA loci, they 
may still represent the same strain, but isolates differing in more than two MLVA loci are considered 
to represent different strains. We have performed a separate study, using next generation sequencing 
(NGS) and whole genome mapping, in which we provide support for this rule of thumb (manuscript 
in preparation). Second, clustering of spa-types is performed using the ‘based upon repeat pattern’ 
(BURP) method, which is very complex and can lead to misinterpretation [10, 22]. BURP needs to take 
into account both the number of repeats and the DNA sequence variation of the repeat units. It also 
excludes spa-types with spa-genes carrying less than five repeats. In our collection, 608 of the isolates 
(2.9%) carry spa-genes with less than five repeats. MLVA profiles are categorical data that can easily be 
used in clustering based on a categorical coefficient without restrictions on the minimum or maximum 
number of repeats. The distance between types is expressed as the difference in the number of loci and 
relatedness can be displayed in trees such as a minimum spanning tree [14]. 
MLVA is as cost-effective as spa-typing, but has the advantage that primers for additional markers can 
be added to the MLVA PCR mixes. In our MLVA, we added primers for the detection of mecA, mecC and 
the lukF (PVL) genes, saving time and costs otherwise needed to perform additional PCRs.  
One of the drawbacks of MLVA is that the method is not as widely used as spa-typing. This complicates 
comparison of MLVA typing data with data from other studies that used spa-typing. However, because 
we have typed more than 20,000 Dutch S. aureus isolates by both spa-typing and MLVA, we were able 
to create tables to translate a spa-type into a MLVA-type and vice versa. Although MLVA is a fragment-
based method, the number of repeats is deduced from the size of the PCR products assessed on a DNA 
sequencer and therefore very precise. However, small deletions and insertions in the regions flanking 
the repeat units may lead to misinterpretations, making the MLVA results slightly more ambiguous 
than sequence based results. To reduce this type of error, the DNA sequence of each new allele is 
determined to confirm the deduced number of repeats. 
Based on the limited discriminatory power of spa-typing, the fact that performing both methods does 
not increase resolution and the clear advantages of MLVA over spa-typing we conclude that MLVA 
alone will suffice to characterize MRSA isolates for surveillance purposes.  
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PFGE diversity within the methicillin-resistant 






























Livestock has recently been identified as a new reservoir of methicillin-resistant Staphylococcus aureus 
(MRSA). Most isolates belong to ST398 and are non-typeable with PFGE using SmaI, making it difficult 
to study transmission and outbreaks. Therefore, a new PFGE using Cfr9I, a neoschizomer of SmaI was 
optimized and evaluated to investigate ST398 isolates.
After optimizing and evaluating the Cfr9I PFGE, clear and reproducible banding patterns were obtained 
from all previously non-typeable MRSA (NTSmaI -MRSA) isolates. The PFGE patterns of ST398 isolates 
showed more diversity than with spa -typing and/or MLST. The PFGE results showed diversity within 
and between the two most prevalent spa-types of NTSmaI –MRSA (t011 and t108).  No match was 
found, when comparing banding patterns of the NTSmaI -MRSA with 700 different PFGE types, obtained 
with SmaI digestion, in our database of more than 4000 strains. Furthermore, possible transmission 
among veterinarians and their family members was investigated and an outbreak of ST398 MRSA in a 
residential care facility was confirmed with the Cfr9I PFGE.
The adjusted PFGE can be used as a method for selecting important and distinct ST398 isolates for 
further research. The adjustments in the PFGE protocol using Cfr9I are easy to implement to study the 
ST398 clonal lineage in laboratories which already have a PFGE facility.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of nosocomial and community-
associated infections worldwide. Most cases of community-associated MRSA (CA-MRSA) have been 
associated with skin and soft-tissue infections in previously healthy individuals [1, 2]. Since 2003, pigs 
[3-7] and other animals such as horses [8, 9], poultry [10] and calves [11] have been identified as a new 
reservoir for CA-MRSA. Most of the livestock related MRSA strains share the same multi locus sequence 
typing (MLST) type, namely ST398. Throughout Europe [9, 12-14], Canada [6] and in the United States 
[15] ST398 has been found in association with animal husbandry, indicating a worldwide clonal lineage. 
Although the clinical importance of ST398 is still controversial, there are reports indicating transmission 
and infections among humans [16-18]. Pulsed Field Gel Electrophoresis (PFGE) using SmaI is considered 
to be the gold standard for typing MRSA isolates [19]. When PFGE was performed on ST398 isolates, 
no banding patterns could be generated, due to methylation of the SmaI site [20]. Therefore, ST398 
isolates are referred to as PFGE non-typeable (NTSmaI)-MRSA. Some years ago staphylococcal protein 
A (spa) typing was introduced as a highly discriminatory typing method to characterize S. aureus 
isolates [21, 22]. However, spa-typing of the ST398 isolates revealed very limited variation within this 
group and 80% of our ST398 isolates had either spa-type t011, t108 or t034 [23]. Recently, a multiple-
locus variable number of tandem repeat analysis (MLVA) has been presented [24]. Although MLVA 
is significantly more discriminatory than spa-typing, it was unable to yield a better discrimination of 
the isolates of the ST398 lineage. The lack of a typing method that can discriminate ST398 strains has 
hampered studies on the origin and transmission routes of this MRSA clade.
In the Netherlands, all first MRSA isolates obtained from patients with staphylococcal disease and from 
patients that carry the pathogen are sent to the National MRSA reference centre for typing. In 2007, 
30% of all forwarded MRSA isolates were NTSmaI -MRSA [23].
Recently, a neoschizomer of SmaI, designated as Cfr9I, was shown to be insensitive for the DNA-
methylation leading to NTSmaI -MRSA isolates. In two studies, this restriction enzyme was used for 
generating PFGE profiles of NTSmaI -MRSA isolates [18, 25]. In the study presented here, we optimized 
PFGE with restriction enzyme Cfr9I and evaluated its use to characterize NTSmaI -MRSA isolates.
The data will yield important information about the genetic diversity of the ST398 clonal lineage in the 
Netherlands and demonstrates that Cfr9I PFGE is a powerful tool to study possible transmission and 
outbreaks of MRSA isolates, previously not typeable by conventional PFGE approaches.  
Material and Methods
Bacterial isolates
The National Institute for Public Health and the Environment (RIVM) serves as the Dutch National 
MRSA reference center. All first MRSA isolates, one per patient, are sent to the RIVM for further typing. 
PFGE was carried out using restriction enzyme SmaI according to the Harmony protocol [26]. From 
this large MRSA collection a number of NTSmaI -MRSA was selected to optimize and validate the Cfr9I 
PFGE. To study the genetic diversity of the two most prevalent spa-types among NTSmaI -MRSA in the 
Netherlands, 60 NTSmaI -MRSA isolates (t011 (n = 30) and t108 (n = 30)) in 2008 from patients living in 
geographical dispersed regions in the Netherlands were used. In addition, 16 strains (8 pairs) from 
veterinarians and one of their family members, the latter whom did not have contact with animals and 
40 pig and pig farmer isolates and 6 strains from an NTSmaI -MRSA outbreak in a residential care facility 
[18] were included in this study to assess the potential of the Cfr9I PFGE to identify transmissions. To 
validate the Cfr9I PFGE method, 10 typeable MRSA (T-MRSA) isolates and the reference strain NCTC 
8325 were tested. Five non-typeable isolates were repeated 3 times with Cfr9I PFGE to ensure the 
reproducibility of the method. 
Molecular typing 
All isolates were characterized with spa-typing [22]. Spa-types were assigned using Bionumerics 
software version 5.1 (Applied Maths, Sint-Martens-Latem, Belgium). SCCmec typing of the isolates was 



















In order to obtain clear and reproducible PFGE banding patterns using Cfr9I as restriction enzyme, the 
Harmony PFGE protocol had to be adjusted. This resulted in the following protocol: From each isolate, 
100 µl bacterial suspension of an overnight Trypton Soy Broth (TSB) culture, was embedded in a plug 
mold (Biorad) with 1.2% low-melting-point agarose (Seakem gold®, Biorad). Then, 500 µl lysostaphine 
(100 µg/ml, Sigma) was added and incubated for 6 h at 37°C. Subsequently, the plugs were incubated 
overnight at 55°C with 500 µl Proteinase K (50 µg/ml, Merck). The plugs were then washed, 6 to 10 
times in a shaking incubator for 30 min. in 1 x Tris-EDTA buffer (Fluka, pH 7) at 50°C in order to remove 
cell debris. Finally, the plugs were equilibrated in 1 x Cfr9I buffer (Fermentas, Ontario, Canada) for 
15 min. at room temperature prior to digestion and then submerged in 200 µl of 1 x Cfr9I reaction 
buffer containing 40 U of Cfr9I restriction enzyme (Fermentas, Ontario, Canada). The reaction tubes 
were incubated overnight at 37°C in a shaking incubator. Further steps were carried out according 
to the Harmony protocol [26]. Briefly, a 1% agarose gel was poured into a gel tray and positioned 
in a contour-clamped homogeneous electric field (CHEF) (Biorad) tank and submerged in 1,700 ml 
of 0.5 x Tris-Borate-EDTA (TBE). The total run time was 22 h at 14°C with an initial pulse time of 5 s, 
a final pulse time of 50 s and a voltage of 6 V/cm or 200 V. Gels were stained in ethidium bromide 
(1 µg/ml, Invitrogen) and viewed and photographed with UV transillumination. Digital images were 
analyzed using Bionumerics software, version 5.1. If a difference in PFGE pattern was observed, a new 
pulsed field type was assigned. The definition of a PFGE cluster was based on a similarity cutoff of 80% 
[28] (Dice coefficient, represented by UPGMA, 0.5% optimization and 1.0% tolerance). Different PFGE 
clusters were given in alphabetical order. Every band difference within a PFGE cluster resulted in adding 
a numerical order to the pulsed field cluster.
Results 
Optimization and validation of the Cfr9I PFGE method.
In the initial experiments the SmaI restriction enzyme was replaced by Cfr9I and exactly the same 
conditions were used as in the original PFGE protocol. This led to uninformative PFGE patterns 
consisting mainly of smears and faint bands obtained through partial digestion of the genomic DNA. A 
higher lysostaphine concentration (100 µg/ml), longer incubation steps for lysis (6 h), proteinase K and 
digestion overnight and hot washes at 50°C - instead of washes at room temperature - produced clear 
and reproducible banding profiles. 
After optimizing the PFGE method with Cfr9I, high quality banding patterns from all selected (n=124) 
previously non-typeable ST398 MRSA isolates were obtained. For validation, both PFGE protocols (SmaI 
and Cfr9I) were performed on 10 typeable MRSA isolates and the reference strain NCTC 8325. Side-
by-side comparison of SmaI and Cfr9I PFGE profiles yielded identical banding patterns consistent with 
unequivocal comparability of both restriction patterns. Reproducibility of the method was confirmed 
with 5 NTSmaI -MRSA isolates which were re-analyzed 3 times and yielded identical banding patterns.
Genetic diversity of NTSmaI -MRSA 
All PFGE patterns of the NTSmaI -MRSA were compared with a database consisting of more than 4000 
isolates containing over 700 different PFGE types obtained with SmaI digestion. Surprisingly, newly-
obtained banding patterns of NTSmaI -MRSA isolates did not match with any known PFGE cluster in the 
national database of MRSA isolates collected since 2002. 
Thirty t011 isolates revealed 16 different PFGE patterns (Figure 1). The largest PFGE cluster consisted of 
5 isolates, and 5 patterns were found more than once (n = 19). No correlation was found between PFGE 
cluster and geographic location. The minimal similarity (Dice coefficient, represented by UPGMA, 0.5% 
optimization and 1.0% tolerance) between the different patterns was 64 % (data not shown). Thirty 
t108 isolates revealed 14 different PFGE patterns (Figure 1). 
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Figure 1: Dendrogram of the Cfr9I PFGE results of NTSmaI-MRSA isolates with the 2 most prevalent spa-types 
in the Netherlands.
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The largest cluster contained 12 isolates and 4 patterns were found more than once (n=20). The clusters 
showed no geographical correlation. The minimal similarity of the t108 isolates was 50% (data not 
shown). One t108 isolate yielded a very distinct PFGE pattern (Figure 1, pattern H). Without this isolate 
the minimal similarity of the t108 isolates would be 80%. The minimal similarity of the 60 NTSmaI -MRSA 
isolates was 35%, but most isolates share 80% or more similarity. SCCmec typing of the 60 NTSmaI -MRSA 
isolates showed SCCmec type IV (n =1 4) and SCCmec type V (n = 43). Three isolates yielded a variant of 
SCCmec type V (indicated in figure 1 with V*) and no SCCmec types I, II or III were found.
Figure 2: PFGE patterns of ST398 isolates digested with Cfr9I restriction enzyme using NCTC 8325 as the 
reference standard. Lanes 6, 12, 18, and 24, NCTC 8325; Lanes 1-5, isolates from an outbreak in a residential 
care facility, all PFGE pattern J; Lanes 7-8, and 14-15, two pairs of a veterinarian and a close family member with 
distinct PFGE patterns; Lanes 9-11, and 13, two pairs of a veterinarian and a close family member with identical 
banding patterns; Lanes 16-17, and 19-22, isolates of pig farm 6 with four different PFGE patterns; Lanes 23, and 
25-28, isolates from pig farm 9 with identical banding patterns.
Transmission of ST398 isolates
The results of Cfr9I PFGE of 8 pairs of veterinarians and one of their close family members showed 
that 5 pairs gave indistinguishable banding patterns suggesting possible transmission of ST398 (Figure 
2 shows 2 pairs of indistinguishable banding patterns). Two pairs that did not match also had different 
spa-types. One pair which had the same spa-type differed in a single PFGE band (data not shown). 
Six isolates belonging to an outbreak in a residential care facility with spa-types t2383 and t011 all 
shared the same banding pattern. Furthermore, the transmission between pigs, pig farmers and their 
family on 9 different pig farms (Table 1, Figure 2) was studied. Farms 1 to 5 shared the same spa-
type whereas on farms 6 to 9, two or more different spa-types were present. The number of different 
PFGE patterns (B1-K) differed between farms, ranging from indistinguishable patterns (farm 4) to 5 
different PFGE patterns (farm 8). PFGE patterns B1, D1, D3, D4 and E1 were found on several farms. 
The minimal similarity within the farms varied from 52% (farm 5) to 100% (farm 4) and the minimal 
similarity between the farms was 61% (data not shown). Figure 2 shows the PFGE results of farm 6 with 
4 different PFGE patterns and from farm 9 which all had indistinguishable PFGE patterns.
J    J     J    J    J          A2 D16 B3 B3 B1       B1 D17 E1 D20 E1     D1 D4 D1 D1 D1     D1 D1 D1 D1
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Table 1: Overview of transmission of ST398 MRSA on 9 farms (n = 40).
Strain nr Farm spa-type Origin PFGE pattern Coefficient* 
1110701181 1 t011 farmer B3 70
1110700844 1 t011 pig D7
1110701184 2 t011 farmer D4
861110700857 2 t011 pig D4
1110701182 2 t011 employee E1
1110701185 2 t011 relative E1
1110701429 3 t011 pig B1
871110701595 3 t011 relative B2
1110701592 3 t011 farmer D19
1110701192 4 t108 farmer D1 100
1110700908 4 t108 pig D1
1110701196 5 t567 farmer D18
521110701197 5 t567 relative D18
1110700912 5 t567 pig I
1110701611 6 t108 dust D1
84
1110701614 6 t108 dust D1
1110701604 6 t108 pig D1
1110701200 6 t011 farmer D20
1110701612 6 t011 dust D4
1110701605 6 t011 pig D4
1110701201 6 t011 relative E1
1110701600 7 t2741 employee D14
95
1110701596 7 t011 farmer D14
1110701580 7 t011 pig D14
1110701601 7 t108 employee D21
1110701576 7 t011 pig D21
1110701577 7 t011 pig D21
1110700882 8 t011 pig B1
66
1110700884 8 t108 pig D1
1110700876 8 t108 pig D3
1110700889 8 t2330 dust D4
1110701188 8 t2330 relative D4
1110701191 8 t2330 relative D4
1110700890 8 t108 dust K
1110701791 9 t108 dust D1
86
1110701783 9 t108 pig D1
1110701788 9 t108 pig D1
1110703030 9 t108 relative D1
1110703031 9 t588 relative D1
1110703032 9 t108 relative D3




















MRSA isolates belonging to the ST398 clonal lineage are hard to discriminate based on spa-typing and/
or MLST, hampering the assessment of transmission and outbreaks. Therefore, other techniques such 
as a modified PFGE could provide a new opportunity to differentiate ST398 isolates. The restriction 
enzyme SmaI does not cut the DNA of NTSmaI -MRSA isolates, due to methylation of the SmaI site. 
However, Cfr9I, a neoschizomer of SmaI, can be used for generating PFGE profiles of the NTSmaI -MRSA 
isolates. When the standard SmaI protocol was used for Cfr9I, banding patterns with smears and partial 
digests appeared. Other recently published articles seemed to have encountered similar problems with 
their Cfr9I PFGE [18, 25]. The results indicated that lysis of ST398 isolates and digestion with restriction 
enzyme Cfr9I is more cumbersome than lysis of typeable MRSA and digestion with SmaI [29]. After 
modifying the protocol, banding patterns of similar quality as those of typeable MRSA isolates digested 
with SmaI were obtained. All previously non-typeable MRSA isolates can be typed with the optimized 
PFGE method providing a new opportunity to differentiate the ST398 clonal lineage. 
From April 2002 until January 2008, all MRSA isolates sent to the RIVM have been typed with PFGE 
using SmaI as restriction enzyme creating a database with more than 4000 isolates with over 700 
different PFGE types. Since Cfr9I recognizes the same restriction site as SmaI, Cfr9I enables analysis 
and comparison of the patterns with other profiles in our database. No comparison was found 
when comparing banding patterns of NTSmaI -MRSA with known PFGE patterns, suggesting that SmaI 
restriction modification is confined to a defined clonal lineage. Recently, ST398 isolates were typed 
using amplified fragment length polymorphism (AFLP). These data also suggested that ST398 is a 
distinct cluster recently introduced into the Dutch patient population [30].
The PFGE patterns of the two most prevalent spa-types (t011 and t108) within the NTSmaI -MRSA isolates 
showed more variation than spa-typing or MLST. The genetic diversity within the ST398 clonal lineage 
of MRSA sharing the same spa-type creates an opportunity for improved investigation of outbreak and 
potential transmission events. Spa-typing, which is currently used as a MRSA typing standard, cannot 
differentiate these isolates further. Using Cfr9I PFGE, spa-type t011 seemed to be more diverse than 
t108. Although the minimal similarity of the t108 isolates was 50%, this was mainly caused by a single 
isolate with a very distinct PFGE pattern (pattern H). Without this isolate the minimal similarity of the 
t108 isolates was 80%. The t011 isolates showed a minimal similarity of 64% (data not shown). SCCmec 
typing showed an almost equal distribution between SCCmec type IV (n = 14) and V (n = 16) for t011 
isolates, whereas all t108 isolates carried SCCmec type V or a SCCmec type V variant. Huijsdens and 
colleagues performed SCCmec typing on 300 NTSmaI –MRSA isolates and they showed similar results 
[23]. This variation in SCCmec types may also indicates a higher diversity among t011 MRSA isolates 
compared to t108 isolates. 
The minimal similarity of the Cfr9I PFGE patterns among ST398 isolates was 35% and showed variation 
within  spa -types, but the diversity within this lineage is still limited. Furthermore, one isolate with 
spa-type t108 yielded a very distinct PFGE pattern which causes the similarity to be 35% (Figure 1). 
When excluding this isolate from the dendrogram the minimal similarity was 62%. Comparing the PFGE 
results using the criteria by Tenover et al. and when a similarity cut-off of 80% was applied, most NTSmaI 
-MRSA isolates should be classified as one PFGE cluster [31, 32].  However, the Cfr9I PFGE is still better 
in discriminating possible differences between NTSmaI -MRSA isolates. 
No geographical relation could be found in either spa-type. However, most NTSmaI -MRSA isolates are 
found in areas with the highest pig density. This could be explained by the frequent movement of pigs 
between farms in the Netherlands. This facilitates the dissemination of ST398 MRSA on a national 
scale. A similar situation took place during the foot- and -mouth epidemic in England of 2001 [33].     
To provide additional resolution on the molecular evolution and dissemination of MRSA lineages, 
several typing techniques such as PFGE, SCCmec- and spa-typing have been developed. Since PFGE 
with SmaI does not digest the DNA of ST398 isolates, spa-typing has been the method of choice 
for characterizing NTSmaI -MRSA isolates. However, given the low diversity in spa-types it is hard to 
ascertain health care-associated transmission if two or more different spa-types are present in the 
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same institution. Fanoy et al. described an outbreak in a residential care facility where two spa-types 
(t2383 and t011) were prevalent [18]. After re-examination of the same isolates the PFGE profiles 
using Cfr9I were indistinguishable, indicating isogenicity. Moreover, the discriminatory ability of spa-
typing of NTSmaI -MRSA is compromised by the fact that more than 80% of the NTSmaI -MRSA in the 
Netherlands belong either to spa-type t011 or t108 [23]. With the modified Cfr9I PFGE a better tool for 
epidemiological investigation has become available. 
The results obtained by Cfr9I PFGE of isolates from veterinarians and their close family members 
showed possible transmission of ST398. Five out of eight pairs had identical profiles. The family 
members had themselves no contact with animals and were presumably infected by the occupationally 
exposed veterinarian. Two pairs of PFGE patterns among family members were not identical. Their 
isolates also had different spa-types. Family members may have been colonized by one MRSA through 
the veterinarian and subsequently the veterinarian may have been re-colonized by another MRSA after 
occupational exposure. One pair differed only in a single PFGE band probably as a consequence of 
micro-evolution. 
A study on nine different farms revealed that the PFGE patterns of isolates from seven farms were 
related, but PFGE patterns varied within and between the farms. For example, farm 7, yielded only 2 
very closely related PFGE patterns (D14, D21; similarity 95%), while other farms, like farm 8, showed 
5 different PFGE patterns (B1, D1, D3, D4 and K) and had a similarity of only 66%. Different batches of 
animals entering the farm, carrying different NTSmaI -MRSA, could have caused variation within farms. 
Further study is needed to confirm that farms with a fast turnover of pigs indeed show a higher diversity 
of PFGE patterns of NTSmaI -MRSA.
Conclusion
In conclusion, the modified PFGE protocol for Cfr9I provided highly informative banding patterns and 
showed good reproducibility. The PFGE results showed diversity within and between the two most 
prevalent spa-types among NTSmaI -MRSA. PFGE confirmed transmission of the ST398 clonal lineage 
within families and in a residential care facility. The modified PFGE approach can be used as a method 
for selecting important and distinct ST398 isolates for further research. The adjustments in the PFGE 
protocol using Cfr9I are easy to implement in laboratories which already have a PFGE facility, creating 
a powerful tool to study the ST398 clonal lineage.
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Outbreak of methicillin-resistant Staphylococcus 

































We describe an outbreak of methicillin-resistant Staphylococcus aureus (MRSA) ST398 in a nursing 
home in the Netherlands. Seven residents and  4 healthcare workers were identified with MRSA ST398, 
but 2 of the healthcare workers carried other strains. This study demonstrates that MRSA ST398 can 
spread in nursing homes.
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Introduction
Traditionally, methicillin-resistant Staphylococcus aureus (MRSA) has been considered a hospital-
associated pathogen. Recently, MRSA has expanded its territory to the community, causing severe 
infections in previously healthy persons all over the world [1]. In 2003, a new clone of MRSA was 
identified that was related to an extensive reservoir found in pigs and veal calves [2, 3]. People who 
are in direct contact with pigs and veal calves have a high carriage rate of this MRSA (23% and 29%, 
respectively) [2, 4]. Using multilocus sequence typing (MLST), the vast majority of these strains belong to 
sequence type 398 (ST398). Transmission within families, as well as single cases of colonized healthcare 
workers, have been described [2, 5]. However, up to now there have been few reports of transmission 
of MRSA ST398 in healthcare set- tings. In the hospital setting, MRSA ST398 is reported to be less 
transmissible than other MRSA types [6]. We describe an outbreak of MRSA ST398 in a nursing home.
Material and methods
Setting
This is a prospective epidemiologic analysis of an outbreak of MRSA ST398 that occurred in a nursing 
home in the Netherlands from October 2010 to February 2011. The nursing home is located in the 
southeast of the Netherlands in a region with a high density of pigs (∼3,000 pigs per square kilometer). 
The nursing home consists of 3 separate wards, with a total of 51 residents living in individual units. 
Incident cases were defined as residents and healthcare workers with MRSA obtained from clinical 
cultures (ie, wound) or surveillance cultures (ie, anterior nares, throat, and perineum).
Outbreak Investigation
In October 2010, MRSA was cultured from a wound on the leg of a resident. Subsequently, more 
extensive screening cultures of this resident were obtained in November 2010, which showed that he 
was also colonized in the throat, nose, and perineum. At the same time, another resident of the same 
ward had a wound culture with MRSA-positive test results. Subsequent screening in December 2010 
of contacts among residents and healthcare workers of this ward revealed additional residents and 
healthcare workers with MRSA. Be- cause of the high prevalence of MRSA in this ward, a screening of 
the other 2 wards was performed in January 2011.
Infection Control Measures
According to the current national guidelines for the control of MRSA in nursing homes, transmission-
based precautions were taken when there was physical contact with residents who carried MRSA. This 
means that gowns and gloves were worn when contact with the residents or their equipment was 
anticipated.7 Also, instructions on hand hygiene were given. The healthcare workers who carried MRSA 
were temporarily suspended from work, and decolonization of all colonized subjects was initiated 
with mupirocin nasal ointment, chlorhexidine wash, and systemic treatment with clarithromycine and 
rifampicin.
Microbiologic Methods
Nose, throat, and perineum swab samples were obtained from residents and healthcare  workers. 
Samples were directly inoculated onto chromID  MRSA  (bioMerieux).  In addition, broth enrichment 
containing Mueller-Hinton broth supplemented with 6.5% NaCl was inoculated using the same swabs. 
Direct-inoculated as well as overnight enriched–inoculated plates were read after 18–24 hours of 
incubation at 35°C–37°C. From the 11 individuals who were found to harbor MRSA, 16 MRSA isolates 
were genotyped by staphylococcal protein A (spa)-typing. In addition, all isolates were genotyped by 
pulsed-field gel electrophoresis (PFGE) using  the  restriction



























The additional screening of the first ward in December 2010 revealed 3 residents and 1 healthcare 
worker with MRSA. Subsequent screening of the other 2 wards in January 2011 revealed another 2 
residents and 3 healthcare workers who were colonized with MRSA. During the 2 months preceding the 
sampling, the 4 colonized healthcare workers had worked on all 3 wards and had been in contact with 
all residents. Altogether, the rate of MRSA carriage within residents was 7 of 51 (13.7%). In healthcare 
workers the rate was 4 of 76 (5.3%).
In total, 6 of the 7 affected residents were successfully decolonized with a single course. However, one 
resident failed initial treatment and was treated again with the same regimen, which failed also. This 
resident had been living on a pig farm until recently and reported regular visits to his son at the pig 
farm. In contrast, none of the other residents had contact with livestock.
Two of the 4 colonized healthcare workers reported contact with livestock. Healthcare worker 1 lived 
on the grounds of a pig farm, but she only sporadically had contact with pigs herself. After receiving 
treatment, she was recolonized within 1 month. Healthcare worker 2 lived on a veal calf farm, and 
she reported frequent contact with livestock. Eradication of colonization was not attempted in this 
healthcare worker due to the anticipated risk of recolonization. Healthcare worker 3, who did not have 
livestock contact, was successfully treated with mupirocin nasal ointment and chlorhexidine wash. 
At present, she has had MRSA-negative test results for 3 months. Healthcare worker 4, who did not 
have livestock contact, became MRSA negative without receiving any treatment. In March 2011, all 
healthcare workers and residents who had MRSA-positive test results were consecutively screened for 
the presence of MRSA. Only the index case and the healthcare workers who had contact with livestock 
were still colonized with MRSA. All other healthcare workers and residents had MRSA-negative test 
results 3 times.
All isolated strains were resistant to tetracycline. The resistance profiles of all confirmed MRSA strains 
are depicted in Figure 1.
Figure 1: Dendrogram of the pulsed-field gel electrophoresis (PFGE) data from 16 methicillin-resistant 
Staphylococcus aureus (MRSA) ST398 isolates. Next to the dendrogram the PFGE of Cfr9I macrorestriction 
fragments, host, sample date, spa-type, PFGE cluster type, and antibiotic resistance patterns are given. ci, 
ciprofloxacin; cl, clindamycin; er, erythromycin; fu, fusidic acid; HCW, healthcare worker; I, intermediate 
sensitivity; li, inezolid; mu, mupirocin; R, resistant; ri, rifampicin; S, sensitive; te, tetracycline; tr, trimethoprim/
sulfamethoxazole; to, tobramycin; va, vancomycin.
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Molecular Typing
Relatedness of the MRSA strains was confirmed by PFGE with Cfr9I restriction digestion in 12 of the 16 
isolates [8]. Only the MRSA isolates originating from the 2 healthcare workers who reported livestock 
contact carried MRSA that had a different PFGE cluster type (Figure 1). Strains can also be subdivided 
into 3 different resistance profiles. Each PFGE cluster corresponds to a unique resistance profile.
Moreover, spa-typing showed that 14 of the 16 strains were spa-type t011. Only the isolates originating 
from healthcare worker 1 were spa-type t108. Both spa-types are very frequently found within MRSA 
ST398.
Discussion 
To date, only one outbreak of MRSA ST398 in a Dutch hospital has been reported [9.] We report the 
first outbreak, to our knowledge, of MRSA ST398 in a nursing home that comprised 7 residents and 2 
healthcare workers. The MRSA strain responsible for this outbreak was spa-type t011, which belongs to 
MLST type ST398. The most likely source for this outbreak was the 98-year-old male resident number 
3. The index case had been living on a pig farm until recently, before he moved to the nursing home. 
He reported regular visits to his son at the pig farm. We assume that healthcare workers transmitted 
the outbreak strain to other residents because the index case did not have direct contact with the 
other MRSA-positive residents. Moreover, there was repeated intense physical contact between 
colonized healthcare workers and the index case due to his obesity and immobility. Furthermore, none 
of the other colonized residents had contact with pigs or veal calves. Although we did not assess the 
compliance to hand hygiene of healthcare workers, this is generally low in nursing homes and may have 
contributed to the spread of MRSA. When the outbreak was detected, the importance of hand hygiene 
was communicated to all healthcare workers. Hand sanitizer dispensers were placed at the entrances 
of all patients’ rooms. By doing this, the compliance to proper hand hygiene was probably increased.
Two additional healthcare workers had MRSA-positive test results during the outbreak period, but they 
carried other strains. These healthcare workers reported contact with livestock and had worked for 
a long time in the nursing home. One of the healthcare workers who had contact with livestock had 
a similar spa-type of the outbreak-related strain, but the PFGE pattern was clearly different and the 
resistance profile also showed major differences. We concluded that they were not involved in this 
outbreak on the basis of these differences. The MRSA ST398 strains isolated from these healthcare 
workers were not found in any other residents, who all had been screened. This suggests that healthcare 
workers who are colonized with MRSA ST398 and comply with proper hygiene precautions are not a 
significant risk for transmission. It is unclear whether host adaptation of this animal-derived strain 
plays a role in its transmissibility.
In conclusion, several studies have demonstrated that transmissibility of MRSA ST398 is probably lower 
than hospital- associated MRSA strains [5, 6]. However, this outbreak of MRSA ST398 in a community 
setting shows that substantial human- to-human transmission can occur. Further adaptation to humans 
may occur, and if MRSA ST398 can successfully spread from human to human, it may pose a significant 
public health problem in the future. Therefore, careful monitoring of the evolution and epidemiology 
of MRSA ST398 is important.
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High resolution typing by whole genome mapping 
enables discrimination of LA-MRSA (CC398) strains 





































After its emergence in 2003, a livestock-associated (LA-)MRSA clade (CC398) has caused an impressive 
increase in the number of isolates submitted for the Dutch national MRSA surveillance and now comprises 
40% of all isolates. The currently used molecular typing techniques have limited discriminatory power 
for this MRSA clade, which hampers studies on the origin and transmission routes. Recently, a new 
molecular analysis technique named whole genome mapping was introduced. This method creates 
high-resolution, ordered whole genome restriction maps that may have potential for strain typing. 
In this study, we assessed and validated the capability of whole genome mapping to differentiate LA-
MRSA isolates.
Multiple validation experiments showed that whole genome mapping produced highly reproducible 
results. Assessment of the technique on two well-documented MRSA outbreaks showed that whole 
genome mapping was able to confirm one outbreak, but revealed major differences between the 
maps of a second, indicating that not all isolates belonged to this outbreak. Whole genome mapping 
of LA-MRSA isolates that were epidemiologically unlinked provided a much higher discriminatory 
power than spa-typing or MLVA. In contrast, maps created from LA-MRSA isolates obtained during a 
proven LA-MRSA outbreak were nearly indistinguishable showing that transmission of LA-MRSA can 
be detected by whole genome mapping. Finally, whole genome maps of LA-MRSA isolates originating 
from two unrelated veterinarians and their household members showed that veterinarians may carry 
and transmit different LA-MRSA strains at the same time. No such conclusions could be drawn based 
spa-typing and MLVA.
Although PFGE seems to be suitable for molecular typing of LA-MRSA, WGM provides a much higher 
discriminatory power. Furthermore, whole genome mapping can provide a comparison with other 
maps within 2 days after the bacterial culture is received, making it suitable to investigate transmission 
events and outbreaks caused by LA-MRSA.
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Introduction
Staphylococcus aureus and in particular methicillin resistant S. aureus (MRSA) is a bacterial pathogen 
that is associated with serious hospital- and community-acquired infections [1,2]. In the Netherlands, 
the incidence of MRSA infections is still low due to the restricted use of antibiotics and the successful 
implementation of the ‘search and destroy’ policy. However, the number of MRSA isolates sent to the 
national institute for public health and the environment (RIVM) in the context of the national MRSA 
surveillance, has been gradually increasing in the last years [3]. This increase is mainly caused by the 
emergence of a new single MRSA clade multi-locus sequence type ST398 originating from livestock, 
mainly pigs. ST398 was first described by Voss et al. in 2005 and since then ST398 has been found in 
numerous countries worldwide [4-8]. ST398 has been isolated from different types of domesticized 
animals and therefore is ST398 also known as livestock-associated MRSA (LA-MRSA) [9,10]. After the 
first reports in 2005, LA-MRSA (ST398) has spread very rapidly in the Netherlands and has become the 
predominant MRSA clade since 2007. In 2010, 38% of all isolates sent to the RIVM were LA-MRSA [3].
Typing of LA-MRSA however, has turned out to be a challenge. One of its characteristics is that LA-
MRSA are non-typeable with regular pulsed-field gel electrophoresis (PFGE) due to methylation of the 
SmaI recognition site [11]. In recent years, a number of reports have shown that PFGE with restriction 
enzyme Cfr9I, a neoschizomer of SmaI, can be used to overcome the problems with DNA-methylation 
[12,13]. Although PFGE with Cfr9I yields a relatively high discriminatory power for LA-MRSA isolates, 
PFGE remains a time-consuming, laborious and non-portable method. Other typing techniques, such 
as staphylococcal protein A (spa)-typing and multiple-locus variable number of tandem repeat analysis 
(MLVA), can be used to characterize LA-MRSA, but yield very limited discrimination within this clade. 
From 2008-2012, 17,869 MRSA isolates were characterized by spa-typing and MLVA within our national 
MRSA surveillance. The predominant MLVA complex was MC398, representing LA-MRSA and comprising 
of 7,066 isolates. Although 96 different spa-types and 78 different MLVA-types (MT) were found within 
this clade, the 2 dominant types, spa-type t011, MT398 (n=4093) and spa-type t108, MT572 (n=1282), 
accounted for 76% of all LA-MRSA isolates. In contrast, MC5 (MRSA, n=2520), the most isolated clade 
after MC398, yielded 113 different spa-types and 205 different MLVA-types with spa-type t003, MT130 
(n=182) and spa-type t002, MT5 (n=126) as the predominant types, but accounting only for 12% of all 
MC5 isolates. Strains within MC398 show limited variability and the absence of a highly discriminating 
typing method to characterize MC398 (LA-MRSA) isolates has hampered studies on the origin and 
transmission routes of this MRSA clade. 
 In 2007, a molecular analysis technique was introduced initially called optical mapping and now 
designated as whole genome mapping (WGM), although whole chromosome mapping would be more 
appropriate. A whole genome map is a high-resolution, ordered, whole genome restriction map and 
for S. aureus isolates these maps consists of 200–300 restriction fragments. In contrast, in PFGE of 
S. aureus only 10–15 non-ordered restriction fragments are used for the analysis [14,15]. Although 
Shukla et al. have previously successfully used WGM to characterize MRSA belonging to the USA300 
clade [16], the number of reports in which WGM was used for molecular typing of bacterial pathogens 
is very limited [16-18]. 
In this study, we assessed and validated the capability of whole genome mapping to differentiate LA-




For this study a total of 18 MRSA and 45 LA-MRSA isolates were selected to create 84 different whole 
genome maps (WGMs). Two MRSA strains (NCTC8325, N315) and one LA-MRSA strain (S0385), which 
are often used as reference strains and for which published genomes are available [25-27], were used 
for reproducibility experiments and comparison of whole genome maps created in our laboratory with 
in silico maps. In addition, two LA-MRSA (MC398) isolated from Dutch veterinarians (VET78 (t=0m) 























events was studied using isolates obtained during three well-documented outbreaks in the Netherlands 
of CA-MRSA (USA300), HA-MRSA (MC45) and LA-MRSA (MC398) and 22 LA-MRSA isolates from Dutch 
veterinarians and their household members [6,19,20]. Finally, 16 LA-MRSA isolates originating from 
a longitudinal survey of veterinarians frequently visiting livestock farms were used to investigate the 
discriminatory power of the whole genome mapping method for LA-MRSA (Table 1). All isolates used 
in this study originated from pre-existing collections and the isolates used to create WGMs were also 
characterized by MLVA, spa-typing and PFGE as described previously [21-24].
Table 1: Bacterial strains used in this study.
Experiment MRSA strains LA-MRSA strains Reference*
Re-assembly of raw data NCTC8325 S0385 [25], [27]
Optimal comparison settings NCTC8325 VET78 (t=0m) [25], VET-study
Stability of WGM NCTC8325, N315 VET78 (t=0m), VET35 (t=0m) [25], [26], VET-study
Comparison with in-silico maps NCTC8325, N315 S0385 [25], [26], [27]
MRSA transmission events CA-MRSA (n=8), HA-MRSA (n=8) [19], [20]
Discriminatory power for LA-MRSA VET-isolates (n=16) VET-study
LA-MRSA transmission events Transmission isolates (n=4) [6]
Suspected LA-MRSA transmission VET-isolates (n=22) VET-study
* VET-study, isolates collected for a longitudinal MRSA carriage study among veterinarians and written consent 
was provided by all participants (E. Verkade personal communication).
Isolation of HMW DNA      
Whole genome mapping requires the input of high molecular weight DNA (HMW DNA) with an average 
molecule size of approximately 250,000 bp. The Argus™ HMW DNA isolation kit (OpGen, Gaithersburg, 
USA) provides reagents and a protocol specifically designed for the isolation of HMW DNA. Briefly, 
a single colony was picked from a plate and suspended in cell wash buffer. Bacteria were treated to 
form spheroplasts and subsequently lysed to release the HMW DNA. For the isolation of HMW DNA 
of S. aureus this protocol required small but essential adaptations. First, we doubled the amount of 
lysostaphine (15 units/sample) used during the spheroplasting step and tripled the incubation time (3 
hrs) recommended by the manufacturer. Furthermore, to obtain sufficient yield of HMW DNA for WGM 
we empirically determined that the isolated DNA required to relax and go into solution for at least 24 
hrs at room temperature before proceeding to the dilution step. In our protocol, a 1:40 dilution was 
usually optimal for S. aureus. The quality (e.g. the average molecule size (AMS)) and the concentration 
of the DNA samples were checked using so-called Quality Control cards (Argus™ QCard kit, OpGen, 
Gaithersburg, USA). We found that for S. aureus a minimum of 5–10 DNA molecules of approximately 
250,000 bp should be present per image in order to obtain good WGMs. 
Creating whole genome maps
Whole genome maps were created using the manufacturer’s instructions. Shortly, HMW DNA was 
applied to Mapcards containing micro channels in which DNA molecules were stretched, bound to 
a glass surface, and subsequently digested with AflII and stained with a fluorescent agent in a micro 
fluids system. The restriction fragments were sized in the whole genome mapper and assembled into 
a whole genome map in which the restriction sites are mapped in the order in which they occur in the 
chromosome using MapManager software version 1.1 (OpGen). For assembly, only DNA molecules 
larger than 150,000 bp and with a minimum of 12 restriction sites were included. In a complete map, 
each assigned restriction site should have been found in at least 30 single molecules (coverage) and 
typically an average depth of 50 to 80 molecules is found. To assess whether assembly using the 
settings recommended by OpGen resulted in reproducible maps, the same raw data obtained from 
DNA of reference strains NCTC8325 and S0385 were assembled into WGMs 5 times each. Comparison 
of the generated maps revealed identical WGMs demonstrating the reproducibility of the assembly 
under the recommended conditions. After assembly, the generated restriction maps were imported 
into MapSolver software version 3.0 (OpGen, Gaithersburg, USA) to create the final circular whole 
genome map and without further manipulation the map was subsequently saved in .xml file format.  
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Analyzing whole genome maps
The .xml files containing the ordered maps were imported into a database created with an alpha 
version of BioNumerics version 7.0 (Applied Maths, Sint-Martens-Latem, Belgium). For clustering and 
alignment of the maps, we chose the first restriction fragment after the origin of replication in the 
chromosome as the starting point of the map, using a map rotation plugin in BioNumerics. For rotation 
of LA-MRSA maps, the in silico whole genome map of LA-MRSA strain S0385 (AM990992) was used as 
a template and for regular MRSA strains an in silico map of NCTC8325 (CP000253) was utilized. The 
BioNumerics software allowed alignment and clustering of WGMs using filtering of small fragments 
and size tolerance settings. The background on the algorithms used for the comparisons of whole 
genome maps in BioNumerics will be described in detail elsewhere. In the alignment, two fragments 
were considered to be identical if their sizes differed no more than the value set for the absolute 
tolerance. If this criterion was not met, two fragments were still considered identical if they met the 
relative tolerance criterion. This relative tolerance is defined as the difference between two fragments 
dived by their average; (size fragment 1 – size fragment 2) / ((size fragment 1 + size fragment 2)/2). 
The similarity between the whole genome maps was calculated by dividing the number of matched 
fragments by the total number of fragments. The method we chose for cluster analysis was UPGMA. In 
the BioNumerics software WGMs are represented as linear maps displaying the fragments in randomly 
chosen colours, with matching fragments sharing the same colour. Fragments of maps that were 
excluded from the comparison as a result from the fragment filtering were not deleted from the maps, 
but displayed as blocks with reduced height in the maps.
Results
Assessing optimal settings for comparisons        
The whole genome mapping encompasses procedures in which the restriction fragments are sized and 
subsequently assembled into ordered restriction maps. However, there is experimental variation in the 
sizing and also smaller restriction fragments may variably be lost during the procedure. The reason for 
this loss is that smaller DNA fragments have a relatively low net charge and as a result a weaker bond 
to the glass surface of the Mapcard. To compensate for both the variation in sizing and the presence or 
absence of smaller fragments during clustering and alignment, tolerance and filtering were employed 
in the BioNumerics software. In order to assess the optimal filtering and tolerance settings, DNA 
isolated from a MRSA and a LA-MRSA isolate was repeatedly used to create WGMs on 4 consecutive 
days and analyzed in BioNumerics using an range of filtering and tolerance settings. A combination of 
a filtering setting that excluded fragments <3,000 bp from the comparison and a relative tolerance of 
15% combined with an absolute tolerance of 1,000 bp resulted in maps with a similarity of >99% for 
replicates of the DNA samples, whilst unrelated samples yielded distinct maps. Settings that were more 
stringent resulted in artificial differences between maps of the replicates while less stringent settings 
resulted in loss of the ability to discriminate unrelated samples.
Stability of whole genome maps and comparison with in silico maps
To assess the temporal stability of MRSA genomes as reflected in whole genome maps under laboratory 
conditions, single colonies from 2 LA-MRSA and 2 MRSA isolates were sub-cultured for 30 consecutive 
days. The similarity between the WGMs obtained from the DNA isolated on day 1 and day 30 ranged 
between 99.4% and 100%, showing that under laboratory conditions the MRSA genome was stable 
enough to yield virtually identical maps. 
To determine to what extend WGMs accurately reflect the composition of a whole genome sequence, 
maps obtained from NCTC8325 (MRSA) [25], N315 (MRSA) [26] and S0385 (LA-MRSA) [27] were 
compared to their in silico counterparts generated in the Mapsolver software. The similarity between 
the WGMs created in the laboratory and their in silico counterparts varied between 95.5% and 98.7% 
for these isolates. Close inspection of the differences between the real WGMs and the in silico maps 
revealed that in general, sizing of the restriction fragments by the whole genome mapper in general 























Furthermore, there were several locations where the composition of the predicted maps clearly 
differed from the maps generated in the laboratory (Figure 1).    
Figure 1: Examples of differences between the WGMs created in the lab and their in-silico counterparts. 
The figure shows details of the comparisons of the maps of LA-MRSA strain S0385 and MRSA strains N315 and 
NCTC8325. The WGMs are represented as linear maps displaying the fragments in randomly chosen colours, with 
matching fragments sharing the same colour.
Capability of WGM to identify transmission events of MRSA
To determine whether whole genome mapping is capable of identifying transmission events, two earlier 
reported MRSA outbreaks were investigated. The first outbreak comprised 8 community-acquired 
MRSA (CA-MRSA) isolates obtained during an outbreak in a Dutch beauty salon in 2006 [19]. According 
to the authors of this study, PFGE showed that, all isolates belonged to the so-called USA300 cluster and 
had indistinguishable PFGE banding patterns. However, renewed inspection of the PFGE profiles during 
our study revealed that 5 isolates had identical PFGE profiles, but 3 isolates had an additional band of 
approximately 80 kb. Molecular typing characterized all isolates as Panton–Valentine Leukocidin (PVL)-
positive, spa-type t024 and MT308 (MC8). The whole genome maps of the isolates were also highly 
similar with a similarity of 97.9% between the most distinct maps. Remarkably, the 3 isolates that had 
an additional band in PFGE also carried an additional, approximately 40 kb DNA segment which was 
absent in the 5 other isolates (Figure 2).
Figure 2: Detail of the whole genome maps of an outbreak of CA-MRSA (USA300) showing an additional DNA 
segment in 3 isolates. All isolates had spa-type t024 and MLVA-type MT308. The gel image on the right hand side 
shows the PFGE profiles with an additional 80 kb band in the lower 3 isolates.
Based on the results with the replicates, that yielded >99% similar profiles, and the result of the above 
described outbreak we chose to set the cut-off value at 98% for indistinguishable profiles. This will 
allow for the variation in WGMs due to the presence or absence of mobile elements. The second set of 
isolates were presumed hospital-acquired MRSA (HA-MRSA) and originated from an outbreak in two 
large medical care facilities in the Netherlands that started in 2001 and persisted for a period of 20 
months [20]. 
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Since many MRSA were isolated during this outbreak, we randomly selected 8 isolates with identical 
genotypes (spa-type t445 and MT512 (MC45) and indistinguishable PFGE) from one facility for whole 
genome mapping. Although the WGMs of 4 of the isolates were closely related with similarities of 
>98.5%, there were major differences with the maps of the other isolates resulting in only 90.4% 
similarity between the most distinct maps (Figure 3).
Figure 3: Detail of whole genome maps showing differences between HA-MRSA outbreak isolates obtained 
from a large medical care center in the Netherlands. Based on molecular typing (spa-typing, MLVA and PFGE) all 
isolates were indistinguishable.
Discriminatory power of whole genome mapping for LA-MRSA
LA-MRSA isolates obtained from 16 epidemiologically unrelated veterinarians frequently visiting 
livestock farms were subjected to molecular typing, including whole genome mapping. Spa-typing 
and MLVA could hardly discriminate these isolates yielding only 5 different spa- and 4 MLVA-types 
caused by variations in the number of spa-repeats only. In contrast, whole genome mapping was able 
to discriminate these isolates and the average similarity between maps ranging from 77.0% to 98.3%. 
However, 2 of the 16 WGMs were nearly identical, with a similarity of 99.6%. Considerable variation 
was seen in the SCCmec region of these isolates with 11 different compositions of the SCCmec region 
among the 16 isolates (Figure 4).
Figure 4: Detail of the WGMs of 16 LA-MRSA isolates originating from unrelated veterinarians showing the 
discriminatory power of whole genome mapping. The limited variation obtained by MLVA- and spa-typing is 
























Capability to identify transmission events of LA-MRSA
We investigated the capability of whole genome mapping to identify LA-MRSA transmission events 
using LA-MRSA isolates obtained during a LA-MRSA outbreak that occurred in 2004 [6]. The 4 isolates 
used in the study presented here were obtained from a pig farmer’s family and originated from a 
mother suffering from LA-MRSA mastitis, from the infant that she nursed, from the farmer who is 
the father of the child and from one of the pigs that were sampled during the study. All isolates were 
spa-type t108, MT572 and PFGE profiles were identical. The WGMs of the 4 isolates were virtually 
indistinguishable yielding a similarity of 99.1%, showing that the transmission event within this family 
could be confirmed by WGM (Figure 5).
Figure 5: Complete WGMs of LA-MRSA isolates obtained from a confirmed transmission event. The 4 isolates 
represent 3 household members and 1 isolate originated from a pig on the farm. All isolates were identical in 
PFGE, spa-typing and MLVA.
WGM to study suspected LA-MRSA transmission events
A set of samples originating from two families of epidemiologically unrelated veterinarians frequently 
visiting livestock farms that were screened for MRSA carriage on 5 time points during a fourteen-
month survey period were used to assess the capability of WGM to track transmission of LA-MRSA 
from veterinarians to their household members. After the first screening (t = 0 m), sampling took place 
during home visits after 2 months (t = 2 m) and by the veterinarians themselves after 6, 10 and 14 
months (t = 6 m, t = 10 m, t = 14 m). During this study period, 24 LA-MRSA isolates were cultured from 
the two families. Thirteen LA-MRSA isolates were obtained from veterinarian VET45 and his household 
members, while 11 isolates were cultured from veterinarian VET66 and his household members. Spa-
typing and MLVA characterized 21 of 24 isolates as spa-type t011 and MT398 (MC398). The spa and 
MLVA profiles from the 3 other isolates, all originating from the family of VET66, differed only slightly 
from the 21 other isolates. PFGE yielded indistinguishable banding patterns for 11 of the 13 isolates 
obtained from the family of VET45 and the profiles of the other 2 isolates, differed from that of the 
11 isolates in a single band and in 2 bands, respectively. Nine of the 11 isolates from VET66 and his 
household members had identical PFGE patterns, while the remaining 2 isolates were clearly different. 
The PFGE profiles of the two families represented two distinct groups, which was corroborated by 
WGM. Within the isolates from VET45 and his household members, two different WGM-clusters were 
identified. The first cluster (cluster A) was comprised of 8 isolates with a similarity of 97.9% between 
the most distinct WGMs and 6 of the maps were more than 99.5% similar. The second cluster (cluster 
B) was comprised of WGMs from 4 isolates and was distinct from the first cluster with a similarity 
between the first and second cluster of 93.3%. PFGE profiles of 11 of the 12 isolates belonging to these 
clusters were identical, showing the high discriminatory power of WGM. The remaining WGM obtained 
from the first isolate (t = 0 m) cultured from VET45, was quite distinct and did not belong to cluster A or 
cluster B. This isolate also had a distinct PFGE profile, indicating that the veterinarian carried a different 
strain at this time. Within the 11 LA-MRSA isolates obtained from the second family (VET66), the maps 
of 9 isolates were nearly identical with a similarity of 96.2% between the most distinct maps within 
this cluster (cluster C). These 9 isolates were also indistinguishable with PFGE. The remaining 2 isolates 
differed considerably in all typing analyses (Figure 6). 
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Figure 6: Detail of the WGMs of two veterinarians and their household members showing transmission 
events. A and B denote the clusters with highly similar WGMs of isolates obtained from VET45 and his household 
members (light red block). C denotes the cluster with highly similar WGMs of isolates obtained from VET66 and 
his household members (blue block). Sampling time-points, sampling sites, spa-type, MLVA-type and PFGE-type 
are indicated on the right hand side of the maps. The PFGE-type numbers are arbitrary numbers. 
The sample from veterinarian VET66 taken at t = 0 m contained LA-MRSA with a WGM that was 
identical to those found for the LA-MRSA from the same veterinarian up to 14 months later. At sampling 
points from 6 to 14 months this LA-MRSA was also isolated from the household members at sampling 
moments 6 to 14 months. Remarkably, the veterinarian apparently carried 2 distinct LA-MRSA strains 
in nose and throat at the 6 month sampling point and it was the strain found in the nose that had been 
transmitted to its household members. In the family of VET45, WGM suggested that transmission with 
2 different strains had taken place at different time points. The first strain (cluster A) was isolated from 
VET45 and his household members at the 6 months sampling point and thereafter. The second strain 
(cluster B) was isolated from VET45 at the 2 months (nose) and 10 months sampling point (nose and 
throat). This strain was also found in contact45.1 (HHM45.1) at 10 months (throat), but remarkably, a 
different strain was isolated from the same contact at the same sample moment, albeit in a different 
anatomic site (nose) (Figure 6).
Discussion
LA-MRSA isolates are hard to discriminate when using current molecular typing techniques, such as 
spa-typing, MLST and MLVA. Although the PFGE using Cfr9I provides a much better differentiation of 
MC398 isolates this method is laborious and yields data that are not easily electronically exchanged. 
This hampers the study of possible transmission events and outbreaks caused by this MRSA clade. The 
whole genome mapping presented here provides a typing method with high discriminatory power that 
appears to be suitable to identify LA-MRSA transmission events. 
The discriminatory power of WGM was illustrated by the ability to type and differentiate LA-MRSA 
isolates obtained from epidemiologically unrelated veterinarians frequently visiting livestock farms 
for which spa- and MLVA-typing failed to provide clear distinction. Among these unrelated isolates 
many different compositions of the SCCmec region existed indicating that variation in this locus 
significantly contributes to observed genomic diversity among LA-MRSA. Furthermore, WGM was 
able to confirm well documented CA-MRSA, HA-MRSA and LA-MRSA transmission events. In the first 
outbreak, involving transmission of a USA300 strain in a beauty salon, WGM identified a DNA segment 
of approximately 40 kb present in only 3 of the 8 isolates. Although this was not reported as such in 























likely represents a bacteriophage which usually has a genome size of approximately 40 kb and has the 
ability to jump in and out of bacterial genomes [28]. This shows that variation may occur within the 
same strain by gain or loss of mobile elements. Such events will lead to very localized changes whereas 
differences between distinct strains are the result of various genetic events and therefore in general 
occur scattered throughout the chromosome. This is an important criterion to decide whether two 
isolates may represent the same strain and thus might indicate the occurrence of a transmission event. 
WGM of isolates presumably belonging to a HA-MRSA outbreak in the Netherlands revealed that several 
isolates did not belong to the outbreak. Although, this multi-center outbreak expanded over a long 
period of time and involved many different patients, the isolates we selected for this study originated 
from one center and were received within 2 weeks of each other. We believe that we were unable 
to assign all isolates as part of the outbreak because multiple strains yielding the same molecular 
characteristics (spa-typing, MLVA and PFGE) were circulating at the time of the outbreak. Indeed in 
2002, 19% (n=265) of all MRSA isolates sent to the RIVM had the PFGE-type that was identified as the 
outbreak-type. Of these isolates one-third originated from health care centers other than the two that 
were identified as the outbreak centers. This shows that the higher discriminatory power of WGM 
makes it possible to better assess whether isolates belong to an outbreak or not.      
We employed WGM to assess whether the technique is suitable to identify transmission events of 
LA-MRSA in a community setting (i.e. transmission from veterinarians to their household members). 
Indeed, we obtained virtually identical WGMs of the isolates obtained from the veterinarians and 
their household members. However, not all isolates were identical and two different clusters were 
identified among the isolates of one veterinarian and his household members. These results suggest 
that veterinarians may pick up different LA-MRSA strains during their visits to animal farms and become 
colonized for a longer time period. Apparently, veterinarians may carry different LA-MRSA strains in their 
nose and throat at the same time and both may be transmitted to their direct contacts. We conclude 
that WGM now enables us to identify transmission events of LA-MRSA which would be impossible using 
spa-typing or MLVA and with much more uncertainty when using PFGE. We are currently conducting 
WGM of isolates obtained from a larger number of veterinarians and their household members to 
study LA-MRSA transmission among this group in further detail.
Based on the comparisons made of replicates of both MRSA and LA-MRSA isolates in this report and 
allowing for the presence of occasional mobile elements we now consider MRSA isolates with WGMs 
that have similarities of 98% or higher as indistinguishable. Isolates with WGMs with similarities 
between 95–98% may represent the same strain or should be regarded as highly related strains and 
those with maps that have similarities below 95% are deemed different strains. These cut-off values 
are supported by a recent report of Shukla et al. in which WGM of S. aureus was described and where 
a map distance of 5% was chosen as a cut-off point to define a WGM cluster [16]. This cut-off value was 
used for WGM of clonally related USA300 MRSA isolates using XbaI as restriction enzyme, but seems to 
be valid for LA-MRSA and other restriction enzymes as well.  
We do acknowledge that based on our cut-off criteria the in silico maps and the maps created in our lab 
would not be designated as identical as would be expected. Although showing good concordance, we 
found inconsistencies in the size, number and order of fragments between the WGMs created in the 
lab and the in silico maps. The fragments present in the in silico maps were generally larger, but that 
should have been compensated for by the tolerance settings. The subcultures of the reference strains 
from which DNA was isolated to generate the whole genome sequences which were used to create the 
in silico maps and the subcultures used in our lab to create the real WGMs were not identical. Since 
the isolates used for comparison of in silico and real maps may have been subcultured for many years 
in various laboratories, changes in the genome may have occurred over time and this might explain 
for some of the observed differences. Another possible explanation could be that either the whole 
genome sequences of the isolates used for generating in silico maps contain sequence errors or that 
the assembly of the WGMs is inaccurate. However, the reproducibility of the WGM procedure assessed 
by repeated mapping of the same DNA sample on 4 consecutive days turned out to be excellent. To 
exclude that subculture of the reference isolates caused the observed differences we are currently 
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assessing the complete genome sequences of 3 LA-MRSA isolates and we will compare the in silico 
maps based on these sequences with those obtained in the lab. 
Molecular typing is used to characterize pathogens like MRSA in order to provide evidence that will 
support epidemiological studies on transmission and outbreaks. Furthermore, it is used to study 
changes in bacterial population structures e.g. to assess the effects of human intervention such as 
widespread antibiotic treatment and vaccination. WGM seems to be suitable to type LA-MRSA and 
identify transmission events where existing typing methods usually fail. An alternative that was not 
included in the analysis, but is rapidly gaining interest as typing tool, is whole genome sequencing 
(WGS). WGS has many advantages over WGM e.g. it will be very difficult to infer phylogenetic 
relationships and assess population structures using WGM, whereas WGS is very well suited for these 
purposes. Furthermore, sequencing can potentially reveal all details on gene composition, the presence 
of virulence factors, etc. Although we believe that WGS is the ultimate typing method, there may be a 
number of drawbacks for outbreak investigations leaving a niche for methods like WGM. WGS has been 
suggested as the best tool for typing during outbreak investigations and a number of papers have been 
published supporting this claim [29-32]. However, these studies are all retrospective investigations 
and they do not yet show the utility of real time WGS. Due to the relatively simple data analysis, WGM 
can provide a comparison with other maps within 2 days after the bacterial culture has been received, 
making it suitable to investigate real time transmission events and outbreaks involving pathogens such 
as LA-MRSA. Furthermore, the generated WGM data can be stored as a table containing the ordered 
restriction fragments e.g. in .xml-format and therefore are easy accessible, allowing users to quickly 
exchange data and compare isolates. 
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Transmission and persistence of livestock-associated 
























After the first isolation of livestock-associated MRSA (LA-MRSA) in 2003, this MRSA variant quickly 
became the predominant MRSA obtained from humans in the Dutch national MRSA surveillance. 
Previous studies have suggested that human-to-human transmission of LA-MRSA rarely occurs 
compared to other MRSA lineages. However, these reports describe the transmission of LA-MRSA 
based on epidemiology and limited molecular characterization of isolates, making it difficult to assess 
whether transmission actually occurred. In this study, we used whole genome mapping (WGM) to 
identify possible transmission of LA-MRSA between humans. For this, we used LA-MRSA isolates 
originating from a 2-year prospective longitudinal cohort study in which livestock veterinarians and 
their household members were repeatedly sampled for the presence of S. aureus. Considerable degree 
of genotypic variation amongst LA-MRSA strains was observed. However, there was very limited 
variability between the maps of the isolates originating from the same veterinarian, indicating that 
each of the veterinarians persistently carried or had re-acquired the same LA-MRSA. Comparison of 
WGMs revealed that LA-MRSA transmission had likely occurred within virtually every veterinarian 
household. Yet, only a single LA-MRSA strain per household appeared to be involved in transmission. 
The results corroborate our previous finding that LA-MRSA is genetically diverse. Furthermore, this 
study shows that transmission of LA-MRSA between humans occurs and that carriage of LA-MRSA can 
be persistent, thus posing a potential risk for spread in the community of this highly resistant pathogen.
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Introduction
Shortly after the introduction of methicillin in 1959, methicillin resistant Staphylococcus aureus (MRSA) 
emerged as an important human pathogen [1]. Currently, MRSA is held responsible for numerous 
hospital-acquired infections worldwide, such as skin infections and toxic shock syndrome [2]. MRSA 
also emerged as a community-acquired pathogen and in recent years has increasingly been isolated 
from livestock [3, 4]. Livestock-associated MRSA (LA-MRSA) can be separated from other MRSA strains 
as all strains belong to one MLST clonal complex. Since the first detection of LA-MRSA in 2003, it 
has been found in many countries worldwide [5-7]. In the Netherlands, LA-MRSA has become quite 
prominent making up for approximately 40% of all MRSA isolated from humans that were sent to the 
National Institute for Public Health and the Environment (RIVM) for molecular typing for the Dutch 
national MRSA surveillance. 
From 2002 until 2007 all Dutch MRSA isolates were typed with PFGE using SmaI, but because of its 
labor intensive character and the subjectivity involved in interpretation this method was replaced by 
spa-typing in 2007 [8, 9]. In addition, multiple-locus variable number of tandem repeat analysis (MLVA) 
was introduced for S. aureus in 2008 [10-12] and since then all isolates have been characterized by 
MLVA and spa-typing.
Although spa- and MLVA-typing are very well suited for characterizing most MRSA isolates, they 
provide very low discriminatory power for isolates belonging to MLVA complex 398 (MC398) [10, 13]. 
The limited differentiation of MC398 isolates, representing LA-MRSA, has impeded investigations on 
transmission events and possible outbreaks caused by LA-MRSA.
Transmission of LA-MRSA has been described in multiple reports, suggesting that human-to-human 
transmission of LA-MRSA is less likely to occur compared to other MRSA lineages [14, 15]. However, 
these reports describe the transmission of the MC398 (or CC398) clade based on epidemiology and 
limited molecular characterization of isolates, making it difficult to interpret if actual transmission-
events with LA-MRSA did occur. 
Recently, a new high-resolution typing technique for LA-MRSA was introduced named whole genome 
mapping (WGM) [13]. Using this method, epidemiologically unrelated LA-MRSA isolates that were 
previously indistinguishable by spa- and MLVA-typing, can now be differentiated. Furthermore, the 
method is able to identify transmission events between livestock veterinarians and their household 
showing its potential as typing tool for LA-MRSA. 
In the study presented here, we further investigated the potential of WGM to identify possible 
transmission of LA-MRSA between humans. To assess this, we used LA-MRSA isolates originating from 
a 2-year prospective longitudinal cohort study in which livestock veterinarians and their household 
members were repeatedly sampled for the presence of S. aureus [16, 17].    
Material and methods
Bacterial isolates and study design 
In this study, MRSA belonging to MC398 is defined and referred to as LA-MRSA. We used LA-MRSA 
isolates collected during a 2-year prospective longitudinal cohort study among 135 Dutch livestock 
veterinarians and their household members [16, 17]. Samples were taken at baseline (0 months, t = 
0m) and at 2-3 (t = 2m), 6 (t = 6m), 10 (t = 10m) and 14 (t = 14m) months after inclusion. From this study, 
we selected 161 LA-MRSA isolates from 16 epidemiologically unrelated veterinarians with presumed 
LA-MRSA transmission to their household members based on MLVA and spa-typing. Of the 161 LA-
MRSA isolates, 110 originated from the veterinarians and 51 LA-MRSA isolates were obtained from 
their household members (Table 1). 
All isolates were subjected to molecular characterization using the previously described spa-typing and 






































VET35 5 2–6 cl-05 4 H1 (1) None None
VET45 8 6–14 cl-10 3 H1 (3), H2 (2) H1: 6–10 cl-10
VET59 6 2–14 cl-01 3 H1 (1) None cl-01
VET66 7 0–14 cl-07 2 H1 (1), H2 (3) H2: 10–14 cl-07
VET78 6 0–10 cl-13 3 H1 (5) H1: 6–14 cl-13
VET84 7 2–14 cl-02 4 H1 (1), H2 (2) None cl-02
VET100 8 0–14 cl-06 3 H1 (1) None cl-06
VET155 8 0–14 cl-09 3 H1 (3) H1: 6–14 cl-09
VET212 9 0–14 cl-04 3 H1 (1) None cl-04
VET223 8 0–14 cl-07 1 H1 (3) H1: 6–10 cl-07
VET226 6 0–2, 6–10 cl-07, cl-08 4 H1 (6), H2 (2) H1: 2–6 and 6–14; H2: 6–10 cl-07, cl-08
VET247 7 0–14 cl-04 3 H1 (1), H2 (1) None cl-04
VET300 7 0–14 cl-02, cl-07 4 H1 (1), H2 (5), H3 (2) H2: 2–10 cl-07
VET312 6 0–10 cl-03 3 H1 (2) None cl-03
VET360 8 2–10 cl-11 1 H1 (2) H1: 2–6 cl-11
VET361 4 2–6 cl-07, cl-12 3 H1 (1), H2 (1) None cl-12
Veterinarians     Household members 
Table 1: Bacterial isolates used in this study
Household by
Whole genome mapping of S. aureus isolates
Whole genome maps (WGMs) of the 161 S. aureus isolates were created as described before [13]. 
Briefly, whole genome maps were created using DNA that was digested with restriction enzyme AflII in 
a micro-fluids system. The resulting restriction fragments were sized in the whole genome mapper and 
assembled into a whole genome map and subsequently imported into a database of Bionumerics version 
7.0 (Applied Maths, Sint-Martens-Latem, Belgium) for further analysis [13]. WGMs with similarities of 
≥98% were considered indistinguishable, LA-MRSA strains with WGMs with similarities between 95% 
and 98% were classified as highly related strains and LA-MRSA isolates with maps with a similarity 
<95% were regarded as different strains. Minimum spanning trees were created using a similarity 
matrix, whereas nodes with identical colors represent isolates from the same veterinarian (similarity 
bin size = 0). The halos represent complexes based on a similarity cut-off value for indistinguishable 
WGMs of ≥ 98%.
Ethics Statement 
This study was approved by the medical ethics committee of the St. Elisabeth Hospital in Tilburg, the 
Netherlands (protocol number 0749). All adult subjects had provided written informed consent. In case 
of any child participant, a parent or guardian provided written informed consent on their behalf. The 
reviewing medical ethics committee approved this consent procedure.
Results
Genetic diversity of LA-MRSA
MLVA-based molecular typing revealed that the 161 LA-MRSA isolates comprised 13 different MLVA-
types (MTs) of which 159 isolates belonged to MLVA-complex 398 (MC398). Although two isolates did 
not fulfil the MC398 complex-assignment criteria, they yielded MLVA-types that were strongly related 
to the MC398 complex MLVA-types and therefore were considered to be LA-MRSA.
When a cut-off value for indistinguishable whole genome maps of 98% was applied on all LA-MRSA 
isolates originating from 16 veterinarians (n = 110), 13 different clusters and 8 singletons were identified 
(Figure 1, A).  
Clustering of the WGMs in a minimum spanning tree revealed that 10 of the 13 clusters contained 
LA-MRSA isolates obtained from a single veterinarian, whereas three clusters (cl-02, cl-04 and cl-07) 
yielded isolates originating from multiple veterinarians. Of these three clusters, cl-02 contained all 
isolates from VET84 and five isolates from VET300. One of the other clusters (cl-04) yielded isolates 
belonging to two veterinarians (VET212 and VET247). Although isolates from these veterinarians were 
separated from each other in the dendrogram, the overall similarity between the most distinct maps of 
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the VETs in this cluster was 98.2%.  The third cluster (cl-07) comprised all isolates of VET223 and VET66 
(98.5%), three isolates from VET226 (99.2%), two isolates originating from VET300 (98.9%) and a single 
isolate from VET361 (98.3%).   
The isolates that did not partition into a cluster belonged to six different veterinarians. Half of these 
singletons (4/8) were grouped with isolates originating from the same veterinarian (2 isolates of 
VET45 (cl-10), 1 isolate of VET226 (cl-08) and 1 isolate of VET35 (cl-05)). The remaining four singletons 
clustered within a group of isolates from a different veterinarian.   
The genetic diversity of LA-MRSA was not observed with MLVA and spa-typing as eight of the 16 



















































Figure 1: Minimum spanning tree depicting the genotypic diversity among LA-MRSA isolates originating from 
veterinarians (n = 110). Each node in this minimum spanning tree represents the WGM of a single LA-MRSA 
isolate. Nodes with identical colors represent isolates from the same veterinarian. The halos represent groups 
based on a similarity cut-off value for indistinguishable WGMs of ≥ 98% (A). The demographic location of each 
veterinarian is represented in the map of the Netherlands (B). In the smaller version of the minimum spanning 
tree the colors of the nodes represent the spa-types (C).
Persistent carriage or re-acquisition of LA-MRSA
Although the genetic diversity of LA-MRSA found among the veterinarians in this study was high enough 
to distinguish different strains, there was very limited variability between the maps of the isolates 
originating from the same veterinarian. Based on the criterion of indistinguishable WGMs (≥98% 
similarity), each of the 16 veterinarians persistently carried or had re-acquired the same LA-MRSA 
strain during at least 2 sampling moments with carriage periods ranging between 4 and 14 months. 
In eight veterinarians the LA-MRSA isolates obtained at all sampling moments were indistinguishable, 
yet each veterinarian carried his own distinct strain. In addition, a single veterinarian likely carried the 






















isolates of the same veterinarian were 96.9% (VET35, cl-05) (Figure 1). This indicates that, according to 
our criteria, one of these isolates was a highly related yet distinct strain.
In three other veterinarians, isolates with indistinguishable WGMs were obtained at multiple sampling 
moments, but for each veterinarian an isolate with a different map belonging to a different cluster was 
found at one of the sampling moments (Figure 1, VET100, VET361 and VET78). In three of the remaining 
four veterinarians, two isolates differed from the other isolates originating from the veterinarian 
(Figure 1, VET300, VET45 and VET360). In a single veterinarian (VET226) two distinct LA-MRSA strains 
were obtained at multiple time points. The first strain was isolated at t = 0m and t = 2m (cl-07), whilst 
the second was isolated at t = 6m and at t = 10m (cl-08) (Figure 1, VET226).      
Transmission of LA-MRSA
Comparison of WGMs of LA-MRSA revealed that transmission had likely occurred within 14 of the 16 
veterinarian households (similarities per household ranging from 98.5% − 100%). In these 14 households, 
only a single LA-MRSA strain per household appeared to be involved in transmission and the WGMs of 
these LA-MRSA strains differed considerably between households (Figure 2). In addition, in one of the 
two remaining households (VET35), there was no likely transmission between the veterinarian and his 
household member, the similarity between the maps was 92.7% and following the definition, these 












































































Figure 2: Minimum spanning tree displaying transmission of LA-MRSA between veterinarians and household 
members. Each node in this minimum spanning tree represents the WGM of a single LA-MRSA isolate. Nodes 
with identical colors represent isolates from the same household. The isolates obtained from the household 
members of each veterinarian are indicated with “H”. The halos represent groups as defined in the minimum 
spanning tree of Figure 1.
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Multiple transmission events were observed within the household of veterinarian VET226. Over time, 
two different LA-MRSA strains were isolated from the two household members (HHM) and veterinarian 
at multiple sampling moments. The first strain, found in HHM226.1 at t = 2m (nose and throat) and t 
= 6m (nose), was also present in both isolates obtained from HHM226.2. The WGMs of three isolates 
from VET226 (t = 0m, t = 2m, t = 14m, nose) were considered as highly related to the maps of this LA-
MRSA strain (similarities ranging 96.2 − 97.0%). The second LA-MRSA strain of HHM226.1 was found at 
t = 6m (throat), t = 10m (nose) and t = 14m (nose).  This strain was also present among the LA-MRSA 
isolates of the veterinarian on sampling moments t = 6m (nose) and t = 10m (throat), while another 






























































Figure 3: Whole genome maps of isolates obtained from household (VET226) displaying colonization and 
transmission with different LA-MRSA strains at multiple sampling moments. The blocks in the maps represent 
the restriction fragments and blocks that were considered the have same size carry the same color. Blocks 
with reduced height were ignored in the comparison of the profiles. The upper panel of the figure displays the 
complete WGMs, the lower panel depicts a zoomed in region of the maps to display the variation in the restriction 
fragments. The origin of the sample, the sampling moment and the anatomic location of the sampling is indicated 
on the right. The dendrogram on the left displays two clusters A and B and the similarity between the most distant 
members of the clusters.
Besides transmission, persistent carriage or re-acquisition of the same LA-MRSA strain among 
household members was found in eight different households. Indistinguishable WGMs were found 
for LA-MRSA isolates obtained from household members at different sampling moments (Figure 2). 
In six of the households, this occurred in a single contact of each household and in the two remaining 
households persistence of LA-MRSA was observed in two household members (VET226, VET45). The 
























In this study, we used whole genome mapping, which revealed a considerable degree of genetic variation 
of LA-MRSA isolated from veterinarians and their household members from different geographic sources. 
Furthermore, we showed that there was frequent transmission of LA-MRSA between veterinarians and 
their household members. In addition, we have shown that both veterinarians and their household 
members carried LA-MRSA strains for prolonged periods of time with carriage lasting up to 14 months. 
This provides arguments that LA-MRSA is a successful human colonizer. 
Price et al. already showed that there is considerable genetic diversity among LA-MRSA CC398 isolates 
using whole genome sequence based SNP analysis. However, in their study, a broad selection of LA-
MRSA isolates originating from different countries, various sources and isolated between 1993 and 
2010 was used. In addition, only 30% (n = 26) of the LA-MRSA isolates in this study originated from 
humans. Genetic diversity is to be expected in such a broad selection of LA-MRSA strains. In our 
study, all LA-MRSA isolates originated from the Netherlands, were cultured from humans (specifically 
veterinarians and their household members) and were isolated within a period of 14 months. Even 
within this narrow selection, we still observed a considerable degree of genetic diversity. However, 
even with a high-resolution typing method as whole genome mapping LA-MRSA remains a clade that is 
genetically more homogenous compared to other MRSA variants. This was illustrated by the fact that 
WGMs of the most distinct LA-MRSA isolates used in this study still had an 83.9% similarity, whereas 
WGMs of other MRSA variants yielded similarities of approximately 60 − 70%.  For example, within a 
selection of seven pairs of MRSA isolates that all yielded MC8 and spa-type t008, the most distinct maps 
showed a similarity of 74% (data not shown).  In a minority of cases, we were unable to make a clear 
distinction between isolates obtained from two different veterinarians. This indicates acquisition of 
the same LA-MRSA strain in both veterinarians. A possible explanation may be that these veterinarians 
were colonized with LA-MRSA while visiting pig farms. Considering that pigs are distributed from one 
source to several farms, it is likely that identical strains are present in different farms [19, 20].  However, 
this remains speculation as we are unaware of what type of livestock farms the veterinarians visited 
and what the frequency of these visits were.  
Veterinarians and their household members were sampled longitudinally. Analysis of the WGMs of the 
LA-MRSA isolated during this period showed they carried the same strain up to 14 months. Whether 
this reflects persistent carriage or re-acquisition of the same LA-MRSA strain remains uncertain, but 
the veterinarians in this study generally visited two to three different farms each working day and up to 
ten different farms each week. Moreover, the household members had no direct contact with livestock 
animals. Therefore, it is likely that this reflects persistence of LA-MRSA within one individual and not 
re-acquisition. Also, Köck et al. showed that 59% of the subjected farmers enrolled in their study did 
not clear MRSA colonization during leave, corroborating our hypothesis that farmers are more likely to 
be persistently colonized with LA-MRSA than transiently contaminated [21].
Since its emergence in 2003, the ability of LA-MRSA to cause transmission from humans to humans 
has been a subject of debate. Many of the reports describe the limited transmissibility of the LA-MRSA 
(CC398) clade in general and rely on sub-optimal typing methods such as spa-typing, making it difficult 
to determine whether these events were actual transmissions [14, 15, 22, 23]. In our study, we focused 
on presumed LA-MRSA transmission events in a well-defined longitudinal cohort study using a high-
resolution typing technique, and this revealed that the presumed transmissions were indeed likely 
transmissions in nearly every household. However, we do acknowledge that the previously described 
transmissibility studies were performed in hospital settings and that the outcome might differ 
considerable under these conditions. Contact between veterinarians and their household members will 
be more frequent and prolonged than contact between healthcare workers and patients and between 
patients. Therefore, transmission will be more likely to occur in households of veterinarians than in 
healthcare facilities. To assess whether the presumed nosocomial transmission of LA-MRSA is really 
occurring or whether this is a misinterpretation due to the use of low-resolution typing methods, we 
are currently analyzing isolates obtained from persons involved in presumed nosocomial transmission 
of LA-MRSA.
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In conclusion, our results show that LA-MRSA is genetically diverse and that this genetic variation can 
be used to characterize LA-MRSA strains. Also, we showed that carriage of LA-MRSA in veterinarians 
and their household members can be persistent, lasting up to 14 months. Furthermore, this study 
demonstrates that transmission of LA-MRSA between veterinarians and their household members 
occurs, posing a potential risk for spread in the community of this highly resistant pathogen. 
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Changing characteristics of livestock-associated 
meticillin-resistant Staphylococcus aureus isolated 
from humans. Emergence of a subclade transmitted 













































Since 2007, livestock-associated meticillin-resistant Staphylococcus aureus (LA-MRSA) has become 
the predominant MRSA clade isolated from humans in the Netherlands. To assess possible temporal 
changes, we molecularly characterised over 9,000 LA-MRSA isolates submitted from 2003 to 2014 to 
the Dutch MRSA surveillance. After an initial rapid increase with a peak in 2009 (n = 1,368), the total 
number of submitted LA-MRSA isolates has been slowly decreasing to 968 in 2014 and over 80% of LA-
MRSA belonged to one of three predominant MLVA/spa-types. Next generation sequencing (n=118) 
showed that MT569/t034 isolates were genetically more diverse than MT398/t011 and MT572/t108. 
Concurrent with the decrease in LA-MRSA, fewer people reported having contact with livestock and this 
was most prominent for people carrying MT569/t034 LA-MRSA. The proportion of LA-MRSA isolated 
from infection-related materials increased from 6% in 2009, to 13% in 2014 and most of these isolates 
originated from patients older than 50 years of age. Remarkably, 83% of these patients reported not 
having contact with livestock. The results reveal an ongoing change in the genotypic and epidemiological 
characteristics of Dutch LA-MRSA isolated from humans with the emergence of a LA-MRSA subclade 




Meticillin-resistant Staphylococcus aureus (MRSA) is an important cause of hospital-acquired and 
community-acquired infections [1]. In 2003, a clonal lineage of MRSA cultured from pig farmers and 
designated as multilocus sequence typing clonal complex 398 (CC398), emerged in the Netherlands 
and France [2, 3]. A large number of countries reported CC398 cultured from animals, revealing a 
worldwide prevalence [4, 5]. CC398 has been found in pigs and other livestock, such as calves, and 
poultry [6, 7], and therefore designated as livestock-associated MRSA (LA-MRSA). LA-MRSA is prevalent 
in many European countries and LA-MRSA CC398 isolated from humans has become the predominant 
MRSA clade among isolates submitted for typing in the Dutch MRSA surveillance programme since 
2007 [5, 8].
Despite its widespread occurrence, the number of reported infections with LA-MRSA among humans 
remains low. In addition, nosocomial transmission of LA-MRSA in Dutch hospitals was reported to 
be 72% less likely to occur compared with non-LA-MRSA, although outbreaks of LA-MRSA have been 
described [9, 10]. The reason for this limited transmissibility remains unclear, but several studies 
suggest that the human innate immunomodulatory genes on bacteriophage φ3 are important genetic 
markers for the adaptation of LA-MRSA towards humans and human-to-human transmission of CC398 
[11-13].
LA-MRSA represents a homogenous clade with limited differentiation using typing techniques such as 
multiple-locus variable number of tandem repeat analysis (MLVA), and staphylococcal protein A (spa-
) typing [14]. In contrast, whole genome mapping, and next generation sequencing (NGS), revealed 
more genotypic diversity and suggested a distinction between livestock- and human-associated CC398 
clades, although most studies are dominated by isolates obtained from animals and the human-
associated isolates were mostly comprised of meticillin-sensitive S. aureus [12,14-16].
In this study, molecular characterisation, including NGS, and epidemiological data of more than 9,000 
LA-MRSA isolates submitted to the national MRSA surveillance from 2003 to 2014 were used to assess 
the characteristics of the most predominant MRSA clade in the Netherlands.
Material and methods
Bacterial isolates
MRSA isolates, obtained from humans admitted to healthcare centers, were submitted for molecular 
typing to the National Institute of Public Health and the Environment (RIVM) to the Dutch national MRSA 
surveillance. All S. aureus isolates were subjected to spa-typing, and MLVA. The MLVA also includes the 
detection of the genes for mecA, mecC and the lukF gene, indicative for Panton-Valentine leucocidin 
(PVL) [15, 16]. Isolates belonging to MLVA complex 398 (MC398) were classified as LA-MRSA. All isolates 
not belonging to MC398 were designated as non-LA-MRSA. The discriminatory power of MLVA was 
assessed using Simpson’s index of diversity, while the determination of the confidence intervals (CI) of 
the Simpson’s indices was calculated as described by Grundmann et al. [17, 18]. Only the first isolate 
per person per year was included. Medical microbiologists or infection control practitioners filled out 
questionnaires regarding epidemiological risk factors for MRSA colonisation or infection, including 
contact with livestock.
Classification of materials
The MRSA isolates were sampled from various materials and sites. Materials were subdivided in four 
different classes. Swabs from nose and/or throat, and/or perineum were regarded as material indicative 
for ‘carriage’. Blood, cerebrospinal fluid (CSF), pus, sputum, urine, and wounds were considered as 
‘infection-related’ materials. Other human materials were grouped as ‘other’ and if submitted without 
information regarding material, they were grouped as ‘unknown’.
Next generation sequencing
The first 10 (if available) isolates of the three predominant LA-MRSA MLVA/spa-types from 2003 to 






























isolates was performed as part of the 100k genome project by Davis University using the Hiseq 2000 
[19]. Data were used for whole genome multilocus sequence typing (wgMLST), and single nucleotide 
polymorphism (SNP-) analysis. wgMLST was performed by SeqSphere software version 2.3.0 (Ridom 
GmbH, Münster, Germany) using the available wgMLST S. aureus scheme. For SNP analysis, the core 
genome, of a complete, circular and annotated reference chromosome of a Dutch LA-MRSA isolate was 
used. SNPs were identified using the CLCbio Genomics Server/Workbench, version 7.5 (CLCbio, Aarhus, 
Denmark) and SNP data were imported into Bionumerics version 7.5 for analysis (Applied Maths, Sint-
Martens-Latem, Belgium).
φ3-specific PCR
We designed the φ3-specific primers based on the φ3 sequence present in reference strain NCTC8325 
(CP000253): fluorescently labelled forward primer Sa3-Int-PET-f (TGATTTGTACGGGTTGTC), and the 
reverse primer Sa3-Int-r (TACTTATGACGTCCATAATGTG). The φ3 primers (10 pmol/µl) were added in 
our MLVA mix2, allowing detection of φ3 as a 160 bp peak. All LA-MRSA and non-LA-MRSA isolates 
obtained from August 2012 to October 2013 were tested for the presence of φ3.
Results
Genotypic diversity of LA-MRSA vs non-LA-MRSA
During the study period, we identified 17,079 isolates as non-LA-MRSA and 10,318 as LA-MRSA. 
Inclusion of only the first isolate per person per year resulted in 9,246 LA-MRSA isolates, and 13,699 
non-LA-MRSA isolates to be analysed in this study for the period from 2003 to 2014. Questionnaires 
were available for 5,958 persons from whom LA-MRSA was isolated during the period from 2006 to 
2013.
Genotypic diversity among non-LA-MRSA isolates was higher than LA-MRSA (Figure 1). For instance, 
MC5 (n = 3,202), the most frequently found non-LA-MRSA MLVA complex, comprised 244 MLVA-types 
(MTs). In contrast, MLVA yielded only 144 MTs among the 9,246 LA-MRSA (MC398) isolates, resulting 
in a diversity index (DI) of 0.64 (95% CI: 0.63–0.65). The predominant MT was MT398 (n = 5,111, 
55%), followed by MT572 (n = 1,872, 20%), and MT569 (n = 603, 7%). Spa-typing was slightly less 
discriminatory yielding 120 spa-types (DI = 0.60, 95% CI: 0.59–0.61). Spa-types t011 (n = 5,422, 59%), 
t108 (n = 1,860, 20%), and t034 (n = 723, 8%) were predominant.
Based on MLVA and spa-typing combined, the three predominant LA-MRSA types were MT398/t011 
(n = 5,043, 55%), MT572/t108 (n = 1,742, 19%), and MT569/t034 (n = 594, 6%). These top three types 
accounted for 80% of all LA-MRSA isolates. No other combination of MT and spa-type accounted for 
more than 2% of the LA-MRSA isolates.
Panton-Valentine leukocidin and φ3 in Dutch LA-MRSA isolates
The presence of the lukF gene, indicative for the production of the Panton-Valentine leukocidin (PVL), 
was determined in all 9,246 LA-MRSA isolates, but found in only 23 (0.2%) with a great variety in MLVA/
spa-types. Ten of the 23 PVL positives originated from persons younger than 10 years, four of whom 
were adoption children from China. The proportion of non-LA-MRSA isolates carrying the lukF gene 
was 26% (n = 3,585).
Between August 2012 and October 2013 1,538 LA-MRSA and 3,405 non-LA-MRSA isolates were tested 
for the presence of φ3. The prevalence of φ3 among LA-MRSA isolates was 2% (34/1,538). There was 
a difference in φ3 prevalence among the top three MLVA/spa-types; 7% (11/166) in MT569/t034, 2% 
(13/838) in MT398/t011, and 0.6% (1/180) in MT572/t108 isolates. In contrast, prevalence in non-LA-











Figure 1: Minimum spanning tree of S. aureus isolates typed by MLVA, the Netherlands, 2008-2014 (n = 22,945).
Clustering of MLVA profiles was done using a categorical coefficient and the MLVA types are displayed as circles. 
The size of each circle indicates the number of isolates with this particular type. Colors denote MLVA types that 
belong to the same MLVA complex, which are also indicated in characters e.g. MC398. Due to the large number 






























Whole genome multilocus sequence typing and single nucleotide polymorphism analysis
Both wgMLST and SNP analysis of 118 isolates of the three predominant LA-MRSA types showed that 
they clustered in three different groups (Figure 2). Of the 1,864 genes of the S. aureus wgMLST scheme, 
1,831 were present in all 118 isolates and used for comparison and tree construction. LA-MRSA isolates 
belonging to MT398/t011 (n = 45) clustered closely together as did MT572/t108 (n = 44) isolates. The 
average distance between MT398/t011 isolates was allelic variation in 25 genes with a maximum of 60 
genes and for MT572/t108, the average distance was 24 genes with a maximum of 52 genes. The closest 
related isolates of the two groups differed in 145 genes. Compared with MT398/t011 and MT572/t108, 
the genetic diversity among the MT569/t034 (n = 29) isolates was higher. The MT569/t034 isolates 
differed on average 34 genes with a maximum of 148 genes. The distances between MT569/t034 and 
MT398/t011, and MT572/t108 were 102 and 136 genes, respectively.
We identified 7,944 SNP positions in the core genome and used these for comparison. The minimum 
spanning tree was comparable to the wgMLST tree with groups of closely related MT398/t011, and 
MT572/t108 isolates and a genetic diverse MT569/t034. The average number of SNPs that differed 
among members of the MT398/t011 group was 43 with a maximum of 117 SNPs, while the MT572/
t108 isolates differed on average in 39 SNPs with a maximum of 80 SNPs between the most distant 















Figure 2: Minimum spanning trees based on next generation sequencing of LA-MRSA isolates, the Netherlands, 
2003-2012 (n = 118). The left panel displays the minimum spanning tree based on 1,831 genes of the S. 
aureus wgMLST scheme, while the right panel shows the tree based on 7,944 SNPs. Colors represent the top 3 
representatives of LA-MRSA, MT398/t011 (n = 45), MT572/t108 (n = 44) and MT569/t034 (n = 29). The lengths 
of the lines between isolates represent either the number of different genes (wgMLST) or the number of SNPs.
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Decrease in the number of submitted LA-MRSA isolates
After its emergence in 2003, the number of LA-MRSA isolates submitted for typing rapidly increased 
from 20 in 2003 to 1,019 in 2008. At its peak, in 2009, 1,368 of the 3,163 (43%) MRSA isolates (first 
isolate per person per year) sent to the RIVM were LA-MRSA, but since then the numbers dropped. In 
2014, the total number of submitted MRSA isolates was 3,228, of which 968 (30%) were LA-MRSA. The 
decrease could be largely attributed to the drop in submitted MT398/t011, and MT572/t108 isolates. 
In contrast, the number of isolates with MT569/t034 has been increasing since 2008. In 2014, 12% 
(n = 117) of the 968 LA-MRSA isolates were of MT569/t034, surpassing MT572/t108 as the second 
most frequently isolated Dutch LA-MRSA type.
A geographical comparison between 2009 and 2014 showed a steady decrease of MT398/t011 in the 
four provinces, Noord-Brabant, Gelderland, Limburg, and Overijssel, where LA-MRSA is predominant 
and a slight increase in the other Dutch provinces (Figure 3A). This was most prominent in the province 
of Noord-Brabant where a decrease of 40% occurred over time. A similar trend was seen for MT572/
t108 LA-MRSA, a type predominantly found in Noord-Brabant resulting in a 69% decrease between 
2009 and 2014. In contrast, there was a marked increase until 2013 in the number of submitted MT569/
t034 isolates that was not restricted to a particular province. In 2014, the number of isolates slightly 
decreased in the four provinces, but this did not to occur in the rest of the Netherlands. In 2009, 56% of 





































































































Figure 3: Geographic origin of the top three LA-MRSA genotypes by provinces, the Netherlands, 2009 and 
2014. The number of submitted isolates of the top-three LA-MRSA representatives in the four provinces where 
LA-MRSA was predominant vs the rest of the Netherlands is shown in panel A. The geographic origin of LA-MRSA 






























Concurrent with the drop in the number of submitted LA-MRSA, a decrease in the number of pig 
farms in the Netherlands occurred (Figure 4). This decline was most prominent in the provinces 
Noord-Brabant and Gelderland. In addition, the number of people working in the Dutch agricultural 
sector has declined by 35% between 2000 and 2014 [20]. However, the number of pigs remained 
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Figure 4: Number of pig farms and number of pigs by provinces, the Netherlands, 2009 and 2014.
Data source: statline.cbs.nl/statweb.
LA-MRSA related to contact with livestock
In 2008, 60–66% of persons carrying any of the three predominant LA-MRSA types reported contact 
with livestock. When stratified by the top three MLVA/spa-types an initial increase of contact with 
livestock from 2008 to 2010 was reported for people carrying isolates with MT398/t011, and MT572/
t108 (Figure 5). After 2010, the proportion of humans reporting contact with livestock decreased again 
for both types reaching 62% (244/391) and 66% (49/74) for MT398/t011, and MT572/t108, respectively. 
In contrast, a considerable decrease in reported livestock contact occurred in people with MT569/t034 





























Figure 5: Changes in the proportion of people carrying LA-MRSA who report having contact with livestock, the 
Netherlands, 2008‒13. The proportion is expressed as the percentage of people who reported having livestock 
contact per MLVA/spa-type for the top three LA-MRSA types.
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Sample origin of LA-MRSA isolates
Most of the isolates submitted for typing originated from carriage-related materials. In 2009, 6% 
(76/1,205) of the LA-MRSA isolates were cultured from infection-related materials and despite a drop 
in the number of LA-MRSA, this proportion increased to 13% (111/841) in 2014 (Figure 6A). In contrast, 
the number of non-LA-MRSA isolates increased during the same period, yet the proportion of isolates 
from infection-related materials decreased from 35% (529/1,510) in 2009 to 27% (487/1,835) in 2014.
Of the infection-related LA-MRSA isolates, most samples originated from wounds and sputum (Figure 
6B). In 2009, 3% (37/1,205) of the LA-MRSA isolates were cultured from wounds and this increased to 
7% (61/841) in 2014. For LA-MRSA isolates originating from sputum, an increase from 1% (16/1,205) 
in 2009 to 4% (29/841) in 2014 was seen. In contrast, the proportion of wound and sputum samples 
in the non-LA-MRSA slightly decreased during the same period. The distribution of MLVA/spa-types of 













































































Figure 6: Sample origin of submitted MRSA isolates, the Netherlands, 2009 and 2014 (n = 5,391). The graph in 
panel A shows the number of persons with submitted carriage or infection-related LA-MRSA and non-LA-MRSA 
isolates. The numbers above the bars are the exact number of submitted isolates for each material class. The 
sample origin of the infection-related LA-MRSA and non-LA-MRSA are depicted in panel B.
Age-distribution among people carrying LA-MRSA
The median age of people carrying LA-MRSA and those carrying non-LA-MRSA was similar at 48 (range 
0 to 105 years), and 49 years (range 2 to 103 years), respectively. However, stratification into age groups 
revealed a large difference between LA-MRSA carriers and non-LA-MRSA carriers (Figure 7A). In people 
carrying LA-MRSA, age categories followed a Gaussian distribution with a peak at 41–50 years. The 
proportion of infection-related isolates increased with increasing age, from 5% in the 0–9 years age 
group to 44% in the 80–89 years age group. In contrast, there was an almost even age distribution in 
persons carrying non-LA-MRSA and the proportion of infection-related isolates increased from 18% 
to 37% in age groups 0–9 years, and 80–89 years, respectively. Remarkably, there was a dip in the age 






























There was a Gaussian age distribution of people carrying LA-MRSA, who reported having contact with 
livestock, and the vast majority was carriage (Figure 7B). The age groups of people carrying LA-MRSA, 
who reported not having contact with livestock, were also distributed in a Gaussian fashion, but with 
lower amplitude. The proportion of infection-related isolates was much higher than in the group of 
people reporting contact with livestock, increasing from 10% in age group 0–9 years to 59% in the age 
group 80–89 years. In contrast, in people reporting livestock contact, proportions were only 2%, and 



















































































































B. LA-MRSA carriers who reported livestock contact  LA-MRSA carriers who reported not having livestock contact
Figure 7: Age distribution among people carrying MRSA, the Netherlands, 2003-14. The graphs in panel A 
show the age distribution of persons carrying LA-MRSA or non-LA-MRSA. The left graph in panel B shows the age 
distribution of people carrying LA-MRSA who reported having contact with livestock, while the right graph shows 
the age distribution of LA-MRSA carriers who reported not to have contact with livestock. The stacks in the bars in 
both panels represent the material classes of the submitted isolates. The proportion of infection-related isolates 
is displayed above the bars.
Discussion
In this study, we used a collection of more than 9,000 LA-MRSA isolates originating from humans 
obtained over the years 2003 to 2014. We showed an increase in the number of MT569/t034 LA-
MRSA isolates, despite a decrease in the total number of LA-MRSA isolates in the Netherlands in 
recent years. NGS demonstrated that MT398/t011 isolates and MT572/t108 isolates partitioned in two 
genetically homogeneous groups, while MT569/t034 isolates did not partition in a single group and 
were genetically more diverse. Since 2010, humans carrying LA-MRSA less frequently reported having 
contact with livestock and this was most prominent for persons carrying MT569/t034 LA-MRSA.
The total number of MRSA isolates submitted for typing to the Dutch MRSA surveillance has been 
increasing since the start of the surveillance programme in 1989.
Since the first finding in 2003, the number of submitted LA-MRSA isolates increased rapidly until 2009 
when the proportion of LA-MRSA was 43%. After that, the number of submitted LA-MRSA isolates 
dropped from 1,393 in 2009 to 968 in 2014 and as a result, the proportion of LA-MRSA decreased to 
30% in 2014. Possible explanations for this decrease could be a reduced number of persons exposed to 
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LA-MRSA, since we observed a concurrent decline in the number of pig farms and people working the 
agricultural sector, although the number of pigs did not diminish. Also, there may be a reluctance of 
medical microbiology laboratories to submit LA-MRSA isolates as current typing poorly discriminates 
LA-MRSA, transmissibility between humans is considered to be low, and the perception may exist that 
infections with LA-MRSA occur only sporadically. However, we observed an increase in the number 
of submitted LA-MRSA isolated from infection-related materials, and this resulted in doubling the 
proportion of infection-related LA-MRSA from 6% in 2009 to 13% in 2014 and the majority of infection-
related LA-MRSA originated from wounds and sputum. This shows that LA-MRSA is not only successful in 
colonising humans, but is also capable of causing infections. It also suggests that medical microbiology 
laboratories that have already assessed that an isolate is LA-MRSA, prefer to submit LA-MRSA isolated 
from infection-related materials rather than carriage isolates. This is not the case for non-LA-MRSA, as 
the number of submitted carriage-related isolates is increasing, while the number of infection-related 
isolates remains unchanged.
Analyses of the NGS data of the three predominant LA-MRSA types revealed three different groups. 
There was no overlap between the types, suggesting that these LA-MRSA types are three unique and 
independently evolving LA-MRSA clades. The genetically most diverse variant was MT569/t034, the 
type that rapidly increased in the Netherlands in recent years. This finding suggests that this particular 
LA-MRSA variant is more adapting towards humans leading to spread to regions of the Netherlands 
where LA-MRSA is not the predominant MRSA variant and where density of livestock farms is relatively 
low. Furthermore, the observation that there was a strong decrease in the number of people who 
reported having contact with livestock while carrying MT569/t034 LA-MRSA suggests that the spread 
of this LA-MRSA variant also occurs through routes other than livestock-human transmission. Recently, 
two studies from the Netherlands showed that a large proportion of the MRSA without known origin 
belonged to the LA-MRSA clade, corroborating our suggestion that LA-MRSA is capable of spreading 
without livestock exposure [21, 22]. The φ3 phage, proposed by several studies as one of the markers 
for the adaptation of LA-MRSA towards humans, was nearly absent in our collection, although φ3 
prevalence was highest (7%) among MT569/t034 isolates [11, 12, 23]. This suggests that φ3, at least in 
the Netherlands, plays a limited role in the adaptation of LA-MRSA to the human host.
Previous studies have shown that carriage of LA-MRSA is strongly associated with working in livestock 
farms. The Gaussian age distribution of people carrying LA-MRSA who reported livestock contact with 
most of the isolates from people aged between 21–70 years, i.e. the period when most people have an 
active working career, corroborates this association. The age distribution curve in people who reported 
not to have contact with livestock was flatter and had a dip in the age group 11–20 years similar to the 
dip in the non-LA-MRSA curve. Furthermore, the proportion of infection-related isolates in those who 
reported livestock contact was lower than in those reporting not to have contact with livestock. In the 
latter group, this proportion increased with age. The reasons for this remarkable difference in apparent 
pathogenicity remain unclear. However, it suggests that LA-MRSA are becoming more adapted to 
humans and start to resemble non-LA-MRSA in transmissibility and pathogenicity.
Our study has a number of limitations. First, all MRSA isolates originated from humans, limiting a 
comparison between LA-MRSA obtained from animals and humans. Second, we do not know if the 
question regarding animal contact in the available questionnaires was answered correctly. It could be 
that patients failed to remember livestock contact or misinterpreted the question and answered not 
having livestock contact. Third, our study only used the φ3 phage as indicator for animal or human 
CC398 lineages. Other markers such as tetracycline resistance and canonical SNPs as reported by 
Stegger et al. could perhaps have provided more differentiation [24]. Finally, we grouped the MRSA 
isolates in different material classes. However, it is uncertain whether isolates obtained from infection-
related materials really caused MRSA infections. For instance, LA-MRSA positive sputum samples 
could also be the result of a contamination of the sputum sample due to carriage with LA-MRSA in the 
bacterial flora of the throat.
In conclusion, the emergence of a LA-MRSA subclade transmitted without livestock contact could have 






























future adaptations in for instance virulence of LA-MRSA could be unnoticed for prolonged periods if 
different strategies are used. Therefore, careful monitoring of the different LA-MRSA MC398 types 
through the national MRSA surveillance and a uniform search and destroy policy regardless which 
MRSA variant, remains necessary.
Acknowledgements
We would like thank the Dutch medical microbiology laboratories and hospitals for sending in the 
Staphylococcus aureus isolates for molecular typing. Without their contribution this study could not 
have been performed.
References
1. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, et al. Community-acquired methicillin-resistant 
Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerging infectious diseases. 
2003;9(8):978-84.
2. Armand-Lefevre L, Ruimy R, Andremont A. Clonal comparison of Staphylococcus aureus isolates from healthy pig 
farmers, human controls, and pigs. Emerging infectious diseases. 2005;11(5):711-4.
3. Voss A, Loeffen F, Bakker J, Klaassen C, Wulf M. Methicillin-resistant Staphylococcus aureus in pig farming. Emerging 
infectious diseases. 2005;11(12):1965-6.
4. Bhat M, Dumortier C, Taylor BS, Miller M, Vasquez G, Yunen J, et al. Staphylococcus aureus ST398, New York City and 
Dominican Republic. Emerging infectious diseases. 2009;15(2):285-7.
5. van Cleef BA, Monnet DL, Voss A, Krziwanek K, Allerberger F, Struelens M, et al. Livestock-associated methicillin-
resistant Staphylococcus aureus in humans, Europe. Emerging infectious diseases. 2011;17(3):502-5.
6. Graveland H, Wagenaar JA, Verstappen KM, Oosting-van Schothorst I, Heederik DJ, Bos ME. Dynamics of MRSA 
carriage in veal calves: a longitudinal field study. Preventive veterinary medicine. 2012;107(3-4):180-6.
7. Nemati M, Hermans K, Lipinska U, Denis O, Deplano A, Struelens M, et al. Antimicrobial resistance of old and 
recent Staphylococcus aureus isolates from poultry: first detection of livestock-associated methicillin-resistant strain ST398. 
Antimicrobial agents and chemotherapy. 2008;52(10):3817-9.
8. Huijsdens XW, Bosch T, van Santen-Verheuvel MG, Spalburg E, Pluister GN, van Luit M, et al. Molecular 
characterisation of PFGE non-typable methicillin-resistant Staphylococcus aureus in The Netherlands, 2007. Euro surveillance 
: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 2009;14(38).
9. Huijsdens XW, van Dijke BJ, Spalburg E, van Santen-Verheuvel MG, Heck ME, Pluister GN, et al. Community-acquired 
MRSA and pig-farming. Annals of clinical microbiology and antimicrobials. 2006;5:26.
10. Wassenberg MW, Bootsma MC, Troelstra A, Kluytmans JA, Bonten MJ. Transmissibility of livestock-associated 
methicillin-resistant Staphylococcus aureus (ST398) in Dutch hospitals. Clinical microbiology and infection : the official 
publication of the European Society of Clinical Microbiology and Infectious Diseases. 2011;17(2):316-9.
11. McCarthy AJ, van Wamel W, Vandendriessche S, Larsen J, Denis O, Garcia-Graells C, et al. Staphylococcus aureus 
CC398 clade associated with human-to-human transmission. Applied and environmental microbiology. 2012;78(24):8845-8.
12. Price LB, Stegger M, Hasman H, Aziz M, Larsen J, Andersen PS, et al. Staphylococcus aureus CC398: host adaptation 
and emergence of methicillin resistance in livestock. mBio. 2012;3(1).
13. Foster TJ. Immune evasion by staphylococci. Nature reviews Microbiology. 2005;3(12):948-58.
14. Bosch T, Verkade E, van Luit M, Pot B, Vauterin P, Burggrave R, et al. High Resolution Typing by Whole Genome Mapping 
Enables Discrimination of LA-MRSA (CC398) Strains and Identification of Transmission Events. PloS one. 2013;8(6):e66493.
15. Harmsen D, Claus H, Witte W, Rothganger J, Claus H, Turnwald D, et al. Typing of methicillin-resistant Staphylococcus 
aureus in a university hospital setting by using novel software for spa repeat determination and database management. 
Journal of clinical microbiology. 2003;41(12):5442-8.
16. Schouls LM, Spalburg EC, van Luit M, Huijsdens XW, Pluister GN, van Santen-Verheuvel MG, et al. Multiple-locus 
variable number tandem repeat analysis of Staphylococcus aureus: comparison with pulsed-field gel electrophoresis and spa-
typing. PloS one. 2009;4(4):e5082.
17. Lekkerkerk WS, van de Sande-Bruinsma N, van der Sande MA, Tjon ATA, Groenheide A, Haenen A, et al. Emergence 
of MRSA of unknown origin in the Netherlands. Clinical microbiology and infection : the official publication of the European 
Society of Clinical Microbiology and Infectious Diseases. 2012;18(7):656-61.
18. van Rijen MM, Bosch T, Verkade EJ, Schouls L, Kluytmans JA, Group CAMS. Livestock-associated MRSA carriage in 
patients without direct contact with livestock. PloS one. 2014;9(6):e100294.
19. McCarthy AJ, Witney AA, Gould KA, Moodley A, Guardabassi L, Voss A, et al. The distribution of mobile genetic 
elements (MGEs) in MRSA CC398 is associated with both host and country. Genome biology and evolution. 2011;3:1164-74.
20. Stegger M, Liu CM, Larsen J, Soldanova K, Aziz M, Contente-Cuomo T, et al. Rapid differentiation between livestock-
associated and livestock-independent Staphylococcus aureus CC398 clades. PloS one. 2013;8(11):e79645.
82
Next generation sequencing confirms presumed 







































Livestock-associated MRSA was detected in 2003 and rapidly became the predominant MRSA clade in 
the Netherlands. Studies have shown that transmissions are difficult to identify since this MRSA variant 
represents a genetically homogenous clade when current typing techniques are used. Here, next 
generation sequencing was performed on 206 LA-MRSA isolates to assess the capability of LA-MRSA 
to transmit between humans. The usefulness of single nucleotide variants (SNVs), the composition of 
the SCCmec region and the presence of plasmids to identify transmission of LA-MRSA was assessed. In 
total, 30 presumed putative nosocomial transmission events and two LA-MRSA outbreaks were studied 
and in most cases, SNV analysis revealed that the isolates of the index patient and the contact(s) 
clustered closely together. In three presumed events, the isolates did not cluster together indicating 
that transmission was unlikely. The composition of the SCCmec region corroborated these findings. 
However, plasmid identification did not support our SNV analysis since different plasmids were present 
in several cases where SNV and SCCmec analysis suggested that transmission was likely.
Next-generation sequencing shows that transmission of LA-MRSA does occur in Dutch health care 
settings. Transmission was identified based on SNV analysis combined with epidemiological data 
and in the context of epidemiologically related and unrelated isolates. Analysis of the SCCmec region 
provided limited, albeit useful information to corroborate conclusions on transmissions, but plasmid 
identification did not.
Importance
In 2003, a variant of methicillin-resistant Staphylococcus aureus (MRSA) isolated from pigs was also 
found in pig farmers in France and the Netherlands. Soon thereafter, this livestock-associated MRSA 
(LA-MRSA) was identified in many other countries. Transmission of LA-MRSA between humans, 
particularly in the health care setting, is regarded to occur sporadically. Moreover, studies that do 
describe LA-MRSA transmission used molecular characterization of isolates with limited discriminatory 
power, making the validity of the conclusion that transmission occurred questionable. In our study, we 
sequenced the complete genomes of 206 LA-MRSA isolates, obtained from more than 30 presumed LA-
MRSA transmission events. Analysis of the data showed that transmission of LA-MRSA between humans 
had indeed occurred in more than 90% of these events. We conclude that transmission of LA-MRSA 
between humans does occur in Dutch health care settings and therefore a decision to discontinue the 
search and destroy policy for LA-MRSA should be taken with caution.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is an important cause of hospital-acquired and 
community-acquired infections [1]. In 2003, a MRSA variant cultured from pigs and pig farmers emerged 
in the Netherlands and France [2, 3]. This clonal lineage was designated as MLST clonal complex 398 
(CC398) and a large number of countries reported CC398 cultured from animals, revealing a worldwide 
prevalence [4, 5]. Besides pigs, CC398 has been found in other livestock animals, such as veal calves, 
and poultry [6, 7], and was therefore designated as livestock-associated MRSA (LA-MRSA). In the 
Netherlands, LA-MRSA CC398 isolated from humans has become the predominant MRSA clade among 
isolates submitted for typing in the Dutch MRSA surveillance program since 2007 [5, 8]. 
Despite its high prevalence, the capability of LA-MRSA to transmit between humans has been a subject 
of debate. Transmission of LA-MRSA between animals and from animals to humans has been described 
in detail and transmission occurs frequently [9]. For human-to-human transmission of LA-MRSA, this is 
less clear and studies on this subject focused on two topics, namely transmission between humans in 
a livestock setting or within a healthcare setting. Within the livestock setting, transmission of LA-MRSA 
between humans has been described in livestock farmers where transmission among broilers, humans 
and their environment was found [10]. A recent study showed that transmission of LA-MRSA from the 
livestock veterinarian to household members who reported not having livestock-contact occurred in 15 
of the 16 investigated households [11]. Surveys on the transmission of LA-MRSA within the healthcare 
setting showed that LA-MRSA was 4 to 6 times less transmissible than other MRSA lineages [12, 13]. In 
addition, nosocomial transmission of LA-MRSA in Dutch hospitals was reported to be 72% less likely to 
occur compared to non-LA-MRSA [14]. On the other hand, outbreaks of LA-MRSA have been described 
and two recent reports showed that between 21% and 26% of the MRSA isolates cultured from persons 
without known MRSA risk factors, the so-called MRSA of unknown origin (MUO), were LA-MRSA [15, 
16]. These MUOs suggest spread of LA-MRSA through other routes than by livestock exposure. 
One of the difficulties regarding investigations on transmission routes of LA-MRSA is that this MRSA 
variant represents a genetically homogenous clade resulting in limited differentiation using frequently 
used typing techniques such as MLST, MLVA, and spa-typing [17]. Recently, studies using next generation 
sequencing (NGS) and whole genome mapping revealed more genotypic diversity among LA-MRSA and 
suggested a distinction between livestock- and human-associated CC398 clades [11, 18-20]. However, 
the use of NGS for LA-MRSA in these studies focused mainly on the population structure of LA-MRSA 
using isolates from different geographical sources and origin. Studies where NGS was applied for 
transmission studies have thus far been limited to human associated non-LA-MRSA clades, such as 
E-MRSA 15 [21, 22].
In this study, we performed NGS on more than 200 LA-MRSA isolates obtained from humans submitted 
for the Dutch national MRSA surveillance. Together with epidemiological data, we assessed the 
capability of LA-MRSA to transmit between humans in Dutch healthcare settings.
Materials and methods 
Bacterial isolates
Virtually all MRSA isolates (one isolate per person per year), obtained from humans admitted to health 
care centers, are submitted for molecular typing to the National Institute of Public Health and the 
Environment (RIVM) for the Dutch national MRSA surveillance. In addition, medical microbiologists 
or infection control practitioners fill out questionnaires regarding epidemiologic risk factors for MRSA 
colonization or infection, including contact with livestock, for the persons from whom the MRSA were 
cultured. In this study, LA-MRSA was defined as isolates with MLVA-types belonging to MLVA complex 
398 (MC398).
To assess the capability of LA-MRSA to cause nosocomial transmission we included 12 LA-MRSA isolates 
from a presumed outbreak in a Dutch healthcare facility and 12 isolates from an outbreak in a Dutch 
nursing home [23]. Furthermore, inspection of the 9,698 questionnaires obtained from 2008-2012, 
showed that in 1,291 cases MRSA was isolated because nosocomial transmission was suspected. In 




























involved LA-MRSA, but in 15 events, the isolates of the index and secondary cases did not have the 
same MLVA/spa-types. As a result, 26 presumed LA-MRSA nosocomial transmission events comprising 
60 isolates were included in this study. Besides these 26 events, four presumed transmission events, 
comprising eight isolates, in Dutch healthcare settings as described by van Rijen et al.  [16] were also 
included resulting in a total of 30 investigated events. Of the 30 presumptive transmission events, 25 
were single transmissions and the other five involved multiple transmissions.
In addition to these presumed LA-MRSA transmission isolates, 114 LA-MRSA isolates comprising the 
three predominant LA-MRSA MLVA/spa-types; MT398/t011, MT572/t108 and MT569/t034, in the 
Netherlands obtained between 2003 and 2012 were included for analysis to provide epidemiological 
context. All available MT398/t011, MT572/t108 and MT569/t034 isolates from 2003 (n = 12), 2004 (n = 
12) and 2005 (n = 10) and the first five isolates (if available) of those three types from 2006 until 2012 
were used.
All 206 isolates were previously characterized using staphylococcal protein A (spa-) typing, multiple-
locus variable number of tandem repeat analysis (MLVA) and whole genome mapping [17, 24, 25].
Next generation sequencing
All 206 LA-MRSA isolates included in this study were subjected to NGS. In total, 148 LA-MRSA isolates, 
originating from the three predominant LA-MRSA MLVA/spa-types, the previously described outbreak 
[23], the presumed LA-MRSA outbreak  and the five presumed nosocomial transmission events [16] were 
sequenced as part of the 100k genome project by Davis University on a Hiseq 2000 (www.100kgenome.
vetmed.ucdavis.edu). The other 58 isolates were commercially sequenced on a Hiseq2500 sequencer 
(BaseClear, Leiden, Netherlands). 
Core-genome single nucleotide variants (SNV-) analysis 
The complete, annotated genome of LA-MRSA strain RIVM1295 with MT572/t108 (accession number 
CP013616), isolated from a Dutch patient was determined by NGS. Furthermore, complete, annotated 
chromosomes from the two other LA-MRSA obtained from Dutch patients representing the two 
other dominant MLVA/spa-types, MT398/t011 (RIVM1607, CP013619) and MT569/t034 (RIVM3897, 
CP013621) were used for comparison with the reference genome RIVM1295 to exclude non-core 
genome regions in the SNV analysis (Supplemental Figure 1). In total, 30 regions, mostly comprising of 
genes encoding transposases (n = 10), a single bacteriophage, small regions flanking the insertions sites 
of bacteriophages present in strains RIVM1607 and RIVM3897 (n = 8) and the six rRNA gene regions, 
were excluded. The regions that were excluded from the core genome are indicated as annotations 
in the complete genome sequence (CP130616). The CLCbio Genomics Server/Workbench, version 7.5 
(CLCbio, Aarhus, Denmark) was used for the identification of SNVs and SNV data were imported into 
Bionumerics version 7.5 for comparative analyses (Applied Maths, Sint-Martens-Latem, Belgium).
Staphylococcal cassette chromosome mec (SCCmec) and plasmid identification in LA-MRSA isolates
We assessed the SCCmec region and plasmid composition of LA-MRSA isolates to collect additional 
information from the accessory genome. The SCCmec region of all 206 LA-MRSA isolates was mapped 
against all known SCCmec references (www.sccmec.org) available in the NCBI database in October 
2015 and SCCmec types were assigned if a complete match was found. Divergent variants were named 
after the most similar SCCmec type followed by an extension to indicate their distinctive characteristics. 
To study the diversity of plasmids among Dutch LA-MRSA isolates we used the sequences of three 
plasmids [accession numbers AM990993, AM990994 and AM990995] found in ST398 reference strain 
S0385 [accession number AM990992] and sequences obtained from the NCBI database of six plasmids 
isolated from ST398 strains and sequenced by other researchers (Table 1, [26-32]). Furthermore, 
sequences from three plasmids, pRIVM1295-1 (CP013617), pRIVM1295-2 (CP013618) and pRIVM1607 
(CP013620), identified in our in house LA-MRSA reference strains were also used. During screening of 
the 206 LA-MRSA isolates against the plasmids, NGS reads of 53 LA-MRSA isolates mapped against only 
parts of the plasmids pS0385-2, pS0385-3 and pKKS627.  De novo assembly and a blast of the rep genes 
86
against the NCBI database revealed the complete sequence of five novel plasmids and three novel 
incomplete plasmids in the collection, resulting in 20 plasmids used for screening. The novel plasmid 
sequences were submitted to the NCBI database and are available under accession numbers CP13622 
to CP13629. 
      
Role of the funding source
The funding source had no role in the study design, data collection, data analysis, data interpretation, 
or writing of the report. The corresponding author had access to all the data of the study and the final 
responsibility to submit for publication.
Table 1: Overview of plasmid screening among 206 LA-MRSA isolates
Results
SNV analysis                     
In total, 6,461 SNPs were identified among the 206 isolates in the collection and used for comparison 
(Table 2, Supplemental Figure 1). Most SNVs were found in coding regions of the chromosome and 
comprised of non-silent (n = 2,920), silent (n = 1,768) and missense mutations (n = 104), while in the 
non-coding regions, 1,669 SNVs were identified. The majority of SNVs represented transitions (n = 
4,467, 69%), whereas 1,994 SNVs were transversions.
The minimum spanning tree based on SNV analysis showed that the 206 isolates used in this study 
mainly clustered into two groups. One group was contained virtually all MT398/t011 isolates and two 
isolates with a MT566/t1456 (Figure 1). The average SNV distance between members of the MT398/
t011 group was 31 SNVs with a range of 3 to 115 SNVs between two isolates in this group. The other 
group contained all MT572/t108 isolates that clustered closely together with an average distance of 
39 SNVs and a range of 6 to 85 SNVs between two MT572/t108 isolates. There was a 265 SNV distance 
 
 
            
Nr Plasmid Prevalence (n) Resistence genes Accession number 
Size 
(kb) Reference 
1 pRIVM1295-1 61 ermC CP013617 2.4 This study 
2 pRIVM4294 14 
 
CP013625 3.1 This study 
3 pRIVM1295-2 13 
 
CP013618 3.0 This study 
4 pRIVM4296 13 
 
CP013626 3.0 This study 
5 pRIVM1183 9 tetL, dfrK, ermT CP013627 7.3* This study 
6 pRIVM4390 7 aadD CP013623 4.6 This study 
7 pRIVM0677 5 
 
CP013622 4.4 This study 
8 pRIVM1076 3 
 
CP013624 2.2 This study 
9 pRIVM1607 1 
 
CP013620 1.5 This study 
10 pRIVM4293 1 tetL,  dfrK, aadD CP013628 6.2* This study 
11 pRIVM4256 1 tetL,  dfrK, aadD CP013629 6.7* This study 
12 pS0385-1 104 tetK AM990993 5.2 [27] 
13 pS0385-2 11 aadD AM990994 4.4 [27] 
14 pS0385-3 2 
 
AM990995 3.2 [27] 
15 pSWS2889 3 spd HG803547 3.9 [33] 
16 pKKS627 2 tetL, dfrK FN390948 6.2 [32] 
17 pKKS825 0 tetL, dfrK, vgaC, aadD NC_013034 14.3 [31] 
18 pKKS966 0 dfrK FN677368 5.0 [30] 
19 pUR2940 0 tetL, dfrK, ermC/ermT NG041022 20 [29] 
20 pNVH01 0 qacJ AJ512814 2.7 [28] 




























between the closest members of MT572/t108 and MT398/t011 isolates. The MT569/t034 isolates 
were genetically more diverse and did not cluster in a group. The range of SNVs between two MT569/
t034 isolates was 3 to 398 SNVs.






Figure 1: Minimum spanning tree based on SNV analysis of 206 LA-MRSA isolates. The tree was based on 
6,461 SNV positions and clustering was done using a categorical coefficient. Each isolate in the tree is displayed 
as a circle. The colors represent the MLVA/spa-types and the lines between the isolates denote the distance in 
number of SNVs.
SCCmec analysis
In total, four different SCCmec types could be assigned in 202 of the 206 LA-MRSA isolates. Within 
the four SCCmec types, 16 different SCCmec variants with distinct compositions were identified 
(Supplemental Figure 2). Most isolates (n = 99) carried SCCmec type V (5C2&5C). A variant of type 
V (5C2&5C), from which a 5.2 kb fragment comprising two transposase-encoding genes and the tetK 
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gene were deleted, was found in 15 isolates. Six other variants of type V (5C2&5C), with deletions 
varying from 3 kb to 22 kb, were present in 11 isolates. The second most frequently identified SCCmec 
type was type IV (2A) and was carried by 59 isolates. However, all isolates had a 1 kb deletion in the 
distal part of the SCCmec region compared to the SCCmec reference. Five isolates carried variants of 
SCCmec type IV (2A) with deletions of 1.2 kb (n = 3) or 2.2 kb (n = 2), respectively. A third SCCmec type, 
present in seven isolates, did not match with any known reference and was designated as SCCmec 
type RIVM3897. A single isolate carried the complete cassette, while the remaining six isolates had 
a 1 kb deletion. The fourth SCCmec type was V (5C2&5). Two isolates carried a variant with 1.2 kb & 
1.6 kb deletions and four isolates carried 1 kb, 1.2 kb & 1.6 kb deletions. The NGS data of four isolates 
contained no reads representing the SCCmec region. Consequently, no SCCmec type could be assigned 
to the four remaining isolates. Plotting of the four SCCmec types in a minimum spanning tree based on 
SNVs revealed that type V (5C2&5C) was present in all MT572/t108 isolates, while in isolates yielding 
MT398/t011 a clear distinction was observed between type V (5C2&5C) and type IV (2A) isolates 
(Figure 2). These two SCCmec subgroups did not differ in the average number of SNVs (34 vs 30) or SNV 








Figure 2: Distribution of the SCCmec types among 206 LA-MRSA isolates. The tree was based on 6,461 SNV 
positions and clustering was done using a categorical coefficient. Each isolate in the tree is displayed as a circle. 
The colors represent the different SCCmec types. LA-MRSA isolates for which no NGS reads for the SCCmec region 
were present are indicated as white circles. The blue halo contains all isolates with MLVA/spa-type MT398/t011 
and the red halo comprises all MT572/t108 isolates.
Plasmid screening   
Based on screening for the presence of 20 plasmids, we identified 16 different plasmids among the 
206 LA-MRSA isolates. The predominant plasmids were pS0385-1 (n = 104), pRIVM1295-1 (n = 61) and 
pRIVM4294 (n = 14), while plasmids pNVH01, pKKS825, pKKS966 and pUR2940 were not present (Table 
1). The 16 plasmids identified in isolates carried a variety of resistance genes, but tetL (tetracycline), 
dfrK (trimethoprim) and aadD (kanamycin and neomycin) were predominant.
Plotting of the two predominant plasmids pS0385-1 and pRIVM1295-1 in the minimum spanning tree 
based on the SNV analysis, showed that there was no clear relationship between SNV branches and the 
presence of plasmid pRIVM1295-1 (Supplemental Figure 3A). In contrast, plasmid pS0385-1 was only 




























in the reference sequence of SCCmec type (KF593809) the 5.2 kb plasmid sequence of pS0385-1 is an 
integral part of the SCCmec region and was flanked by two transposons. This suggested that the 5.2 kb 
region might have been misclassified as plasmid pS0385-1. This was corroborated by comparison of the 
whole genome map of strain S0385 and its in silico counterpart based on the whole genome sequence 
(AM990992) (Supplemental Figure 3).
NGS of two LA-MRSA outbreaks 
Isolates originating from two different outbreaks were subjected to NGS analysis. The first set of 12 
isolates belonged to a previously reported outbreak in a Dutch nursing home [23]. SNV analysis of the 
isolates showed a maximum of 23 SNVs between the isolate from the index patient and other outbreak 
isolates (Figure 3). The SCCmec region of these isolates were type V (5C2&5C) with a 5.2 kb deletion 
that included the tetK gene. This SCCmec variant was only found among these 12 LA-MRSA isolates 
and in three other non-related isolates. None of the 20 plasmids were present in the isolates of this 
outbreak. 
The second LA-MRSA outbreak, also comprising 12 isolates, occurred in a Dutch hospital. The number 
of SNVs between the outbreak isolates and the first isolate from the index patient ranged from 17 
to 25 SNVs. The second isolate of the index patient, taken from the toe, differed in 59 SNVs from the 
first isolate of the index patient, which originated from a throat/nose/perineum sample. All isolates 
carried SCCmec type IV (2A). All isolates carried plasmid pRIVM1295-1, except for the second isolate 
of the index patient. The second isolate of the index patient carried another plasmid designated as 
pRIVM4390 that was also found in one of the other outbreak isolates, but was lacking from the other 
isolates. Although a subset of SNVs was present in multiple isolates in both outbreaks, the transmission 
route could not be inferred from the distribution of accumulated SNVs.
Previously reported outbreak (max 23 SNPs)







Figure 3: SNV analysis of two LA-MRSA outbreaks displaying clustering indicative for transmission. The tree 
was based on 6,461 SNV positions and clustering was done using a categorical coefficient. Each node in this 
minimum spanning tree represents a single LA-MRSA isolate. Nodes with identical colors represent isolates from 
the same LA-MRSA outbreak. On the right hand site, the SNV positions relative to the sequence of the isolate of 
the index patients of each of the outbreaks are given. Each colored ring represents a single isolate belonging to 
the outbreak.
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NGS of the 30 presumed LA-MRSA transmission events   
In the 25 presumed single transmission events, a difference ranging from 2 to 105 SNVs between the 
isolates of a pair belonging to a transmission was found (Table 3, Figure 4). In 22 of the 25 cases, the 
pairs of isolates carried the same SCCmec type. The exceptions were two isolates of two presumed 
transmissions that carried no SCCmec, while in a single event (A3) different SCCmec types were carried 
by the isolates, namely type V (5C2&5) and IV (2A) ∆1 kb. In 11 of these 25 transmissions, the pairs of 
isolates also carried the same plasmids. None of the 20 plasmids were present in both isolates of eight 
other pairs, while different plasmids were found in the isolates of the remaining six pairs. In five of 
the six pairs, the plasmids present in the isolate of the index patient were absent in the isolate of the 
contact. In the other pair, the isolate of the contact carried plasmid pRIVM1295-2, which was absent 


























































Figure 4: Minimum spanning tree displaying clustering indicative for transmission of LA-MRSA between index 
patients and contacts in Dutch healthcare settings. The tree was based on 6,461 SNV positions and clustering 
was done using a categorical coefficient. Each node in this minimum spanning tree represents a single LA-MRSA 
isolate. Nodes with identical colors represent isolates from the same presumed transmission event. Circles with 
thicker lines represent isolates where transmission seems unlikely. The number of SNVs between isolates of the 
same presumed transmission is indicated adjacent to the lines connecting the nodes in the minimum spanning 
tree.
 In four of the five cases (C, D, I, L and Y), the isolates belonging the same multiple presumed nosocomial 
transmission event clustered closely together (Table 4, Figure 4). The exception was event I where 126 
SNVs between the isolate of the index and the isolate of one of the two contacts was found. The isolate 
of the other contact differed only in four SNVs from the isolate of the index patient. In four of the five 
events, the same SCCmec type was carried by all isolates. In the remaining event (I, three isolates), 
SCCmec type IV (2A) was present in two isolates that differed in only four SNVs, but the other isolate 
differing in 126 SNVs carried a SCCmec type V (5C2&5C). An identical plasmid composition was found in 
the isolates of event Y, where pRIVM1295-1 was carried by all isolates. Different plasmid compositions 
between the isolates were seen in event C, D and I, while no plasmids were found in isolates from event 




























































































































































































































































































































































































































































































































































































































































































































one of the contacts, but the isolate of this person also acquired plasmid pRIVM1295-2. In event D, the 
isolates of the index patient and one of the contacts carried plasmid pRIVM1295-1, while no plasmids 
were present in the isolate of the other contact. In the remaining event (I), plasmid pRIVM1295-2 was 
found in the isolates that differed in four SNVs. The latter plasmid was absent from the isolate of the 
contact that differed in 126 SNVs, but this isolate carried plasmid pRIVM1295-1 instead.
In the NGS data of two presumed single transmission events, no reads for the SCCmec were found 
in one of the isolates in each of two events (A2 and E). However, the number of SNVs between the 
isolates belonging to the same pair was low, amounting 32 and 17 SNVs, respectively. In addition, 
whole genome mapping, previously performed on a different DNA sample of the isolates, showed 
indistinguishable fragments in the SCCmec region, indicating that the SCCmec was previously present 
in both isolates. Repeated PCR analysis of the DNA preparations used for NGS revealed that this batch 
of DNA of the two aberrant isolates did not contain a mec gene, corroborating the NGS analysis.
Table 4: NGS of the multiple presumed nosocomial LA-MRSA transmission events 
Discussion
In this study, we used NGS data of 206 LA-MRSA isolates obtained from humans and found that 
nosocomial transmission of LA-MRSA in Dutch healthcare facilities does occur. Transmissions were 
inferred from SNV data and conclusions were supported by data on the composition of the SCCmec 
region. However, variation in the SCCmec region is too limited to use only this region as a genetic marker 
in transmission studies. This is also true for use of data on the presence and composition of plasmids. In 
addition, plasmids appear to be lost and acquired quite rapidly after LA-MRSA is transmitted from one 
patient to the other, making it a poor marker to assess whether transmission has occurred.
In total 32 LA-MRSA presumed transmission events comprising 25 single events, five multiple events and 
two outbreaks each comprising 12 patients were studied. In the majority of the putative transmission 
events, the isolates of the index patient and the contact(s) clustered closely together in a SNV based 
minimum spanning tree with 2 to 45 SNVs between the isolates. In only four presumed transmission 
events, the number of SNVs between isolates of the index and the contact exceeded 50 SNVs. In three 





SNPs SCCmec Plasmids 
Y index MT398/t011 
 
IV (2A)∆1kb pRIVM1295-1 
 
event 1 MT398/t011 5 IV (2A)∆1kb pRIVM1295-1 
 
event 2 MT398/t011 8 IV (2A)∆1kb pRIVM1295-1 
 
event 3 MT398/t011 5 IV (2A)∆1kb pRIVM1295-1 
 
event 4 MT398/t011 7 IV (2A)∆1kb pRIVM1295-1 
 
event 5 MT398/t011 3 IV (2A)∆1kb pRIVM1295-1 
C Index MT398/t011 
 
IV (2A)∆1kb pRIVM1295-1 
 
event 1 MT398/t011 8 IV (2A)∆1kb no plasmids 
 
event 2 MT398/t011 13 IV (2A)∆1kb pRIVM1295-1, pRIVM1295-2 
D Index MT572/t108 
 
V (5C2&5C) pRIVM1295-1 
 
event 1 MT572/t108 9 V (5C2&5C) no plasmids 
 
event 2 MT572/t108 20 V (5C2&5C) pRIVM1295-1 
L index MT569/t034 
 
IV (2A)∆1kb & ∆1.2kb no plasmids 
 
event 1 MT569/t034 27 IV (2A)∆1kb & ∆1.2kb no plasmids 
 
event 2 MT569/t034 23 IV (2A)∆1kb & ∆1.2kb no plasmids 
I index MT398/t011 
 
IV (2A)∆1kb          pRIVM1295-2 
 
event 1 MT398/t011 126 V (5C2&5C) pRIVM1295-1 




























remaining event, one of two isolates, obtained from different anatomically locations of the presumed 
index of an outbreak, differed 59 SNVs from its closest related outbreak isolate. However, it obviously 
belonged to the outbreak suggesting that a LA-MRSA strain colonizing or infecting different sites within 
the same person may evolve independently over time. Recent reports that applied whole genome 
sequencing on multiple colonies from the same person also identified a cloud of diversity among the 
isolates [21, 33, 34]. These studies were carried out on ST22 and ST239 MRSA isolates, but similar 
findings might be expected from LA-MRSA. 
This study showed that the number of SNVs alone is not sufficient to assess whether transmission 
has occurred. Combining NGS data and epidemiological data is essential to determine transmission 
and the use of SNV data of epidemiologically unrelated isolates as context proved extremely helpful. 
Furthermore, analysis of NGS data other than SNVs may be used to provide additional information 
to assess transmission events. Although variation of the SCCmec region turned out to be limited in 
LA-MRSA, it provided supportive evidence for several transmission events. For example, all isolates 
from a previously reported LA-MRSA outbreak had a distinctive 5.2 kb deletion in the SCCmec region 
that supported conclusion that transmission was indeed likely. Conversely, differences in SCCmec types 
provided further proof that transmission did not occur in other cases. Unexpectedly, two isolates 
belonging to two different transmission events and previously identified as LA-MRSA carried no SCCmec 
cassette. The most likely explanation for this observation is that the isolates consisted of heterogenetic 
populations comprising both SCCmec positive and negative variants and that the SCCmec positive 
variants were lost during sub-culturing to prepare DNA for NGS. 
The plasmid composition was identical in isolates of some of the transmissions. However, no plasmids 
were found in other events and in several cases differences in plasmid composition were observed 
although SNV and SCCmec analysis indicated that transmission was likely. Stanczak-Mrozek et al. 
recently showed MRSA variants that have acquired or lost mobile genetic elements were common in 
nasal colonizing populations [35]. Furthermore, a study using CC398 isolates showed that horizontal 
gene transfer including plasmids occurred in a very high frequency in vivo [36]. Since only a single 
colony was used for the initial culture from the clinical material and for various subcultures, different 
variants of the same strain, with or without plasmids, may have been sequenced, resulting in the 
observed differences. 
Our study has a number of limitations. First, all sequenced isolates belonged to the LA-MRSA (MC398) 
clade. This limits a comparison of NGS data between LA-MRSA and other MRSA variants and hampers 
studies on the transmission rates of the different MRSA clades in Dutch healthcare facilities. Second, the 
presumed nosocomial transmission events were selected based on the epidemiological data provided 
by the medical microbiology laboratories and affiliated infection prevention practitioners. We do not 
know whether all transmission events were correctly identified and this could lead to either an under- 
or over-representation of the number of presumed nosocomial transmissions. Finally, our NGS data 
were only screened for plasmids that were associated with livestock. Other plasmids were not taken 
into account and this could have provided more information. Furthermore, the use of data from other 
mobile genetic elements, such as bacteriophages were not included in this study [35]. In conclusion, 
our study strongly suggests that transmission of LA-MRSA in Dutch healthcare settings does occur. NGS 
could confirm previously reported transmission events and indicated that transmission was unlikely in 
three presumed transmissions. We conclude that investigations regarding transmissions of LA-MRSA 
should be supported by epidemiological data and be investigated using context of epidemiologically 
related and unrelated isolates. Analysis of SCCmec region proved to provide useful information to 
support SNV analysis, but plasmid identification did not.
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Supplemental Figure 1: SNVs mapped on the core genome of LA-MRSA strain RIVM1295. The lines in the 
colored rings show the distribution of the SNVs identified in the 206 LA-MRSA isolates relative to the core genome 
of strain RIVM1295. Each colored ring represents a different type of SNV as explained in the center of the circle. 
The outer ring displays the core genome of RIVM1295 used for SNV analysis and the distribution of the excluded 
variable regions that are depicted in orange. The complete genome of strain RIVM1295 is deposited in the NCBI 
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Supplemental Figure 3: Distribution of plasmids among 206 LA-MRSA isolates. The trees were based on 6,461 
SNV positions and clustering was done using a categorical coefficient. Each isolate in the trees is displayed as a 
circle. The distribution of plasmid pRIVM1295-1 over the SNV tree is shown in panel A. The spread of plasmid 
pS0385-1 among the LA-MRSA isolates is depicted in panel B. Panel C shows a detail of the whole genome maps 
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Background: Livestock-associated MRSA (MC398) has emerged and is related to an extensive reservoir 
in pigs and veal calves. Individuals with direct contact with these animals and their family members are 
known to have high MC398 carriage rates. Until now, it was assumed that MC398 does not spread to 
individuals in the community without pig or veal calf exposure. To test this, we identified the proportion 
of MC398 in MRSA positive individuals without contact with pigs/veal calves or other known risk factors 
(MRSA of unknown origin; MUO).
Methods: In 17 participating hospitals, we determined during two years the occurrence of MC398 in 
individuals without direct contact with livestock and no other known risk factor (n = 271) and tested in 
a post analysis the hypothesis whether hospitals in pig-dense areas have higher proportions of MC398 
of all MUO.
Results: Fifty-six individuals (20.7%) without animal contact carried MC398. In hospitals with high pig-
densities in the adherence area, the proportion of MC398 of all MUO was higher than this proportion 
in hospitals without pigs in the surroundings.
Conclusions: One fifth of the individuals carrying MUO carried MC398. So, MC398 is found in individuals 
without contact to pigs or veal calves. The way of transmission from the animal reservoir to these 
individuals is unclear, probably by human-to- human transmission or by exposure to the surroundings 
of the stables. Further research is needed to investigate the way of transmission.
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Introduction
Since 2003, the so-called livestock-associated MRSA (LA-MRSA) has emerged in animals and humans 
in areas with intensive animal farming in Europe, North America, and Asia [1]. Human carriage of LA-
MRSA is strongly related to direct contact with pigs, veal calves and broilers [2, 3]. The majority of 
these LA- MRSA strains belong to multilocus sequence type clonal complex 398 (CC398) [4]. After its 
emergence, the risk factor ‘direct contact with living pigs, veal calves and broilers’ was added to the 
Dutch national MRSA guideline and an active screening program in hospitals was implemented [5]. By 
the end of 2011, 39% of all newly identified MRSA strains in humans in the Netherlands belonged to 
this variant in the Netherlands [6].
Recent surveys showed that MRSA CC398 was 4 to 6-fold less transmissible than other MRSA strains in 
a hospital-setting [7–8]. At present, the human-to-human  transmissibility of MRSA
CC398 in a community setting is still unclear. Considering the extensive reservoir in animals and people 
who work with livestock, the occurrence of MRSA CC398 in people who are not directly involved in 
farming is strikingly low. So far, there are no indications that MRSA CC398 has spread extensively into 
the general population [9]. A cross-sectional survey in a livestock- dense region found that only 0.2% 
of adult individuals without livestock contact were positive for MRSA CC398 [10]. On the other hand, 
there are observations that proximity of farms is a potential risk factor, even in absence of direct 
contact between humans and animals [11–13]. In addition, in a recent exploratory study an association 
was found between consumption of poultry and MRSA carriage [14]. A spectrum of infections with 
MRSA CC398 have been documented, ranging from relatively minor or localized infections including 
abscesses [15–17] and various skin and soft tissue infections (SSTI) [18–20], urinary tract infections 
[16], wound infections [16], mastitis [4], and conjunctivitis [21], as well as more serious or invasive 
infections, including bacteremia [21–24], endocarditis [24, 25], pneumonia (including necrotizing 
pneumonia, osteomyelitis, pyomyositis, and postoperative infections [26]. Despite the diverse array 
of infection types reported, it has been suggested that MRSA CC398 is less virulent than other human 
MRSA strains [27].
Apart from LA-MRSA and hospital-associated (HA)MRSA, MRSA rates also are rapidly increasing in 
community dwelling individuals without known healthcare- or livestock-associated risk factors. This 
third entity has been referred to as community- acquired (CA) MRSA [28] or MUO [29]. In this study, 
the proportion of CC398 in MUO isolates was determined. We hypothesized that people living in an 
area in which CC398 is common have more risk of MRSA CC398 carriage than persons living in an area 
in which CC398 is rare.
Methods
Ethics Statement
Ethical approval for the study was obtained by the medical ethics committee of the St. Elisabeth Hospital 
in Tilburg (NL 19489.008.07, protocol 0749, March 9th, 2009). Patient information was anonymized 
and de-identified prior to analysis.
MRSA source identification
To identify MRSA sources in the Netherlands, Infection Control Practitioners (ICP) from seventeen 
hospitals (three academic, seven teaching and seven general hospitals) throughout
the Netherlands were asked to complete a questionnaire on a website for all consecutive patients that 
were found to be MRSA positive (both infection and carriage) for the first time in the microbiological 
laboratory of the hospital from January 2009 until December 2010. Samples were taken during a visit 
to the outpatient’s clinic or during a stay on a ward in the hospital. Patients who had already been 
found MRSA-positive in the past were not included. The questionnaire on the website contained data 
about patient type (in- or outpatient), demographics, positive body sites, molecular typing results and 
probable source of MRSA. The MRSA source was identified based on the patient’s history combined 
with molecular typing results and then classified in risk groups described in the national infection 

























as ‘MRSA of unknown origin (MUO)’.
Genotyping of MRSA isolates
All MRSA isolates were genotyped by multiple-locus variable number of tandem repeat analysis (MLVA) 
by the Dutch National Reference Center (RIVM, Bilthoven, the Netherlands) [30]. MLVA is known for 
its higher discriminatory power for LA- MRSA strains as compared to either multilocus sequence 
typing (MLST) or pulsed-field gel electrophoresis (PFGE) [30]. The MLVA profiles were clustered using a 
categorical clustering coefficient (unweighted-pair group method using arithmetic aver- ages, UPGMA) 
and a minimum spanning tree was constructed to display the relationships between the various MLVA 
complexes (MC) and MRSA sources. For this study, we incorporated phiSa3 into the MLVA scheme. 
Furthermore, tetM was determined by use of DNA microarray (Identibac S. aureus Genotyping, Alere).
Data analysis
The percentage of MC398 in the group with individuals not reporting contact with pigs or veal calves 
was determined. We hypothesized that individuals without direct contact with pigs/veal calves living 
in a pig-dense area have more chance to become colonized with MC398 MUO than individuals living 
in areas without many pigs. Hospitals were divided into two categories: 1) Hospital with an adherence 
area with a high pig-density; 2) Hospital with an adherence area with a low pig-density. Municipality 
level data of the number of pigs were downloaded from the website of the Central Institute for 
Statistics (CBS) [31]. To test our hypothesis, the numbers of MC398 MUO positive individuals in these 
two categories were compared in a Chi-square test in a post analysis. To avoid bias by possible different 
screening policies of the 17 different hospitals, only MRSA infections were included in this analysis. In 
this way, unexpected findings in contract tracings were excluded.
Results
During 2009–2010, 1020 patients (368 inpatients and 652 outpatients) were found to be MRSA-positive 
in the seventeen participating hospitals. From 299 (29.3%) patients, MRSA-positive samples were 
obtained from body sites other than nose, throat, and perineum, mainly urine, sputum and wounds. 
Eight patients suffered from a bacteremia with MRSA (0.8%). In 39 patients (3.8%), MRSA was found in 
the perineum sample only, while other tested sites were found to be negative for MRSA.
MRSA source analysis is depicted in Table 1.
 
MLVA typing of the strains showed that 649/1020 (63.6%) strains were MC398. Two-hundred and 
seventy one (26.6%) of all newly identified carriers were of unknown origin, and 56 (20.7%) of them 
were MC398. These 56 MC398 isolates were tetM positive and lacked the prophage Sa3 (phiSa3). The 
mean risk to find a MC398 MUO in a participating hospital was estimated at 1 per 8 months (1 per 12 
months for infections only). Thirty-five of the 56 (62.5%) individuals suffered from an infection. Figure 
1 shows MUO, hospital- and animal-related MRSA and their MLVA complexes. MC398 MUO and MC398 
Total MC398
Source N % of total n % within source
Pigs/veal calves 603 59.1 587 97.3
Foreign hospital 75 7.4 3 4.0
Nosocomial transmission 44 4.3 3 6.8
Transmission in nursing home 5 0.5 0 0.0
Adoption children 18 1.8 0 0.0
Dialysis patients from foreign countries 2 0.2 0 0.0
Unknown origin (MUO) 271 26.6 56 20.7
No data 2 0.2
Total 1020 100 649 63.6
Table 1: MRSA sources in patients in 17 Dutch hospitals, 2009–2010
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of patients with animal contact cluster together. To test our hypothesis that individuals without animal 
contact have more chance to carry MC398 MRSA in pig-dense areas than in areas without many pigs, 
a Chi-square test was performed for hospitals with an adherence area with many pig farms compared 
to hospitals in an area without many pigs. Data of all participating hospitals is shown in Table 2. Pig-
densities in the Netherlands are shown in Figure 2. We found an indication that, in hospitals with high 
pig-densities in the adherence area, the proportion of MC398 infection of all MUO infection is higher 
than in hospitals without pigs in the surroundings (32/148 vs. 3/ 59; RR 4.25 95% CI 1.35–17.21, P = 
0.004).
Figure   1:   Genotypic   relatedness   of   1020   MRSA   isolates represented  as  a  minimum  spanning 
tree  based  on  MLVA types. Clustering of MLVA profiles was obtained using a categorical coefficient to create 
a minimum spanning tree in which the MLVA types are displayed as circles. The size of each circle indicates 
the number of isolates with this particular type. MLVA complexes (MC) are indicated in characters e.g. MC398 

























Figure 2: Pig-densities in the Netherlands. Hospitals with high pig-densities in the adherence areas are 



































































































































































































































































































































































































































































































































































The majority (n = 603, 59.1%) of  newly  identified  MRSA- positive patients in 17 hospitals in 2009 
and 2010 was related to exposure to livestock. A substantial proportion could not be classified to an 
established risk group (n = 271, 26.6%) and are therefore assumed to have acquired their MRSA in the 
community. One fifth (20.7%) of these MRSA strains belonged to MC398. The presence of the tetM 
resistance gene and the absence of the phiSa3 suggest that these isolates were animal- associated 
[22, 32]. We found an indication that, in hospitals with high pig-density in the surroundings, the 
proportion of MC398 infection of all MUO infection was higher than in hospitals with a low pig-density 
in the surroundings. This indicates that LA-MRSA may be spreading through other sources than direct 
exposure to livestock. Until now it was assumed that LA-MRSA is able to spread to the pig/veal calf 
farmers and others who are in close contact with the animals, but is less able to spread from the 
farmer to household members who do not enter the stables, and is almost unable to spread to persons 
in the community without pig or veal calf exposure. Thus, it is assumed that constant pressure of LA- 
MRSA from animals with MRSA must be present to maintain the LA-MRSA colonization in humans. 
However, several recent studies have shown that persistent colonization with MC398 is possible 
[33–35]. Moreover, pig-, dairy cow, and veal calf densities per municipality were also found to be 
independent risk factors for carriage of MRSA MC398 in two recently published case-control studies 
[11, 14]. Although it cannot be excluded that human-to- human transmission occurs in areas with a 
high MRSA MC398 pressure, environmental contamination with MRSA MC398 may play a role as well. 
MRSA MC398 has been shown to be present in air and soil samples collected downwind of pig and 
swine barns [13]. Other transmission routes can play a role as well. For example, regular consumption 
of poultry was recently found to be associated with CA-MRSA transmission in an exploratory hospital-
based case-control study [14]. De Boer et al. demonstrated that a substantial part of the meat products 
obtained from retail stores in the Netherlands were colonized with MRSA, including both MC398 and 
non-MC398 strain types [36]. However, meat consumption cannot explain the increased prevalence in 
people who live in pig-dense areas. We expect the risk, associated with meat consumption, to be the 
same for all areas over the country. Unless, locals consume more meat from their own area.
Limitations
We performed a post hoc analysis to study whether the proportion of MC398 MUO infection is higher in 
hospitals in pig- dense areas than in areas with a low pig-density. Our study was originally not designed 
for this purpose. Therefore, we have to be careful with the conclusions. An analysis in which pig-density 
was determined based on postal code of the individuals would have been more reliable. These data 
were not available because of privacy issues. Also, the stratification of hospitals in ‘pig-dense’ and ‘pig-
arm’ areas is arbitrary. Based on the CBS data, we classified the hospitals that are known to be situated 
in the most urbanized parts of the country as ‘pig-arm’. This resulted in four hospitals in pig-arm areas 
and 13 hospitals in pig-dense areas. So, more hospitals in pig-dense areas were included in the analysis. 
Furthermore, there may be detection bias due to differences in screening policies between hospitals. 
It is possible that physicians in some hospitals take more clinical samples than physicians in other 
hospitals. This may lead to an underestimation in the number of MUO findings. Also, classification bias 
may occur depending on the reliability of the history of risk factors. However, all participating hospitals 
screened the MRSA risk groups described in the national MRSA guideline [5]. After coincidental MRSA 
findings, patients were asked for these risk factors also.
In conclusion, this study shows that the majority of newly identified MRSA patients in these 17 
hospitals were acquired by direct contact with pigs/veal calves. The second largest group is the group 
of unknown origin. One fifth of these MUO are MC398. We found a significant association between 
individuals living in pig-dense areas and the likelihood of MC398 MUO carriage. MC398 MUO infections 
were rarely detected, i.e. 1 per 12 months for every participating hospital, so, currently, this MC398 
MUO seems not to cause many problems. Because of the absence of known risk factors and probable 
risk for transmission in the healthcare settings, it is worthwhile to monitor the number of MUO in 
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After the first emergence in 1961, methicillin resistant Staphylococcus aureus (MRSA) has been 
considered a human pathogen for several decades. First, MRSA was deemed a problem restricted to 
healthcare settings, but since the 1990s was also recognized as a community-acquired pathogen [1, 2]. 
In 2005, a new reservoir was revealed when MRSA was isolated from pigs and pig farmers in France and 
the Netherlands [3, 4]. Further research in the Netherlands showed that the prevalence of this MRSA 
variant among pigs was high and that this type of MRSA was also present in other animals, leading 
to the term livestock-associated MRSA (LA-MRSA) [5, 6]. The rapid increase in the prevalence of LA-
MRSA in livestock and the fact that contact of humans with livestock was  often associated with human 
LA-MRSA carriage led to an adaption of the Dutch search & destroy guidelines whereby contact with 
livestock was regarded a MRSA risk factor [7]. The emergence of LA-MRSA might pose a serious public 
health threat and it is essential to have insight in the clinical importance of LA-MRSA in regards to its 
ability to transmit and cause disease in humans. In this thesis, we developed and used molecular typing 
tools to assess the capability of LA-MRSA to transmit between humans. Furthermore, we looked at the 
ability of LA-MRSA to cause disease and studied the possible temporal changes in the characteristics 
of the most predominant MRSA clade in the Netherlands. In this chapter, we discuss the experimental 
data, present the main conclusions and depict the future perspectives. 
High-resolution typing reveals that LA-MRSA are genotypically diverse
Studies on the origin and transmission routes of a microorganism require typing techniques with 
sufficient discriminatory power. For several decades, pulsed field gel electrophoresis (PFGE) has been 
considered to be the gold-standard typing tool for MRSA [8]. However, with the introduction of sequence-
based techniques PFGE was replaced by multilocus sequence typing (MLST) and/or Staphylococcal 
protein A (spa-)typing in most laboratories [9, 10]. For most MRSA isolates sufficient discrimination 
could be achieved by any of the three methods, but for LA-MRSA the methods resulted in only limited 
differentiation. For instance, no banding patterns could be obtained when PFGE was applied on LA-MRSA 
isolates, due to a methylation of the SmaI recognition site [11]. MLST of LA-MRSA was applied in many 
of the first reports about this MRSA clade, but virtually all isolates belonged to sequence-type (ST)398 
within clonal complex (CC) 398 [3, 12]. Although spa-typing could identify more LA-MRSA types than 
MLST, over 85% of all submitted Dutch LA-MRSA from humans belonged to either spa-type t011, t108 
and t034 [13, 14]. In addition to spa-typing, the national institute for public health and the environment 
(RIVM) introduced a second typing technique named multiple-locus variable number of tandem repeat 
analysis (MLVA) in 2008 [15]. MLVA proved to be more discriminatory than spa-typing and MLST for 
most MRSA variants, but for LA-MRSA most isolates had either MLVA-type (MT)398, MT572 or MT569 
and these MTs were mostly comprised of the three major spa-types t011 (MT398), t108 (MT572) and 
t034 (MT569) (Chapter 5). A calculation of Simpsons’ index of diversity revealed equally poor results 
for both spa-typing and MLVA, while a comparison by Wallace coefficients of both methods for LA-
MRSA yielded high Wallace coefficients indicating virtually complete congruence (Chapter 2). These 
results indicate that higher resolution typing techniques are required to differentiate isolates belonging 
to this MRSA clade and that the lack of a typing method with sufficient discriminatory power for LA-
MRSA hampers statements on the genetic diversity of this MRSA clade. Therefore, a PFGE using Cfr9I 
was optimized and used for characterizing LA-MRSA (Chapter 3). Since Cfr9I is a neo-schizomer of SmaI, 
it enables comparison with MRSA whose banding patterns were previously obtained with the standard 
PFGE protocol. The PFGE profiles of LA-MRSA were distinct from those of the other MRSA variants 
indicating that LA-MRSA isolates belong to a MRSA clade not previously seen in the Netherlands. 
These results were corroborated by a study using amplified fragment length polymorphism (AFLP) that 
also regarded LA-MRSA as a distinctive cluster recently introduced into the Dutch population [16]. 
In addition, Argudin et al. found that the MRSA controls in their study yielded low PFGE similarity 
compared to their LA-MRSA isolates [17].
Comparative analysis showed that the profiles obtained by Cfr9I PFGE had more variation than spa-
typing and MLST. Analysis of the two predominant spa-types in the Netherlands revealed that PFGE 
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patterns of spa-type t011 were more diverse than those of spa-type t108. However, when the cut-
off values for PFGE were applied, most of the LA-MRSA isolates would still be considered as either 
indistinguishable or highly related [18].  
Another technique that uses restriction enzymes is whole genome mapping (WGM), but instead 10-15 
non-ordered bands obtained by PFGE, a whole genome map of S. aureus consists of 200-300 ordered 
restriction fragments [19]. The discriminatory power of WGM among epidemiologically unrelated LA-
MRSA isolates, for which spa-typing and MLVA failed to provide clear distinction, was high (Chapter 4). 
Many different compositions of the SCCmec region were found among the LA-MRSA isolates and this 
locus contributed the most to the observed variation in WGMs. Price et al. also found a high variation in 
the SCCmec region using next generation sequencing (NGS) on a geographically diverse set of LA-MRSA 
isolates [20]. However, the variation in SCCmec was not observed in other studies where LA-MRSA 
isolates were subjected to PCR-based SCCmec typing, since most LA-MRSA isolates yielded type IV or 
V [14]. This indicates that variation present among LA-MRSA isolates was missed when conventional 
typing methods were applied. Furthermore, NGS of more than 200 LA-MRSA isolates from Dutch health 
care facilities revealed that most isolates carried SCCmec type IV (2A) and V (5C2&5C) and variants 
of those types (Chapter 8), suggesting that SCCmec variation among LA-MRSA in Dutch hospitals is 
limited. The genotypic diversity of LA-MRSA was also seen when 110 LA-MRSA isolates obtained from 
16 livestock veterinarians from different geographical sources were subjected to WGM (Chapter 6). 
The resulting minimum spanning tree revealed 13 clusters and 8 singletons, based on a similarity cut-
off value of 98% for indistinguishable WGMs, whereas only six types were found with spa-typing. In 
the majority of clusters, only isolates belonging to a single veterinarian were present making WGM 
suitable for high-resolution typing of LA-MRSA. However, even with a high-resolution typing method 
such as whole-genome mapping, LA-MRSA remains a clade that is genetically more homogenous than 
other MRSA variants. The most distinct LA-MRSA isolates used for whole genome mapping still had an 
84% similarity, whereas WGMs of other MRSA variants yielded similarities of approximately 60 to 70%. 
The ultimate discriminatory typing method, not only for LA-MRSA, but also for virtually all microorganisms 
is next generation sequencing (NGS). Indeed, Price et al already showed a large genetic diversity among 
LA-MRSA based on singly nucleotide polymorphisms (SNP) and SCCmec analysis [20]. In addition, several 
other studies using NGS have suggested a distinction between livestock- and human-associated CC398 
clades [21, 22]. SNP-analysis and core genome MLST based on the NGS data of the three predominant 
LA-MRSA types submitted to the Dutch MRSA surveillance revealed three different groups (Chapter 7). 
There was no overlap between the types, suggesting that these LA-MRSA types are three unique and 
independently evolving LA-MRSA clades. MT398/t011 isolates and MT572/t108 isolates partitioned in 
two genetically homogeneous groups, while MT569/t034 isolates, did not partition in a single group 
and were genetically more diverse. MT569/t034 rapidly increased in the Netherlands in recent years 
and persons carrying this LA-MRSA variant more often reported not having contact with livestock, 
indicating an emergence of a LA-MRSA subclade transmittable independent of livestock exposure as 
also suggested by others. 
One of the limitations regarding the genetic diversity of LA-MRSA is that the research has only focused 
on isolates belonging to the MLVA complex (MC)398. MC398, representing clonal complex (CC)398 
[15], has been the predominant MRSA clade in the Netherlands since 2007, but other CCs, such as CC9 
and CC97, have also been designated as livestock associated [23, 24]. In Asia, CC9 is more frequently 
found than CC398 isolates and has been associated with spa-types t1430, t899 and t337 [25, 26]. 
More recently, a novel mecA variant, designated as mecC, was identified among bovine MRSA isolates 
from UK and Denmark [27]. These isolates belong to CC130 and have also emerged in France [28]. 
Isolates belonging to these other LA-MRSA lineages have been found among humans in the Dutch 
MRSA surveillance, but in low numbers. Yet, monitoring of these MRSA clades might be important since 
these variants might also spread in the general population.
Confirmation of human-to-human transmission of LA-MRSA     











transmission. The reservoir of LA-MRSA is extensive in livestock and carrier rates in farms and farmers 
are high, but LA-MRSA human-to-human transmission seems to occur sporadically and limited to 
families [5, 7, 12, 29]. The rates of LA-MRSA transmission may even be overrated since most studies used 
typing techniques with limited discriminatory power. To study human-to-human transmission, livestock 
veterinarians and their household members who had no livestock contact were longitudinally followed 
and the obtained LA-MRSA isolates were subjected to high-resolution techniques, Cfr9I PFGE and WGM 
(Chapters 3, 5 and 6). With both techniques, it was clear that transmission with LA-MRSA between the 
veterinarian and the household member (HHM) occurred in 14 of the 16 studied households. In most 
households, a unique LA-MRSA strain was involved in transmission. Likely, transmission took place with 
two different strains in one of the remaining households, while no transmission occurred in the other 
household. These results clearly showed that human-to-human transmission of LA-MRSA occurred in 
individuals that might represent the general population.
Nosocomial transmission of LA-MRSA occurs, but in lower rates than other MRSA variants
There have been several studies suggesting that nosocomial transmission rate of LA-MRSA in the 
Netherlands is limited [30-33]. However, outbreaks in hospitals and nursing homes have been described 
[34-36]. In chapter 4, PFGE using Cfr9I was applied on isolates of a presumed LA-MRSA outbreak in a 
Dutch nursing home [36]. The PFGE profiles showed that transmission likely occurred between isolates 
of seven residents and two healthcare workers (HCWs). Moreover, banding patters of isolates of two 
HCWs, one of which yielded the same spa-type as the outbreak isolates, were distinctive indicating that 
transmission had not likely occurred. NGS of the outbreak isolates confirmed the transmission. SNP 
analysis showed a maximum of 17 SNPs between the outbreak isolates and SCCmec analysis revealed a 
distinctive variant of type V (5C2&5C), that had lost a 5.2kb fragment, including the tetK gene (Chapter 
8). Nosocomial transmission of LA-MRSA was also investigated using MRSA isolates submitted for typing 
to the RIVM that were selected on the basis of available questionnaires filled in by infection prevention 
specialists (Chapter 8). This revealed that nosocomial transmission of LA-MRSA occurred in more than 
90% of the investigated cases. Furthermore, NGS showed that transmission had not occurred in two 
of the 30 presumed transmission events, corroborating previous reports that LA-MRSA transmission 
occurs only limited in Dutch healthcare settings. However, changes in the characteristics of LA-MRSA 
were observed in recent years suggesting that the paths of LA-MRSA human-to-human transmission are 
still evolving (Chapter 7). First, a decrease was seen in the proportion of people carrying LA-MRSA who 
reported having contact with livestock. This was especially prominent for isolates belonging MT569/
t034, a LA-MRSA variant rapidly increasing in the Netherlands in recent years. Second, a study on 
community-acquired MRSA conducted among 17 Dutch hospitals, found that a fifth of all MRSA found 
among persons who had no known MRSA risk factors and who had no livestock contact, belonged 
to LA-MRSA (Chapter 9). Similar findings were reported in another study, where 26% of the MRSA 
of unknown origin was attributed to LA-MRSA [37]. Together these findings indicate that although 
nosocomial transmission of LA-MRSA is still limited, LA-MRSA might still be adapting towards the 
human niche and that transmissions taking place independently of livestock exposure may further 
increase in the future.
A limitation on the studies performed on the transmissibility of LA-MRSA is that the research has 
focused on isolates of human origin. LA-MRSA isolates obtained from livestock were not included and 
have to the best of our knowledge not been compared to human isolates using high-resolution typing 
techniques. The genetic diversity of LA-MRSA among livestock might be different and the factors that 
may play a role in the transmission between animals and humans could reveal relevant information for 
LA-MRSA transmission in the general population. Recent literature of studies that used NGS shows that, 
unlike previous assumptions, extended spectrum beta lactamases (ESBL) isolates found in chickens 
differ from those found among humans despite carrying the same MLST characteristics, shedding a 
different light on transmission routes and mechanisms [38]. Whether this is the case for LA-MRSA 
needs to be investigated. 
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Persistence of LA-MRSA
A second controversy regarding LA-MRSA is its capability to persist in humans. There have been several 
studies indicating that LA-MRSA is a poor persistent colonizer, but reports suggesting the opposite have 
also appeared [39, 40]. However, similar to the studies reporting on LA-MRSA transmission, typing 
was performed with low-resolution techniques making it difficult to assess whether persistence of 
LA-MRSA actually occurred. Longitudinal sampling and analysis using high-resolution WGM showed 
that persistence of LA-MRSA in veterinarians could last up to 14 months (Chapter 5). Possibly, people 
who are in contact with livestock are transiently contaminated with LA-MRSA, as was also suggested in 
another publication [41], but the veterinarians in our study usually visited around 10 different farms a 
week, making reacquisition less likely. In addition, household members who did not have contact with 
livestock were found to be persistent LA-MRSA carriers for periods up to 8 months in the same study. 
A limitation of our study on the persistence of LA-MRSA is that isolates were not subjected to NGS 
and that isolates originating from Dutch health care facilities are lacking. Similar to our studies on the 
transmissibility of LA-MRSA, NGS could provide more detailed information on the presumed persistence 
of LA-MRSA. Furthermore, recent research has shown that a cloud of diversity can be found among 
MRSA isolates in both SNPs and other mechanisms, such mobile genetic elements [42, 43]. To study 
the impact of these findings, comparison of NGS data of LA-MRSA isolates obtained from persons with 
and without livestock contact and other MRSA variants is required.
Increase of LA-MRSA isolated from infection-related materials
A variety of infections have been attributed to LA-MRSA, ranging from skin and soft tissue infections 
to bacteremia [16]. Like human-to-human transmission, it is suggested that infections caused by LA-
MRSA are limited [44] and that this could be attributed to the fact that LA-MRSA isolates rarely carry 
any staphylococcal toxins [45]. Genes coding for the Panton-Valentine leucocidin (PVL) are also rarely 
reported among LA-MRSA isolates [46, 47]. In the Netherlands, only 23 PVL positive LA-MRSA isolates 
were present in a collection of more than 9,000 LA-MRSA isolates submitted for typing (Chapter 7). Of 
these 23, four were cultured from Chinese adoption children. ST398 PVL has previously been found in 
Chinese hospitals and micro-array analysis has shown that the isolates were epidemiologically distinct, 
indicating that PVL positive LA-MRSA originated from a different source [47, 48].
Though most infections with LA-MRSA have occurred in people reporting livestock contact, several 
reports indicated infections with LA-MRSA without contact with the animal reservoir [49, 50]. In 
chapter 7, an increase was found in the proportion of LA-MRSA isolates cultured from infection-related 
materials between 2009 and 2014. When stratified into age-groups it became clear that most LA-MRSA 
obtained from infection-related materials originated from elder people (>60 years). More importantly, 
when subdivided between having contact with livestock or not, 83% infection-related isolates were 
found in the group who reported not having contact with livestock. There could have been a sampling 
bias causing the prominent difference. Since LA-MRSA is a subject of debate in order of pathogenicity 
and transmissibility in the Netherlands, medical microbiological laboratories might predominantly 
send their infection-related LA-MRSA isolates. However, the findings occurred concurrent with the 
emergence of an apparently human-adapted subclade (Chapter 9) suggesting that LA-MRSA starts to 
resemble non-LA-MRSA in terms of pathogenicity. 
One of the limitations regarding the isolates researched in chapter 7 is that they were all MRSA, since 
the Dutch surveillance work focusses on MRSA strains. MSSA belonging to the MC398 clade were 
therefore not included, but could potently reveal additional information on the origin of LA-MRSA. 
Price et al. included LA-MSSA in their NGS study and suggested that CC398 might have jumped from 
humans to livestock as MSSA, obtained the mecA gene and re-entered the human host as MRSA [20]. 
Furthermore, LA-MSSA seems more associated with severe infections. A French report showed that 
17 of the 18 bloodstream infections were LA-MSSA and all isolates in this study came from patients 
lacking contact with livestock [51]. LA-MSSA was also described in a Dutch study, where LA-MSSA was 
identified in two bloodstream infections [52]. Research on the origin and spread of LA-MSSA might 












The research performed during this thesis provided more insight in the genetic diversity, transmissibility, 
persistence and pathogenicity of LA-MRSA in the Netherlands. The main conclusions are listed below:
- MLVA and spa-typing both yield low diversity indices for LA-MRSA and performing both methods does 
not improve discriminatory power.
- PFGE, WGM and NGS show that LA-MRSA are more genetically diverse than previously assumed based 
on current typing techniques, such as MLVA and  spa-typing. However, even with high-resolution typing 
LA-MRSA remains more homogeneous than other MRSA variants.
- NGS showed there was no overlap between the three main LA-MRSA representatives in the Netherlands 
indicating three unique and independently evolving LA-MRSA subclades.
- PFGE, WGM and NGS analysis all showed that human-to-human transmission of LA-MRSA between 
veterinarians and household members occurred in nearly every household .
- Nosocomial transmission of LA-MRSA was confirmed by NGS, but the transmission rate of LA-MRSA is 
lower compared to other LA-MRSA variants.
- The number and proportion of LA-MRSA isolates in the Netherlands is decreasing since 2009. However, 
the presence of a high prevalence of LA-MRSA among MRSA without known origin and the increase 
of MT569/t034 isolates originating from people who report not having livestock contact suggest the 
emergence of a LA-MRSA subclade transmitted without livestock exposure.
- The proportion of LA-MRSA originating from infection-related materials is increasing and most isolates 
were obtained from people who were above 60 years of age and reported not having livestock contact.
Future perspective
The use of high-resolution typing techniques has provided valuable insight in the origin, transmission 
and persistence of LA-MRSA among humans. Particularly next generation sequencing (NGS) has proved 
to be a very useful, because it can provide additional information on antibiotic resistance and virulence 
factors, such as plasmids and bacteriophages, where other tools cannot. I believe that within five years 
typing of MRSA using methods such as spa-typing and MLVA will be completely replaced by NGS in most 
laboratories that perform molecular typing of MRSA. Novel applications, such as whole genome MLST 
and single nucleotide polymorphism typing, can be used on the NGS data (Chapter 7, 8). This results in 
very accurate typing data that is unambiguous, portable and has extremely high discriminatory power. 
However, I think that performing NGS for surveillance purposes is still a couple of years away. First, if 
typing is performed to support infection prevention to identify transmission in healthcare centers, data 
should be accessible and analyzed within one or two days and currently, this cannot be achieved by 
NGS. Second, characterizing large numbers of MRSA isolates by NGS will be costly and one can argue 
whether NGS of all isolates is required. Many laboratories, especially in developing countries, will need 
to rely on current molecular typing techniques for years to come. For those laboratories, we have 
shown that a single molecular typing technique will suffice to characterize MRSA (Chapter 2) and that 
an optimized PFGE using Cfr9I can be used to differentiate between LA-MRSA isolates (Chapter 3). 
Whole genome mapping also proved to be very useful for characterizing LA-MRSA (Chapter 5, 6), 
but I believe this method has come to the end of its lifespan as a typing technique. Despite the high 
discriminatory power of WGM for LA-MRSA, the method has a maximum daily capacity of 12 isolates, 
which might not be sufficient in for example outbreak situations. In addition, the costs for generating a 
single whole genome map exceeds the current costs of creating a whole genome sequence of an isolate 
and the method is not widely used making it difficult to compare data with other laboratories. However, 
there might still be a niche for WGM as it can help finish the assembly whole genome sequences by 
comparing in silico maps of the sequence with the real whole genome map obtained from the isolate. 
This may prove particularly useful for large repetitive DNA regions. 
We observed a decrease in the number of submitted LA-MRSA in the Netherlands since 2009 (Chapter 
7). It is difficult to predict whether this will be a temporary decline or that the drop in the proportion 
of LA-MRSA will continue. However, I think that the observed emergence of the subclade MT569/
t034 indicates that LA-MRSA is still adapting and this process might in the future not be restricted 
114
to this variant alone. In the national MRSA surveillance data, an increase in the number of other LA-
MRSA types concurrent with the increase of MT569/t034 is becoming apparent, but the numbers and 
proportion of the types involved are still very low. I believe this continuing process could have important 
implications for management strategies used in the control of MRSA in healthcare settings in the 
future. Nowadays, the interpretation of the Dutch search & destroy policy in some healthcare facilities 
depends on which MRSA variant is present among persons, rather than regarding every MRSA clade as 
equally pathogenic. Possibly, future adaptations in for instance virulence of LA-MRSA could therefore 
be unnoticed for prolonged periods if different strategies are maintained. Therefore, I would plea for a 
careful monitoring of the different LA-MRSA MC398 types through the national MRSA surveillance and 
that the implementation of the search & destroy policy should remain uniform, regardless the MRSA 
variant involved. I believe that, until proven otherwise, LA-MRSA should be considered as pathogenic 
as most non-LA-MRSA and should be treated as such.
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Staphylococcus aureus has been regarded as a human pathogen since its first detection at the end of 
the 19th century. With the discovery of antibiotics in the 1920s, infections with S. aureus and other 
pathogens seemed to belong to the past. However, S. aureus quickly adapted and became resistant to 
a variety of these drugs. The first appearance of methicillin resistant S. aureus (MRSA) was described in 
1961 and this variant was resistant to all antibiotics in the beta-lactam class. In the first 20 years after 
its emergence, the number of MRSA infections remained relatively low although several outbreaks 
were reported worldwide. In the 1980s, the magnitude of the MRSA problem became apparent with 
the rapid rise in the prevalence of MRSA in many hospitals, replacing methicillin-sensitive S. aureus. 
To contain the spread of MRSA, surveillance systems and restrictions on the use of antibiotics were 
implemented. However, the MRSA control strategies were quickly challenged when MRSA was found 
in people without known risk factors and who had not been previously hospitalized. This MRSA variant, 
designated as community-acquired MRSA (CA-MRSA), first appeared in the USA, but was reported 
globally within a few years. Shortly after its emergence, the presence and transmission of CA-MRSA 
was described in hospitals. In addition, molecular characteristics previously attributed to CA-MRSA, 
such as a smaller staphylococcal chromosomal cassette mec (SCCmec), were reported in MRSA isolates 
that had a clear hospital association, suggesting that the term CA-MRSA does no longer apply.
Even though MRSA infections in cows had been described in 1972, MRSA acquisition in animals was 
generally considered the result of human-to-animal transmission. In 2005, the presence of MRSA 
in pigs and pig farmers was reported in France and the Netherlands. In these studies, molecular 
characterization based on multi-locus sequence typing showed that all isolates were designated as 
clonal complex (CC)398. A follow up study in the Netherlands reported a MRSA CC398 prevalence of 
39% in slaughterhouses. Since these initial reports, MRSA CC398 has been found in other European 
countries, as well as in North America and Asia. In addition, carriage was not restricted to pigs because 
this MRSA clade has also been found in other livestock animals, such as poultry and veal calves, leading 
to the designation livestock-associated MRSA (LA-MRSA).
Concurrent with the high prevalence among livestock, the number of LA-MRSA isolated from humans 
and submitted for typing to the Dutch MRSA surveillance rapidly increased. In 2009, 42% of all isolates 
were LA-MRSA. 
Molecular typing of LA-MRSA has been a challenge. The gold standard technique when LA-MRSA 
emerged was pulsed field gel electrophorese (PFGE). However, PFGE did not work for LA-MRSA because 
of a methylation of the recognition site of the restriction enzyme SmaI. Furthermore, two other typing 
techniques, staphylococcal protein A (spa-) typing and multiple locus variable number of tandem 
repeat analysis (MLVA), did not differentiate LA-MRSA and hampered studies on transmission routes 
and origin of this MRSA clade.
In the studies reported in this thesis, molecular typing tools were developed and used to assess the 
capability of LA-MRSA to transmit, persist and cause disease in humans. In addition, possible temporal 
changes in the characteristics of the most predominant MRSA clade in the Netherlands were studied.
Since 2008, two techniques MLVA and spa-typing have been used for typing isolates in the Dutch MRSA 
surveillance. Whether both techniques are required for the MRSA surveillance was assessed in chapter 
2. The typing results of MLVA and spa-typing were evaluated and compared for >20,000 LA-MRSA 
and non-LA-MRSA isolates received for the national MRSA surveillance in the period 2008–2013. The 
number of MLVA-types (MTs) was twice as high as the number of spa-types for non-LA-MRSA isolates. 
Furthermore, the discriminatory power of MLVA was higher than spa-diversity. Among the top 70% of 
the isolates, 37 spa-types and 139 MTs were found. However, for LA-MRSA isolates, the discriminatory 
power for both methods was comparably low and the top three MTs and spa-types for LA-MRSA 
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comprised more than 80% of all LA-MRSA isolates. This study shows that a single molecular typing 
technique can suffice for characterizing non-LA-MRSA isolates, but that for LA-MRSA high-resolution 
typing tools are required to differentiate isolates belonging to this MRSA clade.
A modified and optimized PFGE protocol using Cfr9I, a neoschizomer of SmaI, showed an excellent 
reproducibility and provided highly informative banding patterns of previously non-typeable LA-MRSA 
isolates (Chapter 3). PFGE results showed more diversity than did spa-typing and could differentiate 
within and between LA-MRSA of the two dominant spa -types, t011 and t108. The modified PFGE 
confirmed LA-MRSA transmission in families and in a residential care facility in the Netherlands. The 
modified PFGE was applied in a presumed LA-MRSA outbreak in a Dutch nursing home (see Chapter 
4). In total, seven residents and four healthcare workers (HCWs) carried LA-MRSA isolates with 
indistinguishable PFGE profiles, showing that human-to-human transmission of LA-MRSA had occurred 
in a community setting. Moreover, PFGE revealed that two additional HCWs carried other LA-MRSA 
strains, not associated with the outbreak.
 
Although PFGE using Cfr9I proved to be discriminatory for LA-MRSA, the method is laborious and 
the data obtained are not exchangeable. In 2007, the molecular technique whole genome mapping 
(WGM) was developed. The capability of WGM to differentiate LA-MRSA isolates has been assessed 
and validated (Chapter 5). WGM has shown to produce highly reproducible results and to have a higher 
discriminatory power for epidemiologically unrelated LA-MRSA isolates than other techniques, such as 
spa-typing, MLVA and PFGE using Cfr9I. WGM was also used to confirm a previously reported LA-MRSA 
outbreak and to show that multiple LA-MRSA strains were transmitted between veterinarians and their 
household members. In contrast to PFGE, WGM provides a comparison with other whole genome 
maps within 2 days of receipt of bacterial cultures, making it more suitable for investigation of LA-MRSA 
transmission events and outbreaks than PFGE. The potential of WGM in transmission and persistence 
of LA-MRSA in humans is discussed in chapter 6. WGM was performed on LA-MRSA isolates from a 
2-year prospective longitudinal cohort of livestock veterinarians and their household members, who 
were regularly sampled for the presence of S. aureus. The isolates showed a considerable degree of 
genotypic variation, which corroborates our previous findings that LA-MRSA is genetically more diverse 
than previously assumed and this genetic variation can be used to characterize LA-MRSA strains. Maps 
of multiple isolates from the same veterinarian obtained over time showed little variation between 
the maps, indicating LA-MRSA persistence or re-acquisition of the same LA-MRSA strain. The observed 
persistence was shown to last up to 14 months in some veterinarians, whereas indistinguishable whole 
genome maps were found in household members over an 8-month period. LA-MRSA transmission 
between a livestock veterinarian and a household member was found in 15 of the 16 households 
investigated. In most households, a single LA-MRSA strain was transmitted, but in one household 
transmission likely occurred with two LA-MRSA strains.
The ultimate typing technique to study LA-MRSA and many other micro-organisms, is next-generation 
sequencing (NGS). This technique results in unambiguous typing data with an extremely high 
discriminatory power. In addition, NGS enables the study of genes involved in virulence, pathogenesis 
and antibiotic resistance. NGS was applied to a subset of 118 LA-MRSA isolates as a part of a larger 
study on assessing possible temporal changes among LA-MRSA submitted in the period 2003 to 2014 
(see Chapter 7). The study showed that after the initially rapid increase, the proportion of submitted 
LA-MRSA isolates peaked in 2009 with a prevalence of 42%. Since 2009, the proportion of LA-MRSA has 
been decreasing and was 30% in 2014. Of the LA-MRSA isolates, more than 80% were MT398/t011, 
MT572/t108 or MT569/t034. NGS of the three predominant LA-MRSA types showed that MT569/t034 
isolates were genetically more diverse than MT398/t011 and MT572/t108 isolates. 
Concurrent with the decrease in LA-MRSA, the number of people who reported livestock-contact 
decreased and this was most prominent for people carrying MT569/t034 LA-MRSA. However, the 







2014. Most of these isolates were obtained from patients older than 50 years of age who reported no 
contact with livestock. These results revealed an emergence of a LA-MRSA subclade independent of 
livestock exposure and showed an ongoing change in characteristics of Dutch LA-MRSA.
NGS was also performed on more than 200 LA-MRSA isolates obtained from humans submitted to the 
Dutch national MRSA surveillance to assess the capability of LA-MRSA to transmit between humans in 
Dutch healthcare settings (Chapter 8). In total, 32 presumed putative nosocomial transmission events 
were studied. SNP analysis showed that the isolates of the index patient and the contact(s) clustered 
closely together in most cases. In three presumed events, the isolates did not cluster together indicating 
that transmission was unlikely. In this study, NGS data were also used to assess of the SCCmec-type 
and the plasmid composition of the isolates. The composition of the SCCmec region corroborated 
the findings based on SNP analysis. However, plasmid identification did not support our SNP analysis 
since different plasmids were present in several cases where SNP and SCCmec analysis suggested that 
transmission was likely. This study showed that nosocomial transmission occurs in Dutch healthcare 
settings where transmission was identified based on SNP analysis combined with epidemiological data 
and in the context of epidemiologically related and unrelated isolates. Analysis of the SCCmec region 
provided limited, albeit useful information to corroborate conclusions on transmissions, but plasmid 
identification did not.
   
To further investigate the changing characteristics and the spread of LA-MRSA the proportion of LA-
MRSA in MRSA positive individuals without contact with pigs/veal calves or other known risk factors, 
MRSA of unknown origin (MUO) was identified (Chapter 9). The occurrence of LA-MRSA was determined 
in 17 hospitals over a two-year period. In total, 56 of the 271 individuals investigated were found to 
carry MC0398, representing LA-MRSA.  In hospitals in areas with high pig-densities, the proportion of 
LA-MRSA among the MUOs was higher than in areas with low pig densities. Transmission is probably 
human-to-human or exposure to livestock without knowledge by the participants. The results showed 
that LA-MRSA was present in 21% of individuals carrying MUO.
Main conclusions and findings of the research in this thesis are:
• MLVA alone can suffice for typing non-LA-MRSA isolates, but to differentiate LA-MRSA, 
typing techniques with a high discriminatory power are required. 
• LA-MRSA are genotypically more diverse than previously assumed if isolates are 
characterized with high-resolution typing techniques, such as PFGE, whole genome 
mapping and next generation sequencing.
• The three predominant LA-MRSA MLVA/spa-types form three LA-MRSA subclades, where 
MT569/t034 isolates are genetically more diverse than MT398/t011 and MT572/t108 
isolates.
• Human-to-human transmission of LA-MRSA occurs in Dutch healthcare facilities and 
between livestock veterinarians and their household members.
• Persistence of LA-MRSA can last up to 14 months in livestock veterinarians and up to 8 
months in their household members.
• Even though the number of LA-MRSA isolates in the Netherlands is decreasing in recent 
years, the number of MT569/t034 isolates is increasing and most of these isolates originate 
from people who report not having livestock contact.
• The number of infection related LA-MRSA isolates doubled from 2009 to 2014. Most of 












Sinds de eerste ontdekking aan het einde van de 19e eeuw wordt Staphylococcus aureus beschouwd als 
een micro-organisme dat pathogeen is voor de mens. Met de ontdekking van de antibiotica in de jaren 
20 van de 20e eeuw leken infecties met S. aureus en andere pathogenen tot het verleden te behoren. 
Echter, S. aureus was in staat zich snel aan te passen en werd resistent tegen een groot aantal van 
deze middelen. Het voorkomen van een methicilline resistente S. aureus (MRSA) werd voor het eerst 
beschreven in 1961 en deze variant was ongevoelig voor alle antibiotica uit de beta-lactam klasse. In 
de eerste twintig jaar na de opkomst bleef het aantal infecties veroorzaakt door MRSA relatief laag, al 
werden meerdere uitbraken gerapporteerd van over de gehele wereld. In de jaren 80 van de vorige 
eeuw werd de volledige omvang van het MRSA probleem duidelijk toen een snelle stijging van de MRSA 
prevalentie in vele ziekenhuizen plaatsvond.
Om de verspreiding van MRSA tegen te gaan, werden surveillancesystemen en beperkingen aangaande 
antibioticagebruik geïmplementeerd. Echter, de strategieën om verspreiding van MRSA onder controle 
te houden kwamen spoedig onder druk te staan toen MRSA werd gevonden in mensen zonder bekende 
risicofactoren en in mensen die niet eerder in een ziekenhuis waren opgenomen. Deze MRSA variant, 
bestempeld als community-acquired MRSA (CA-MRSA), verscheen voor het eerst in de Verenigde 
Staten van Amerika, maar werd binnen enkele jaren wereldwijd gerapporteerd. Spoedig na de opkomst 
werd de aanwezigheid en transmissie van CA-MRSA ook in ziekenhuizen gerapporteerd. Daarnaast 
werden moleculaire karakteristieken die eerder werden toegeschreven aan CA-MRSA, zoals een 
kleiner staphylococcal chromosomal cassette mec (SCCmec), gerapporteerd in MRSA isolaten met een 
duidelijke ziekenhuisassociatie. Dit suggereert dat de term CA-MRSA niet langer van toepassing is.
Ondanks dat MRSA-infecties in koeien reeds in 1972 waren beschreven, werd de acquisitie van MRSA in 
dieren over het algemeen toegeschreven aan mens-tot-dier transmissie. In 2005 werd MRSA gevonden 
bij varkens en varkensboeren in Frankrijk en Nederland. Moleculaire karakterisering, gebaseerd op 
multi-locus sequence typing (MLST), toonde aan dat alle isolaten uit deze studies tot het clonal complex 
(CC)398 behoorden. Een vervolgstudie in Nederland rapporteerde een MRSA CC398 prevalentie 
van 39% in varkens in slachthuizen. Sinds de eerste publicaties is MRSA CC398 ook aangetroffen in 
andere Europese landen, evenals in Noord-Amerika en Azië. Verder bleek dragerschap niet beperkt 
tot varkens, maar werd deze MRSA-clade ook gevonden bij andere vee-gerelateerde dieren, zoals 
pluimvee en kalveren. Dit leidde tot de term livestock-associated MRSA (LA-MRSA). Gelijktijdig met de 
hoge prevalentie in dieren, steeg het aantal LA-MRSA isolaten afkomstig uit mensen en ingestuurd naar 
de Nederlandse MRSA surveillance voor typering razendsnel en in 2009 behoorde 42% van alle isolaten 
tot de LA-MRSA.
Moleculair typeren van LA-MRSA is een uitdaging gebleken. Toen LA-MRSA verscheen was pulsed-
field gel elektroforese (PFGE) de gouden standaard voor typeren. Echter, PFGE werkte niet voor LA-
MRSA door een methylering van het herkenningspunt van het restrictie-enzym SmaI. Twee andere 
typeertechnieken, staphylococcal protein A (spa-) typering en multiple-locus variable number of 
tandem repeat analyse (MLVA), konden LA-MRSA niet verder onderscheiden. Daardoor werd het 
onderzoek naar de transmissieroutes en het ontstaan van deze MRSA-clade belemmerd.
Voor de studies beschreven in dit proefschrift zijn moleculaire typeertechnieken ontwikkeld en gebruikt 
om te bepalen wat het vermogen van LA-MRSA is om zich te verspreiden, te handhaven in de gastheer 
en ziekte te veroorzaken bij mensen. Daarnaast zijn mogelijke veranderingen in de karakteristieken van 
het meest dominante MRSA-clade sinds de eerste ontdekking in Nederland onderzocht.
Sinds 2008 zijn twee technieken, MLVA en spa-typering, gebruikt voor het typeren van isolaten voor de 
Nederlandse MRSA surveillance. Dat het gebruik van beide technieken niet noodzakelijk is voor de MRSA 
surveillance is bepaald in hoofdstuk 2. De typeerresultaten van de MLVA en spa-typering van meer dan 
124
20.000 LA-MRSA en non-LA-MRSA isolaten, ontvangen voor de nationale MRSA surveillance tijdens 
de periode 2008 tot 2013, zijn geëvalueerd en vergeleken. Het aantal MLVA-types (MTs) bleek twee 
keer zo hoog als het aantal spa-types voor niet-LA-MRSA isolaten. Daarnaast was het onderscheidend 
vermogen van de MLVA hoger als die van de spa-typering. Binnen de top 70% van de isolaten werden 
37 spa-types en 139 MTs gevonden. Echter, het onderscheidende vermogen voor LA-MRSA isolaten was 
voor beide methoden vergelijkbaar laag en de top drie MTs en spa-types bevatte meer dan 80% van alle 
LA-MRSA isolaten. Deze studie laat zien dat een enkele moleculaire typeermethode volstaat om non-
LA-MRSA isolaten te typeren, maar dat voor LA-MRSA hoog-resolutie typeertechnieken noodzakelijk 
zijn om isolaten behorend tot deze MRSA-clade van elkaar te kunnen onderscheiden.
Een aangepast en geoptimaliseerd PFGE protocol dat gebruikt maakt van Cfr9I, een neoschizomer van 
SmaI, vertoonde een uitstekende reproduceerbaarheid en leverde zeer informatieve banden patronen 
op van voorheen niet-typeerbare LA-MRSA isolaten (Hoofdstuk 3). De PFGE resultaten lieten meer 
diversiteit zien dan de spa-typering en kon onderscheid maken binnen en tussen de LA-MRSA behorend 
tot de twee dominante spa-types t011 en t108. De aangepaste PFGE bevestigde transmissie van LA-
MRSA binnen families en binnen een verpleegtehuis in Nederland. De gemodificeerde PFGE werd ook 
toegepast in een veronderstelde LA-MRSA uitbraak in een Nederlands verpleegtehuis (zie Hoofdstuk 
4). In totaal droegen zeven bewoners en vier medewerkers LA-MRSA isolaten met niet van elkaar te 
onderscheiden PFGE profielen, waarmee werd aangetoond dat mens-tot-mens transmissie van LA-
MRSA had plaatsgevonden in de omgeving. Bovendien toonde PFGE aan dat twee overige medewerkers 
andere LA-MRSA isolaten droegen, die niet gerelateerd aan de uitbraak waren.
Ondanks dat de PFGE met Cfr9I discriminerend bleek te zijn voor LA-MRSA, blijft de methode tijdrovend 
en kan de verkregen data niet worden uitgewisseld. In 2007 werd een moleculaire techniek ontwikkeld 
genaamd whole genome mapping (WGM). Het vermogen van WGM om onderscheid te kunnen maken 
tussen LA-MRSA isolaten is vervolgens bepaald en gevalideerd (Hoofdstuk 5). WGM liet zien dat het 
zeer reproduceerbare resultaten opleverde en toonde aan dat het een hoger discriminerend vermogen 
had voor epidemiologisch niet-gerelateerde LA-MRSA isolaten dan andere technieken, zoals spa-
typering, MLVA en PFGE met Cfr9I. WGM is ook toegepast om een voorheen gerapporteerde LA-MRSA 
uitbraak te bevestigen en om te laten zien dat meerdere LA-MRSA stammen werden overgedragen 
tussen veeartsen en hun huisgenoten. In tegenstelling tot PFGE kan met WGM een vergelijking met 
andere whole genome maps plaatsvinden binnen twee dagen na ontvangst van de bacterieculturen. 
Dit maakt WGM meer geschikt voor het onderzoeken van LA-MRSA transmissies en uitbraken dan 
PFGE. 
De kracht van WGM om transmissies en persistentie van LA-MRSA bij mensen aan te tonen, wordt 
besproken in hoofdstuk 6. WGM werd hier toegepast op LA-MRSA isolaten afkomstig van een twee 
jarig prospectief longitudinaal cohort van veeartsen en hun huisgenoten, die regelmatig getest werden 
op de aanwezigheid van S. aureus. De isolaten vertoonden een aanzienlijke genotypische variatie, 
daarmee onze eerdere bevindingen bevestigend dat LA-MRSA genetische meer divers is dan eerder 
werd aangenomen en dat deze genetische diversiteit gebruikt kan worden om LA-MRSA isolaten te 
karakteriseren. Whole genome maps van meerdere isolaten afkomstig van dezelfde veearts verkregen 
gedurende een langere periode vertoonde weinig variatie tussen de maps, wat kan duiden op persistentie 
of her-acquisitie van dezelfde LA-MRSA stam. De waargenomen persistentie duurde tot 14 maanden 
bij sommige veeartsen, terwijl niet van elkaar te onderscheiden whole genome maps gevonden bij 
isolaten afkomstig van de huisgenoten over een periode van acht maanden. Transmissie van LA-MRSA 
tussen een veearts en een huisgenoot vond plaats bij 15 van de 16 onderzochte huishoudens van 
de veeartsen. In de meeste huishoudens werd een enkele LA-MRSA stam overgedragen, maar in een 
huishouden vond transmissie waarschijnlijk plaats met twee LA-MRSA stammen.








generation sequencing (NGS). Deze techniek resulteert in ondubbelzinnige typeerdata en heeft een 
extreem hoog discriminerend vermogen. Daarbij maakt NGS het mogelijk om de genen betrokken bij 
virulentie, pathogenese en antibiotica-resistentie te bestuderen. NGS werd toegepast op een subset 
van 118 LA-MRSA isolaten als onderdeel van een grotere studie naar het bepalen van mogelijke 
tijdelijke veranderingen van LA-MRSA ingestuurd van de periode 2003 tot en met 2014 (zie Hoofdstuk 
7). De studie toonde aan dat na een initiële sterke stijging, de proportie van LA-MRSA van ingestuurde 
LA-MRSA isolaten piekte in 2009 met een prevalentie van 42%. Sinds 2009 daalt de proportie LA-MRSA 
en deze was 30% in 2014. Van de ingestuurde LA-MRSA isolaten behoorde ruim 80% tot MT398/t011, 
MT572/t108 of MT569/t034. NGS van deze drie dominante LA-MRSA types toonde aan dat MT569/
t034 isolaten genetisch meer divers waren dan MT398/t011 en MT572/t108 isolaten.
Gelijktijdig met de daling van de LA-MRSA, daalde ook het aantal mensen dat rapporteerde dat zij 
contact hadden met vee en dit was het meest prominent voor mensen die drager waren van MT569/
t034 LA-MRSA. Echter, de proportie van LA-MRSA geïsoleerd uit infectie-gerelateerde materialen 
verdubbelde van 6.3% in 2009 tot 13% in 2014. De meeste van deze isolaten waren afkomstig 
van patiënten ouder dan 50 jaar die aangaven geen contact te hebben met vee. Deze resultaten 
onthulden een opkomst van een LA-MRSA subclade onafhankelijk van blootstelling aan vee en liet 
een voortdurende verandering in de karakteristieken zien van LA-MRSA afkomstig uit Nederland. 
NGS werd ook uitgevoerd op meer dan 200 LA-MRSA isolaten afkomstig van mensen en ingestuurd 
in het kader van de Nederlandse MRSA surveillance, om te bepalen of LA-MRSA in staat is om te 
verspreiden tussen mensen in Nederlandse gezondheidsinstellingen (Hoofdstuk 8). In totaal werden 32 
veronderstelde nosocomiale transmissies onderzocht. Single nucleotide polymorphism (SNP) analyse 
toonde aan dat de isolaten van de index patiënt en die van diens contact(en) in de meeste gevallen 
sterk aan elkaar verwant waren. In drie veronderstelde transmissies clusterden de isolaten niet bij 
elkaar, wat impliceert dat transmissie waarschijnlijk niet heeft plaatsgevonden. In deze studie werd de 
NGS data ook gebruikt om het SCCmec type en de plasmide samenstelling van de isolaten te bepalen. 
De samenstelling van de SCCmec regio bevestigde de bevindingen op basis van de SNP analyse. Echter, 
plasmide identificatie ondersteunde de SNP analyses niet, aangezien verschillende plasmiden werden 
gevonden bij meerdere gevallen waar transmissie op basis van SNP en SCCmec analyse waarschijnlijk 
was. Deze studie toonde aan dat nosocomiale transmissie van LA-MRSA plaatsvindt in Nederlandse 
gezondheidsinstellingen waarbij transmissie werd geïdentificeerd op basis van SNP analyses in 
combinatie met epidemiologische data en in de context van epidemiologisch gerelateerde en niet-
gerelateerde isolaten. Analyse van de SCCmec regio leverde gelimiteerde, maar desondanks bruikbare 
informatie op om de conclusies aangaande transmissies te bevestigen, maar plasmide identificatie 
deed dit niet.
Om de veranderende karakteristieken en verspreiding van LA-MRSA verder te onderzoeken werd de 
proportie LA-MRSA in MRSA positieve individuen zonder contact met varkens of kalveren en zonder 
andere bekende risicofactoren, de MRSA of unknown origin (MUO) geïdentificeerd (Hoofdstuk 9). Het 
voorkomen van La-MRSA was bepaald in 17 ziekenhuizen gedurende twee jaar. In totaal bleken 56 van 
de 271 onderzochte individuen drager te zijn van MC0398, het complex dat LA-MRSA vertegenwoordigt. 
In ziekenhuizen die in gebieden liggen met een hoge varkensdichtheid bleek de proportie van LA-
MRSA hoger te zijn dan in gebieden met een lage varkensdichtheid. Transmission is hier waarschijnlijk 
veroorzaakt door mens-tot-mens transmissie of door contact met vee zonder dat de deelnemer dit 
wist. De resultaten lieten zien dat LA-MRSA werd gevonden in 21% van de individuen die drager waren 
van een MUO.
De belangrijkste conclusies en bevindingen van het onderzoek in deze thesis zijn:
• Het uitvoeren van alleen de MLVA volstaat voor het typeren van niet-LA-MRSA isolaten, maar 
om LA-MRSA isolaten van elkaar te kunnen onderscheiden zijn typeertechnieken met een hoger 
discriminerend vermogen noodzakelijk.
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• Wanneer LA-MRSA isolaten worden gekarakteriseerd met hoog-resolutie typeertechnieken, zoals 
PFGE, whole genome mapping en next-generation sequencing blijken LA-MRSA genotypisch meer 
divers dat eerder werd aangenomen.
• De drie dominante LA-MRSA MLVA/spa-types vormen drie LA-MRSA subclades, waarbij MT569/
t034 isolaten genetisch meer divers zijn dan MT398/t011 en MT572/t108 isolaten.
• Mens-tot-mens transmissie van LA-MRSA vindt plaats in Nederlandse gezondheidsinstellingen en 
tussen veeartsen en hun huisgenoten.
• Persistentie van LA-MRSA kan tot 14 maanden duren in veeartsen en tot 8 maanden in hun 
huisgenoten.
• Ondanks dat het aantal ingestuurde LA-MRSA isolaten in de laatste jaren daalt in Nederland, stijgt 
het aantal MT569/t034 isolaten en de meeste van deze isolaten zijn afkomstig van personen die 
aangeven geen contact te hebben met vee.
• Het aantal infectie-gerelateerde LA-MRSA isolaten verdubbelde van 2009 tot 2014. De meeste van 
deze isolaten werden verkregen van patiënten ouder dan 50 jaar die rapporteerden geen contact 


























Toen ik een kleine 7 jaar geleden begon aan mijn promotieonderzoek kon ik niet inschatten en overzien 
hoeveel werk, tijd en energie mij dit zou kosten. Nu mijn proefschrift afgerond is, kijk ik met trots terug 
op deze periode. Naast de wetenschappelijke kennis heeft mijn promotieonderzoek mij ook in staat 
gesteld om met vele mensen te mogen samenwerken. Hieronder wil ik graag de vele mensen die steun 
en toeverlaat zijn geweest in deze periode bedanken.
Op de eerste plaats staat natuurlijk mijn co-promotor Leo Schouls. Beste Leo, toen ik na mijn eerste 
artikel bij jou terecht kwam, nadat door omstandigheden de andere ‘co-promotoren’ moesten afhaken 
in de begeleiding, moest ik (of wij) een beetje aan elkaar wennen ;-). Jouw manier van werken was 
totaal anders dan ik gewend was, maar het heeft mij absoluut geen windeieren gelegd. Jouw toewijding, 
kennis en inzicht hebben van elk hoofdstuk in dit boekje een volwaardig artikel gemaakt. Daarnaast 
waren je tips,  begeleiding en uitspraken ook goud waard. Ik denk hierbij ‘hou de focus’, ‘alles wat 
tussen haakjes staat kan je net zo goed weglaten’ en natuurlijk ‘het is altijd beter om te schrappen in 
een manuscript dan er iets bij te moeten verzinnen’, die ik ook tot stelling heb gepromoveerd. Kortom 
Leo, ik meen het oprecht dat dit boekje zonder jou niet tot stand was gekomen.
Ten tweede wil mijn 1e promotor Hajo Grundmann bedanken. Hajo, toen ik eind 2009 een andere 
baan had gevonden omdat ik een andere uitdaging zocht kwam jij als toemalig hoofd bacteriologie 
bij het RIVM bij me met de vraag ‘what can I do to make you change your mind?’. Hierop antwoordde 
ik dat ik graag een promotietraject zou willen starten. Binnen een week had jij dit via je positie op 
de universiteit Groningen geregeld en ben ik begonnen aan dit avontuur. We hebben elkaar in de 
promotiejaren soms een tijdje niet gesproken, maar het contact is altijd hartelijk gebleven en ik ben je 
eeuwig dankbaar voor de kans die je mij hebt gegeven.
Als derde wil ik mijn 2e promotor Jan Kluytmans bedanken. Beste Jan, gedurende mijn hele 
promotietraject ben je nauw betrokken geweest bij vrijwel alle onderzoeken in dit proefschrift. 
Daarnaast heb jij mij en het RIVM ook betrokken bij vele grote projecten, zoals de VET-, POM- en 
CAM-studie waarvan een aantal ook hier opgenomen zijn. Je toewijding bij mijn promotie zal ik nooit 
vergeten en ik ben bijzonder trots dat ik je mocht ‘toevoegen’ als 2e promotor. Ik hoop dat we in de 
toekomst nog veelvuldig samen mogen werken.
Ik wil ook graag de leden van mijn lees- en promotiecommissie bedanken voor het beoordelen van mijn 
proefschrift en het zitting nemen in de oppositie.
Veel van de artikelen in mijn proefschrift had ik nooit kunnen schrijven zonder samenwerkingen met 
mensen van buiten het RIVM. Hier wil ik er graag enkele bedanken. Ten eerste Erwin Verkade. Beste 
Erwin, onze samenwerking begon met een tripje naar Washington voor een cursus bij OpGen voor 
de whole genome mapping technologie. Daarna is de VET-studie een verbindende schakel geweest 
tussen ons beider promotietrajecten. Dank voor je enthousiasme, hulp en het meedoen met het RIVM 
tourspel ;-).
130
Ten tweede wil ik Miranda van Rijen bedanken. Miranda, gedurende de jaren hebben we veelvuldig 
contact gehad over het onderwerp van ons beider promotieonderzoek, de Staphylococcen. Dit heeft 
geresulteerd in enkele mooie publicaties, waarvan jouw onderzoek naar de LA-MRSA bij patienten 
zonder diercontact ook in dit boekje is opgenomen. Dank voor de fijne samenwerking!
Als derde wil ik Ronald Burggrave bedanken. Ron, we maakten met elkaar kennis toen jij als penvoerder 
optrad bij het LA-Screen project, waar een gedeelte van mijn proefschrift op is gebaseerd. Daarna 
hebben we veelvuldig contact gehad in je rol als medewerker bij OpGen. Je enthousiasme zorgde ervoor 
dat het project ondanks sommige moeilijkheden toch door bleef gaan. Ook naast het werk hebben we 
veel contact gehad, wat ik als zeer prettig heb ervaren. Ik hoop dat we dit in toekomst blijven doen.
Dan hebben we natuurlijk de collega’s binnen het RIVM die van mijn promotieonderzoek een succes 
hebben gemaakt. Graag wil ik beginnen met het bedanken van Max Heck. Beste Max, als afdelingshoofd 
van BSR ben je als manager nauw betrokken geweest bij mijn traject en heb je mij alle ruimte gegeven 
om mijn onderzoek tot een goed einde te brengen. Daarnaast hebben we vele jaren samen op een 
kamer gezeten. Wat een fantastische periode was dat. Ik herinner mij vooral nog onze voorliefde voor 
de niet-alledaagse muziek. Ik denk dan met een grote glimlach terug aan de Deutsche donnerstag 
(Ich bin wie du ahahaa), de Hollandse 100 (wie kent Joop de Knegt met ‘Ik sta op wacht’ nu niet!) en 
natuurlijk de Freitagmittag, Tanzmittag (Brother Louie van Modern Talking!). Verder hebben we ook 
veel dezelfde interesses zoals voetbal (met name West Ham united en Schalke’ 04), wielrennen en 
eigenlijk alle andere sporten :-). Tenslotte heb ik erg genoten van onze uitstapjes tijdens de verschillende 
buitenlandse congressen over de jaren. Hoogtepunten waren toch wel de wedstrijd van West Ham 
United op de Bobby Moore upper inclusief scheldende Engelsman zonder tanden en het bezoek aan 
de Olympia Gelande in Berlin, waar ik zonodig de toren moest beklimmen en daardoor 4 km om moest 
lopen. Kortom Max, bedankt voor alles!
Mijn onderzoek was nergens geweest zonder de inzet van de Staphylococcen Boys! Gerlinde, 
als vrouwelijk member van de Boys heb je letterlijk vele duizenden isolaten weggewerkt voor mijn 
onderzoek. Het opzetten en regelen van de pipeteerfabrieken zoals we het noemden waren echt aan 
jou besteed. Dat waren echt mooie en bovenal gezellig dagen. Daarnaast ben je een fantastisch lief 
mens, die zeer positief in het leven staat. Het verlies wat je hebt meegemaakt was een verschrikkelijke 
periode voor je, maar ook daar ben je sterker uitgekomen met als recentelijk hoogtepunt de geboorte 
van je zoon. Ondertussen werk je aan de pneumococcen, maar ik hoop dat we elkaar veel blijven zien 
op de gang! Martijn, als mannelijk member van de Boys geldt het bovenstaande ook voor jou. Wat heb 
ook jij keihard gewerkt om de isolaten voor de verschillende studies weg te werken. Jij maakte deze 
dagen nog leuker door het inzetten van de D-I-S-C-O. Man, wat hebben we wat uurtjes Klubbheads 
voorbij horen komen en wat gingen die dagen lekker snel. Op dit moment heb je jezelf helemaal 
omgeturnd naar bioinformaticus en zorg je voor het reilen en zeilen van de databases. Een fantastische 
prestatie en ik hoop nog lang van je kennis en kunde gebruik te mogen maken.
Vervolgens zou ik graag Fabian willen danken. Fabs, als student bij mij begonnen om de whole genome 
















team. Je inzet en hulp bij de vele tussendoor en opdrachten hebben geleid dat vele open eindjes van 
het onderzoek konden worden opgelost en daar ben ik je zeer dankbaar voor. Het was zeer fijn om aan 
iemand iets te kunnen vragen en dan snel antwoord te krijgen.
 
Dan richt ik graag nog een woord van dank aan Angela, Han, Marga en Sandra. Als leden van het AMR 
team hebben jullie de afgelopen jaren bergen werk verzet. Niet alleen voor mijn promotie, maar ook 
voor de nationale surveillance van MRSA en CPE. Sandra, Marga, ik ben jullie erg dankbaar voor jullie 
tomeloze inzet omtrent alle NGS analyses. Ik heb jullie letterlijk bestookt met vragen en jullie gaven mij 
gelukkig altijd bruikbare antwoorden. Angela, als keiharde werker kan het AMR team niet zonder je. 
Dank voor alles en ik hoop dat je een vast contract krijgt ;-). Han, als bioinformaticus heb jij ontzettend 
veel werk gestopt in het ontwikkelen van de Type-Ned en BN databases. Zonder deze gegevens had ik 
mijn onderzoek nooit kunnen uitvoeren.
Dan hebben we natuurlijk nog de rest van de afdeling BSR. Beste collega’s, jullie zijn een fantastische 
club mensen. Ik heb mij altijd gewaardeerd en op mijn gemak gevoeld binnen de afdeling en ik hoop 
dat dit nog lang zo mag blijven. 
Binnen het RIVM wil ook graag Anja Haenen, Dineke Frentz en de overige collega’s van de afdeling EPI 
bedanken voor het aanleveren van de onmisbare epidemiologische gegevens bij mijn onderzoeken. 
Een bijzonder woord van dank gaat uit naar mijn twee paranimfen Kim en Maaike. Kim, in 2003 was ik 
je student bij toen nog de afdeling BBT. Na mijn stage bij het RIVM kwam ik gelukkig niet op je beruchte 
zwarte lijst, maar liet je geen moment onbenut om te benadrukken dat je graag zou willen dat ik bij het 
RIVM kwam werken. In 2007 was het eindelijk zover en sindsdien hebben we zowel zakelijk als prive 
een hechte band. Je parate kennis is ongekend, net als je humor die soms heerlijk op of over het randje 
is. Daarnaast ben je altijd te porren voor een uitje (kerstmarkt!) of een spelletje (Amstellovich cup!). Ik 
waardeer je zeer als collega en als mens en het was een absolute no-brainer wie mijn paranimf moest 
worden. Maaike, ik denk dat een aantal mensen verbaasd waren toen ik zei dat jij mijn paranimf werd. 
Voor mij was het net als bij Kim een no-brainer. Je bent een fantastische collega en in de afgelopen 
jaren heb ik regelmatig wat promotie-ergenissen over je heen kunnen storten en was je een goed 
luisterend oor. Daarnaast ben je qua denkvermogen een super sparringspartner waarbij ik vaak ideeen 
en of tips oppikte voor onderzoek of omgang met bovengenoemde ergenissen. Verder hebben we ook 
prive goed contact, ook al breekt je zoontje ons waterornament af door 50x in 10 seconden op het aan/
uit knopje te rammen ;-).
Naast collega’s zijn er natuurlijk ook heel veel mensen die wetenschappelijk niet hebben bijgedragen 
aan dit onderzoek, maar die voor mij prive ongekend belangrijk zijn. 
Ik wil graag beginnen met Maarten & Shiela, Mike & Linda, Kjeld & Femke, Remco & Annerieke en 
Martin & Debby die al jaren als hecht blok om mij heen staan. Maarten, steun en toeverlaat, dank voor 
alle biertjes op de woensdagavonden, onze trips naar de USA en alle andere fantastische hoogtepunten. 
Met jou heb ik never a dull moment en je bent ook een fantastisch luiterend oor. Mike,  dank voor alle 
avonden Fc Twente en de biertjes daarna bij jullie thuis. Je bent er altijd en bent altijd volledig jezelf. 
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Dat waardeer ik enorm. Kjeld, ik ken je letterlijk mijn hele leven en onze vriendschap is ontzettend 
sterk. Een half woord is vaak genoeg en je hebt altijd een verfrissende kijk op dingen en hebt mij ook 
geleerd minder van andere mensen aan te trekken. Daarnaast ben je al 3 jaar ‘stagiaire’ bij het RIVM 
zodat je lekker mee kunt zaalvoetballen met ons waardoor we elkaar ook regelmatig blijven zien. Ik 
hoop dat we dit, ondanks gebrek aan conditie, nog lang vol blijven houden. Remco, man van weinig 
woorden, maar geweldig droge humor. Onze hamburgeravonden bij de Burgerbar zijn altijd super! Ik 
hoop dat er nog vele volgen! Martin, de laatste tijd wat minder contact, maar daarom niet minder 
belangrijk. Ik kijk weer uit naar ons volgende stapavondje!
Mark, we leerden elkaar kennen tijdens ons jaar BK5. Sindsdien zijn we goede vrienden en ik hoop dat 
we in de toekomst nog wat papadagen met elkaar op pad gaan.
Bjorn, Jasper, Jord en de overige mannen van Sv Houten 7. Toen ik in 2009 bij jullie kwam ballen, 
hebben jullie mij snel opgenomen in het elftal. Het voelt na al die jaren nog steeds als een warm bad, 
al zijn we voetbaltechnisch een tikkeltje achteruit gegaan. Een speciaal dankwoord aan Arno, die naast 
onverschrokken linksback ook trots sponsor is van mijn boekje. 
Tot slot komen we nog bij de meest speciale groep mensen, namelijk mijn familie.
Sebastiaan, beste neef, de afgelopen jaren hebben we regelmatig onder het genot van een Griekje 
(met 2x de Griekse dorps-salade) de voortgang van mijn onderzoek besproken. Vaak gaf je bruikbare 
tips hoe om te gaan met zaken, waarvan ik er eentje heb gepromoveerd tot stelling in mijn proefschrift. 
Hard work always pays off! Je bent voor mij een voorbeeld en ik geniet van alle tripjes en vinkjes die we 
de afgelopen jaren hebben gezet. Dank voor alles!
Kees, Sjanie als schoonouders is ook jullie aandeel in dit boekje niet te onderschatten. Jullie staan 
altijd klaar om ons gezin te helpen met allerlei zaken. Verder passen jullie twee dagen in de week op 
onze kids waardoor Karin en ik alle ruimte kregen om ons te focussen op het werk. Daarnaast zijn jullie 
fantastisch lieve mensen! Dank voor alles wat jullie voor ons gezin doen.
Joyce, Bruno en Lauren als schoonfamilie vormen jullie een belangrijk onderdeel in mijn leven, zeker 
aangezien mijn familie verder weg woont. Samen met Kees en Sjanie zorgen jullie ervoor dat ik mij 
helemaal thuis voel in het Houtense.
Lieve Lianne & Dennis en Lenn. Als zus en zwager zijn jullie onmisbaar voor mij. Jullie vormen een 
heerlijke uitvalsbasis als ik in Hengelo ben. Onze gedeelde liefde voor Amerika zorgt ervoor dat we nooit 
zonder gesprekstof zitten. Daarnaast is het BBQ-en in de zomer door Dennis verheven tot absolute 
haute cuisine en daar mag ik gelukkig vaak van meegenieten.
Lieve pa en ma. De studie is klaar! Jullie waren de basis hiervoor. Altijd hard gewerkt om te zorgen 
dat Lianne en ik niks tekort kwamen. Ons altijd vrijgelaten om zelf onze keuzes te maken in het leven. 

















Lieve Karin, wie had gedacht dat we zouden staan waar we nu staan nadat je mij had gedropt om 
8:00 uur in de morgen op station Houten na onze eerste date? Nu ruim 8 jaar later hebben we een 
fantastisch leventje opgebouwd met twee  prachtige kids. Je geeft mij alle ruimte om mijn eigen ding te 
doen en bij elke nieuwe toevoeging aan mijn 100+ hobbies weet je nog enthousiast te zijn. We weten 
voor de volle honderd procent wat we aan elkaar hebben en dat maakt ons huwelijk zo sterk. Je bent 
de liefde van mijn leven en ik hou ontzettend veel van je!
Dit dankwoord eindig ik met de twee belangrijkste persoontjes in mijn leven. Lieve Twan & Frederique 
jullie zijn mijn alles. Elk cliche over ouderschap is gewoon waar. Het is een fantastische beleving! Jullie 
te zien opgroeien is een genot en soms heerlijk chaotisch. Ik hou van jullie!
The writing an article discography
Een artikel publiceren is een langdurig proces. Hieronder een lijst met nummers die mij altijd hebben 
geholpen bij het voltooien ervan:
Ultimate songs for in the laboratory while pipeting numerous isolates for your manuscript
- Power of American natives - Dance 2 trance
- Heaven - U96
- Flying high - Captain hollywood project
Ultimate songs while preparing your manuscript
- Sundown - Gordon Lightfoot
- Wish you were here - Lee Fields & the Expressions
- L.A. Women - The Doors
- Highwayman - The Highwaymen
- Solitary man - Johnny Cash
- How long - Charles Bradley
- Sunday morning comin’ down - Kris Kristofferson
Ultimate song when you have submitted your manuscript
- Runnin’ down a dream - Tom Petty
Ultimate songs when you manuscript is rejected after ‘careful consideration’
- Break stuff - Limp Bizkit
- The sun ain’t gonna shine anymore - The Walker Brothers 
Ultimate songs while revising your reviewed manuscript
- For what it’s worth - Buffalo Springfield
- Don’t stop believin’ - Journey
- All or nothing - Small Faces
Ultimate songs when your manuscript is (finally) accepted
- Highway to Hell - AC/DC
- Who’s the king - Dog Eat Dog
- Mr. Brightside - The Killers
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